Impacts > Recent publications

Recent publications


Acebo P, Giner D, Calvo P, Blanco-Rivero A, Ortega AD,Fernández PL, Roncador G, Fernández-Malavé E, Chamorro M, Cuezva JM. Cancer abolishes the tissue-type specific differences in the phenotype of energetic metabolism. Transl Oncol. 2009 ;2:138-45.
 
Agell L, Hernández S, Nonell L, Lorenzo M, Puigdecanet E, de Muga S, Juanpere N, Bermudo R, Fernández PL, Lorente JA, Serrano S, Lloreta JA. 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer: SEC14L1 and TCEB1 Genes Are Potential Markers of Progression.Am J Pathol. 2012 ;181:1585-94. doi: 10.1016.
 
Aigner F, Pallwein L, Mitterberger M, Pinggera GM, Mikuz G, Horninger W, Frauscher F. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int. 2009 Feb;103(4):458-63.
 
Albuquerque A, Magro F, Rodrigues S, Lopes J, Lopes S, Dias JM, Carneiro F, Macedo G. Metastatic cutaneous Crohn’s disease of the face: a case report and review of the literature. Eur J Gastroenterol Hepatol 23:954-956, 2011.
 
Allen, TC; Cagle, PT; Popper, HH.: Basic concepts of molecular pathology. Arch Pathol Lab Med. 2008; 132(10): 1551-1556. [Fulltext] [PubMed] [Listed in ISI Web of Science]
 
Alves CC, Carneiro F, Hoefler H, Becker K-F: Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Frontiers in Bioscience 14: 3041-3050, 2009.
 
Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJ, Pötschger U, Ambros PF. A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res. 2011 Feb 15;17(4):792-804.
 
Amiot A, Dokmak S, Sauvanet A, Vilgrain V, Bringuier PP, Scoazec JY, Sastre X, Ruszniewski P, Bedossa P, Couvelard A. Sporadic desmoid tumor. An exceptional cause of cystic pancreatic lesion. JOP. 2008 May 8;9(3):339-45.
 
Anders M, Sarbia M, Grotzinger C, Meining A, Höfler H, Wiedenmann B, Rösch T. Expression of EpCam and villin in Barrett's esophagus and in gastric cardia. Dis Markers. 2008;24(6):287-92.
 
Anders M, Rösch T, Küster K, Becker I, Höfler H, Stein HJ, Meining A, Wiedenmann B, Sarbia M. Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia. Cancer Gene Ther. 2009 Jan 9. [Epub ahead of print]
 
Ardeleanu C, Arsene D, Hinescu M, Andrei F, Gutu D, LucaL, Popescu LM: Pancreatic expression of DOG1 – a novel GIST biomarker. Appl Imm Mol Morphol. 2009,17, 5, 413-418.
 
Arnes JB, Stefansson IM, Straume O, Baak JP, Lønning PE, Foulkes WD, Akslen LA. Vascular proliferation is a prognostic factor in breast cancer. Breast Cancer Res Treat. 2011 Sep 27. [Epub ahead of print] PubMed PMID: 21947750.
 
Arnold D, Schmoll HJ, Lang H, Knoefel WT, Ridwelski K, Trarbach T, Staib L, Kirchner T, Geissler M, Seufferlein T, Amthauer H, Riess H, Schlitt HJ, Piso P. Specific treatment situations in metastatic colorectal cancer. Onkologie. 2010;33 Suppl 4:8-18. Epub 2010 Apr 23. Review. German.
 
Asioli S, Accinelli G, Pacchioni D, Bussolati G. Diagnosis of biliary tract lesions by histological sectioning of brush bristles as alternative to cytological smearing. Am J Gastroenterol. 2008 May;103(5):1274-81. Epub 2008 Jan 2.
 
Asioli S, Odasso C, Macrì L, Palestini N, Bussolati G. Merits of the PMiT (Papillary Microtumor) Terminology in the Definition of a Subset of Incidental Papillary Microcarcinomas of the Thyroid. Int J Surg Pathol. 2008 Jul 8. [Epub ahead of print]
 
Asioli S, Eusebi V, Gaetano L, Losi L, Bussolati G. The pre-lymphatic pathway, the rooths of the lymphatic system in breast tissue: a 3D study. Virchows Arch. 2008 Oct;453(4):401-6. Epub 2008 Sep 4.
 
Asioli S, Bussolati G. Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions. Histopathology. 2009 Apr;54(5):571-9. Epub 2009 Mar 19. PubMed PMID: 19302538.
 
Asselah T, Bieche I, Sabbagh A, Bedossa P, Moreau R, Valla D, Vidaud M, Marcellin P. Gene Expression and Hepatitis C Virus Infection. Gut. 2009 Feb 3. [Epub ahead of print]
 
Asselah T, Bieche I, Laurendeau I, Martinot-Peignoux M, Paradis V, Vidaud D, Valla DC, Bedossa P, Marcellin P, Vidaud M. Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue. Hepatology. 2008 Sep;48(3):953-62.
 
Baak JP, Gudlaugsson E, Skaland I, Guo LH, Klos J, Lende TH, Søiland H, Janssen EA, Zur Hausen A. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Res Treat. 2009 May;115(2):241-54. Epub 2008 Jul 30. Review.
 
Baak JP, Gyllenhaal C, Liu L, Guo H, Block KI. Prognostic proof and possible therapeutic mechanisms of herbal medicine in patients with metastatic lung and colon cancer. Integr Cancer Ther. 2011 Sep;10(3):NP1-NP11. doi: 10.1177/1534735411421172. Epub 2011 Sep 22. PubMed PMID: 21948133.
 
Bader FG, Lordick F, Fink U, Becker K, Höfler H, Busch R, Siewert JR, Ott K. Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up. Onkologie. 2008 Jul;31(7):366-72.
 
Bamba M, Sugihara H, Becker KF, Becker I, Höfler H, Hattori T. A case of multiple diffuse gastric carcinoma with regional expression of mutant E-cadherin. Virchows Arch. 2008 May;452(5):581-3.
 
Bani-Sadr F, Bedossa P, Rosenthal E, Merrien D, Perre P, Lascoux-Combe C, Cacoub P, Perronne C, Pol S; ANRS HC02-Ribavic Study Team. Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients? J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):234-6.
 
Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P; French National Agency for Research on AIDS; Viral Hepatitis-HC02-Ribavic Study Team. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. Clin Infect Dis. 2008 Mar 1;46(5):768-74.
 
Barber M, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick R, Caldas C, Fitzgerald R: Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Journal of Pathology 216:286-294, 2008. doi: 10.1002/path.2415.
 
Barber M, Murrel A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson A, Grehan N, Dwerryhouse S, Lao-Sirieix P, Caldas C, Fitzgerald R: Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. Journal of Pathology 216:295-306, 2008. doi: 10.1002/path.2426.
 
Baró C, Salido M, Espinet B, Astier L, Domingo A, Granada I, Millà F, Carrió A, Costa D, Luño E, Hernández JM, Campo E, Florensa L, Ferrer A, Salar A, Bellosillo B, Besses C, Serrano S, Solé F. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leuk Res. 2008 May;32(5):727-736.
 
Barros-Silva D, Leitão D, Afonso L, Vieira JM, Dinis-Ribeiro M, Fragoso M, Bento MJ, Santos L, Ferreira P, Rêgo S, Brandão C, Carneiro F, Lopes C, Schmitt F, Teixeira MR: Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. British Journal of Cancer 100: 487-493, 2009. doi: 10.1038/sj.bjc.6604885.
 
Barros R, Mendes N, Howe J, Reis CA, de Bolos C, Carneiro F, David L, Almeida R: Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4. Histochemistry and Cell Biology, 131:765-772, 2009. doi: 10.1007/s00418-009-0579-z.
 
Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, Palestini N, Ghigo E, Papotti M, Bussolati G, Martegani MP, Pantellini F, Carpi A, Giovagnoli MR, Monti S, Toscano V, Sciacchitano S, Pennelli GM, Mian C, Pelizzo MR, Rugge M, Troncone G, Palombini L, Chiappetta G, Botti G, Vecchione A, Bellocco R; Italian Thyroid Cancer Study Group (ITCSG). Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol. 2008 Jun;9(6):543-9. Epub 2008 May 19.
 
Beà S, Campo E. Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior. Haematologica. 2008 May;93(5):641-5.
 
Beà S, Salaverria I, Armengol Ll, Pinyol M, Fernandez V, Hartmann EM, Jares P, Amador V, Hernandez L, Navarro A, Ott GK, Rosenwald A, Estivill X, Campo E. Uniparental disomies, homozygous deletions, amplifications and target genes in mantle cell lymphoma revealed by integrative high-resolution whole genome profiling. Blood 2009 (E Published)
 
Becherini F, Castagna M, Iannelli A, Favre C, Abbruzzese A, Caligo MA, Bertacca G, Pingitore R, Bevilacqua G, Cavazzana AO. Choroid plexus carcinoma: a new case associated with a novel TP53 germ line mutation. Neuropathol Appl Neurobiol 34: 564-568, 2008
 
Becker KF, Schott C, Becker I, Höfler H. “Guided protein extraction from formalin-fixed tissues for quantitative multiplex analysis avoids detrimental effects of histological stains”. Proteomics-Clinical Application 2008, in press
 
Becker KF, Mack H, Schott C, Hipp S, Rappl A, Piontek G, Höfler H. Extraction of phosphorylated proteins from formalin-fixed cancer cells and tissues. The Open Pathology Journal 2008, 2, 46-52
 
Becker KF, Walch A, Ueffing M. Meeting Report: Protein analysis of tissues-current views and clinical perspectives. Virchows Arch. 2009 Aug;455(2):191-2.
 
Becker KF and Luber B. E-cadherin. UCSD-Nature Molecule Pages (2010). (doi:10.1038/mp.a003905.01).
 
Becker KF and Keller G (October 2010) Gastric Cancer. In: ENCYCLOPEDIA OF LIFE SCIENCES 2010, John Wiley & Sons, Ltd: Chichester http://www.els.net/
[DOI: 10.1002/9780470015902.a0006056.pub2]
 
Becker KF, Berg D, Malinowsky K, Wolff C, Ergin B, Meding S, Walch A, Höfler H. [Update on protein analysis of fixed tissues]. Pathologe. 2010 Oct;31 Suppl 2:263-7.IF 0.4
 
Becker KF, Taylor CR. "Liquid Morphology": Immunochemical Analysis of Proteins Extracted From Formalin-fixed Paraffin-embedded Tissues: Combining Proteomics With Immunohistochemistry. Appl Immunohistochem Mol Morphol. 2011 Jan;19(1):1-9 IF 1.7
 
Bedossa P. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy. Liver Int. 2009 Jan;29 Suppl 1:19-22.
 
Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009 Jan;50(1):1-3
 
Beirão I, Moreira L, Barandela T, Lobato L, Silva P, Gouveia CM, Carneiro F, Fonseca I, Porto G, Pihno e Costa P. Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys. Clinical Nephrology 74:327-335, 2010.
 
Belicza M, Demirovic A, Lenicek T, Pavic I, Tomic K, Jakovina K, Vukelic M, Jakovina T, Mišic M, Krušlin B. Comparison of occurrence of upper urinary tract carcinomas in the region with endemic villages and non-endemic nephropathy region in Croatia. Coll Antropol 2008;32:1203-7 (CC)
 
Belicza M, Džombeta T, Stanic G, Tomic K, Lenicek T, Peric-Balja M, Vukelic M, Jakovina T, Jakovina K, Krušlin B. Higher apoptotic cell rate in Balkan endemic nephropathy stereologic analysis. Acta Clin 2011;50:45-50 (IM, SCI)
 
Bellon E, Ligtenberg MJ, Tejpar S, Cox K, de Hertogh G, de Stricker K, Edsjö A, Gorgoulis V, Höfler G, Jung A, Kotsinas A, Laurent-Puig P, López-Ríos F, Hansen TP, Rouleau E, Vandenberghe P, van Krieken JJ, Dequeker E. External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds. Oncologist. 2011;16(4):467-78.
 
Bender C, Zipeto D, Bidoia C, Costantini S, Zamò A, Menestrina F, Bertazzoni U. Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agent Cancer. 2009 Apr 16;4:6.PMID: 19371403
 
Benko G, Spajic B, Demirovic A, Štimac G, Krušlin B, Tomas D. Prognostic value of connexin43 expression in patients with clinically localized prostate cancer. Prostate Cancer Prost Dis 2011;14:90-5 (CC.)
 
Bennecke M, Kriegl L, Bajbouj M, Retzlaff K, Robine S, Jung A, Arkan MC, Kirchner T, Greten FR. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010 Aug 9;18(2):135-46.
 
Berg D, Hipp S, Malinowsky K, Böllner C, Becker KF. Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues. European Journal of Cancer 46 (2010) 47-55. IF: 4.4
 
Berg D, Bronger H, Walch A, Höfler H, Becker KF. Analysis of signaling pathways in formalin-fixed breast cancer tissues. Pathologe. 2010 Oct;31 Suppl 2:296-9. IF 0.4
 
Berg D, Langer R, Tran K, Walch A, Schuster T, Bronger H, Becker KF. Protein Microarray-based Comparison of HER2, Estrogen Receptor, and Progesterone Receptor Status in Core Biopsies and Surgical Specimens From FFPE Breast Cancer Tissues. Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):300-5. IF 1.7
 
Berg D, Wolff C, Langer R, Schuster T, Feith M, Slotta-Huspenina J, Malinowsky K, Becker KF. Discovery of new molecular subtypes in oesophageal adenocarcinoma. PLoS One. 2011;6(9):e23985. Epub 2011 Sep 23. IF 4.4
 
Berg D, Wolff C, Malinowsky K, Tran K, Walch A, Bronger H, Schuster T, Höfler H, Becker KF. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. J Cell Physiol. 2012 Jan;227(1):204-12. doi: 10.1002/jcp.22718. IF 3.9
 
Berginc G, Glavac D. Rapid and accurate approach for screening of microsatellite unstable tumours using quasimonomorphic mononucleotide repeats and denaturating high performance liquid chromatography (DHPLC). Dis Markers. 2009;26(1):19-26.
 
Berginc G., Bracko M., Ravnik-Glavac M., Glavac D. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients : implications for a population specific detection strategy of Lynch syndrome. Familial cancer, 2009; 8(4):421-429. ISSN 1573-7292
 
Berginc G., Bracko M., Glavac D. MS-MLPA reveals progressive age-dependent promoter methylation of tumor suppressor genes and possible role of IGSF4 gene in colorectal carcinogenesis of microsatellite instable tumors. Cancer Investig., 2010; 28(1):94-102. ISSN 0735-7907
 
Berkhout M, Roelofs HM, te Morsche RH, Dekker E, van Krieken JH, Nagengast FM, Peters WH. Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis. Br J Surg. 2008 Apr;95(4):499-505. PMID: 18161889 [PubMed - indexed for MEDLINE]
 
Bermudo R, Abia D, Ferrer B, Nayach I, Benguria A, Zaballos A, del Rey J, Lozano J, Miró R, Campo E, Martínez-A C, Ortiz A R, Fernández PL,Thomson TM. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer 2008, 8:315 (publicado on-line 30 Octubre 2008)
 
Bermudo R, Abia D, Mozos A, García E,  Alcaraz A, Ortiz AR, Thomson TM, Fernández PL. Highly sensitive molecular diagnosis of prostate cancer using surplus material from biopsy needles. Br J Cancer. 2011;105:1600-7
 
Berthier A, Navarro S, Jiménez-Sáinz J, Roglá I, Ripoll F, Cervera J, Pulido R. PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Hum Pathol. 2011 Jan;42(1):75-87. Epub 2010 Oct 23.
 
Berthier A, Piqueras M, Villamón E, Berbegall A, Tadeo I, Castel V, Navarro S, Noguera R. Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors. Hum Pathol. 2011 Feb;42(2):301-2.
 
Betge J, Pollheimer MJ, Schlemmer A, Hoefler G, Langner C. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis. Oncol Rep. 2011; 26(3):567-575. Listed in: [ISI:000293426100006]; [PMID:21687951] IF(2011): 1,686; IFnorm: 0,276; Citations (SCI): 0; last update: 16.04.2012. Doi:10.3892/or.2011.1346
 
Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C. Intramural and extramural vascular invasion in colorectal cancer: Prognostic significance and quality of pathology reporting. Cancer. 2012; 118(3):628-638.
 
Bevilacqua G, Inghirami G. Collection, banking and diagnostic archiving of tissues. Pathologica. 100: 49-54, 2008
 
Bevilacqua G. Stromal tumours: which diagnostic approach? J Clin Pathol 62: 289, 2009
 
Bevilacqua G, Bosman F, Dassesse T, Höfler H, Janin A, Langer R, Larsimont D, Morente MM, Riegman P, Schirmacher P, Stanta G, Zatloukal K, Caboux E, Hainaut P. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch. 2010;456:449-54.
 
Blechschmidt K, Kremmer E, Hollweck R, Mylonas I, Höfler H, Kremer M, Becker KF. “The E-cadherin repressor Snail plays a role in tumor progression of endometrioid adenocarcinomas”. Diagn Mol Pathol. 2007 Dec;16(4):222-8.
 
Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Höfler H, Becker KF. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer. 2008, 98, 489-495.
 
Bleeker FE, Lamba S, Rodolfo M, Scarpa A, Leenstra S, Vandertop WP, Bardelli A. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes. Hum Mutat, 30:E451-459, 2009.
 
Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Frattini M, Molinari f, Knowles M, Cerrato A, Rodolfo M, Scarpa A, Felicioni L, Buttitta F, Malatesta S, Marchetti A, Bardelli A: IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high grade gliomas but not in other solid tumors. Hum Mutat, 30:7-11, 2009.
 
Boldt V, Stacher E, Halbwedl I, Popper H, Hultschig C, Moinfar F, Ullmann R, Tavassoli FA. Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression. Genes Chromosomes Cancer. 2010; 49(5):463-470 [Fulltext] [PubMed] [Fulltext MUG-login]
 
Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T,Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S, Matthews V, Schmid RM,Kirchner T, Arkan MC, Ernst M, Greten FR. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression duringcolitis-associated tumorigenesis. Cancer Cell. 2009 Feb 3;15(2):91-102. PubMed PMID: 19185844.
 
Bonin S., Brunetti D., Benedetti E., Dotti I., Gorji N. and Stanta G.:“Molecular Characterisation of Breast Cancer Patients at High and Low Recurrence Risk”, Virchows Arch 452: 241-250; 2008
 
Bonin S, Hlubek F, Benhattar J, Denkert C, Dietel M, Fernandez PL, Höfler G, Kothmaier H, Kruslin B, Mazzanti CM, Perren A, Popper H, Scarpa A, Soares P, Stanta G, Groenen PJTA. Multicentre validation study of nucleic acids extraction from FFPE tissues.Virchows Arch. 2010;457:309-17.
 
Bonin S, Filon Larese F, Trevisan G, Avian A, Rui F, Stanta G and Bovenzi M. Gene expression changes in peripheral blood mononuclear cells in occupational exposure to nickel. Experimental Dermatology 20: 145–158;2011
 
Bonin S, Stanta G. Nucleic acid extraction methods from fixed and paraffin-embedded tissues in cancer diagnostics. Expert review of molecular diagnostics. 2013;13(3):271-82.
 
Bosco M, Carucci P, Pacchioni D, Bruno M, Rizzetto M, Bussolati G, De Angelis C. Endoscopic ultrasound-guided fine needle aspiration diagnosis of extramedullary hematopoiesis in mediastinum. Endoscopy. 2009 Feb;41 Suppl 2:E6-7. Epub 2009 Jan 28. No abstract available.
 
Bosman FT, van den Tweel JG. Unison or cacophony: postgraduate training in pathology in Europe. Virchows Arch. 2009 May;454(5):497-503. Epub 2009 Mar 3. PubMed PMID: 19255781.
 
Bosman FT, Yan P, Tejpar S, Fiocca R, Van Cutsem E, Kennedy RD, Dietrich D, Roth A. Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial. Clin Cancer Res. 2009 Sep 1;15(17):5528-33. Epub 2009 Aug 18. PubMed PMID: 19690194.
 
Boštjancic E, Glavac D. Importance of microRNAs in skin morphogenesis and diseases. Acta Dermatovenerol Alp Panonica Adriat. 2008 Sep;17(3):95-102.
 
Boštjancic E., Zidar N., Glavac D. MicroRNA microarray expression profiling in human myocardial infarction. Dis. markers, 2009; 27(6):255-268. ISSN 0278-0240
 
Boštjancic E., Zidar N., Štajer D., Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology, 2009; 115(3):163-169. ISSN 0008-6312
 
Boštjancic E., Zidar N., Štajner D., Glavac D. MicroRNA miR-1 is Up-regulated in Remote Myocardium in Patients with Myocardial Infarction. Folia Biol (Praha). 2010;56(1):27-31. ISSN 0015-5500
 
Bougel S, Renaud S, Braunschweig R, Loukinov D, Morse HC 3rd, Bosman FT, Lobanenkov V, Benhattar J. PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells. J Pathol. 2010 Jan;220(1):87-96. PubMed PMID: 19806612.
 
Braun M, Menon R, Nikolov P, Kirsten R, Petersen K, Schilling D, Schott C, Gundisch S, Fend F, Becker KF, Perner S. The HOPE fixation technique - a promising alternative to common prostate cancer biobanking approaches. BMC Cancer. 2011 Dec 7;11(1):511. IF 3.1
 
Brcic I, Lenicek T, Ulamec M, Tomic M, Krušlin B. Intrarenal ectopic adrenal tissue associated with renal angiomyolipoma. Pathol Int 2011;61:778-80 (CC)
 
Bremm A, Walch A, Fuchs M, Mages J, Duyster J, Keller G, Hermannstädter C, Becker KF, Rauser S, Langer R, von Weyhern CH, Höfler H, Luber B. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Cancer Res. 2008 Feb 1;68(3):707-14.
 
Briones J, Moga E, Espinosa I, Vergara C, Alvarez E, Villa J, Bordes R, Delgado J, Prat J, Sierra J. Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome. Histopathology 2009; 54:478-485.
 
Brockmöller SF, Bucher E, Müller BM, Budczies J, Hilvo M, Griffin JL, Orešic M, Kallioniemi O, Iljin K, Loibl S, Darb-Esfahani S, Sinn BV, Klauschen F, Prinzler J, Bangemann N, Ismaeel F, Fiehn O, Dietel M, Denkert C. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res. 2012 Feb 3;11(2):850-60. Epub 2011 Dec 15.
 
Brücher BL, Keller G, Werner M, Müller U, Lassmann S, Cabras AD, Fend F, Busch R, Stein H, Allescher HD, Molls M, Siewert JR, Höfler H, Specht K. Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy. Int J Colorectal Dis. 2009 Jan;24(1):69-77. Epub 2008 Aug 13.
 
Brunhuber T, Haybaeck J, Schäfer G, Mikuz G, Langhoff E, Saeland S, Lebecque S, Romani N, Obrist P. Immunohistochemical tracking of an immune response in mammary Paget’s disease. Cancer Lett. 2008 Dec 18;272(2):206-20. Epub 2008 Oct 7.
 
Brunner A, Schönhuber G, Waldner M, Schaefer G, Mikuz G, Verdorfer I. Chromosomal aberrations in urothelial carcinoma of the bladder and the World Health Organization 2004 grading system. Anal Quant Cytol Histol. 2008 Oct;30(5):297-305.
 
Bruno M, Bosco M, Carucci P, Pacchioni D, Repici A, Mezzabotta L, Pellicano R, Fadda M, Saracco GM, Bussolati G, Rizzetto M, De Angelis C. Preliminary experience with a new cytology brush in EUS-guided FNA. Gastrointest Endosc. 2009 Dec;70(6):1220-4. Epub 2009 Aug 8. PubMed PMID: 19665706.
 
Buckendahl AC, Budczies J, Fiehn O, Darb-Esfahani S, Kind T, Noske A, Weichert W, Sehouli J, Braicu E, Dietel M, Denkert C. Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics. Oncol Rep. 2011 Apr;25(4):1005-12. doi: 10.3892/or.2011.1162. Epub 2011 Jan 25.
 
Buckland G, Agudo A, Luján L, Jakszyn P, Bueno-de-Mesquita HB, Palli D, Boeing H, Carneiro F, Krogh V, Sacerdote C, Tumino R, Panico S, Nesi G, Manjer J, Regnér S, Johansson I, Stenling R, Sanchez MJ, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen NE, Key TJ, Bingham S, Kaaks R, Overvad K, Jensen M, Olsen A, Tjønneland A, Peeters PH, Numans ME, Ocké MC, Clavel-Chapelon F, Morois S, Boutron-Ruault MC, Trichopoulou A, Lagiou P, Trichopoulos D, Lund E, Couto E, Boffeta P, Jenab M, Riboli E, Romaguera D, Mouw T, González CA. Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. American Journal of Clinical Nutrition 91:381-390, 2010. doi: 10.3945/ajcn.2009.28209.
 
Buda A, De Bona M, Dotti I, Barbazza R, Piselli P, Zabeo E, Nardon E, Bellumat A, Valiante F, Sturniolo GC, Stanta G, Pignatelli M, Batlle E, De Boni M. Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average risk population: potential implications for CRC screening. Clinical and Translational Gastroenterology (2012) 3, e6; doi:10.1038/ctg.2011.5
Published online 5 January 2012
 
Budczies J, Weichert W, Noske A, Müller BM, Weller C, Wittenberger T, Hofmann HP, Dietel M, Denkert C, Gekeler V. Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays. J Histochem Cytochem. 2011 Feb;59(2):146-57.
 
Bujas T, Pavic I, Lenicek T, Mijic A, Krušlin B, Tomas D.“Axillary apocrine carcinoma associated with apocrine adenoma and apocrine gland hyperplasia“. Acta Dermatovenerol Croat 2007;15:148-151.
 
Bujas T, Marušic Z, Peric Balja M, Mijic A, Krušlin B, Tomas D. MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma. Eur J Histochem 2011;55:39-43 (CC)
 
Buljan M, Situm M, Tomas D, Miloševic M, Krušlin B. Prognostic value of galectin-3 in primary cutaneous melanoma. J Eur Acad Dermatol Venereol. 2010 Dec 22. doi: 10.1111/j.1468-3083.2010.03943.x.  
 
Buljan M, Šitum M, Tomas D, Miloševic M, Krušlin B. Prognostic value of galectin-3 in primary cutaneous melanoma. JEADV 2011;25:1174-81 (CC)
 
Burgues O, Navarro S, “El neuroblastoma como enfoque multidisciplinar y otras aplicaciones de la MIBG: Clasificacion y aspectos anatomopatologicos”. (Capitulo 2; pp:35-62) ISBN: 978-84-611-9464-3. Editores: Luis Diez y Victoria Castel. Ed. SIMED SOFTWARE SL Madrid. 2007
 
Bussolati G, Chiusa L, Cimino A, D'Armento G.: “ Tissue transfer to pathology labs: under vacuum is the safe alternative to formalin”. Virchows Arch. 2008 Feb;452(2):229-31. Epub 2007 Dec 21.
 
Bussolati G, Leonardo E. Technical pitfalls potentially affecting diagnoses in immunohistochemistry. J Clin Pathol. 2008 Nov;61(11):1184-92. Epub 2008 Mar 6. Review.
 
Bussolati G. Proper detection of the nuclear shape: ways and significance. Rom J Morphol Embryol. 2008;49(4):435-9.
 
Bussolati B, Ribatti D, Munaron L, Bartorelli A, Bussolati G. Anti-angiogenic properties of calcium trifluoroacetate. Microvasc Res. 2009 Dec;78(3):272-7. Epub 2009 Jul 23. PubMed PMID: 19631669.
 
Bussolati G. Foreword to the review series on Impact of tumor genotyping on Cancer management. J Cell Mol Med. 2009 Aug 22. [Epub ahead of print] PubMed PMID: 19702663.
 
Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study - ANRS HC02. J Hepatol. 2008 Feb 14
 
Calabuig-Fariñas S, López-Guerrero JA, Ribera MJ, Navarro S, Ramos D, Pellín A, Llombart-Bosch A. Inflammatory fibroid polyp of the small bowel with a mutation in exon 12 of PDGFRalpha. Virchows Arch. 2009 Mar;454(3):327-31.
 
Calvo J, Sánchez-Cid L, Muñoz M, Lozano JJ, Thomson TM, Fernández PL. Infrequent Loss of Luminal Differentiation in Ductal Breast Cancer Metastasis. PLoS ONE 2013; 8: 1-12, e78097. doi:10.1371/journal.pone.0078097
 
Camacho L, Meca-Cortes O, Abad JL, Garcia S, Rubio N, Diaz A, Celia-Terrassa T, Cingolani F, Bermudo R, Fernandez PL, Blanco J, Delgado A, Casas J, Fabrias G, Thomson TM. Acid ceramidase as a therapeutic target in metastatic prostate cancer. J Lipid Res. 2013 Feb 19. [Epub ahead of print]
 
Canedo P, Castanheira-Vale AJ, Lunet N, Pereira F, Figueiredo C, Gioia-Patricola L, Canzian F, Moreira H, Suriano G, Barros H, Carneiro F, Seruca R, Machado JC: The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. European Journal of Cancer Prevention 17:28-32, 2008. doi: 10.1097/CEJ.0b013e32809b4d0f.
 
Canedo P, Pereira F, Lunet N, Suriano G, Figueiredo C, Moreira H, Barros H, Carneiro F, Seruca R, Machado JC: The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut 57:1504-1508, 2008. doi: 10.1136/gut.2007.143578.
 
Canedo P, Durães C, Pereira F, Regalo G, Lunet N, Barros H, Carneiro F, Seruca R, Rocha J, Machado JC: Tumour necrosis factor extended haplotypes and risk for development of gastric carcinoma. Cancer Epidemiology, Biomarkers & Prevention 17: 2416-2420, 2008. doi: 10.1158/1055-9965.EPI-08-0413.
 
Canet B, Pons C, Espinosa I, Prat J. Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior. Hum Pathol. 2011 Jan 3. [Epub ahead of print] PubMed PMID: 21208644.
 
Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudice G, Plebani M, Palli D, Boeing H, Bas Bueno-de-Mesquita H, Carneiro F, Berrino F, Vineis P, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key T, Bingham S, Caldas C Linseisen J, Nagel G, Overvad K, Tjonneland A, Boshuizen HC, Peeters PHM, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Kaaks R, Riboli E, Gonzales CA: DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. International Journal of Epidemiology 37:1316-1325, 2008. doi:10.1093/ije/dyn145.
 
Capelli P, Martignoni G, Pedica F, Falconi M, Antonello D, Malpeli G, Scarpa A. Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med, 133:350-364, 2009.
 
Capodanno A, Camerini A, Orlandini C, Baldini E, Resta ML, Bevilacqua G, Collecchi P. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma. Hum Pathol 40: 1408-1417, 2009
 
Carneiro F, Seruca R: Editorial sobre “Importância e caracterização do carcinoma gástrico em famílias com diagnóstico ou suspeita de síndroma de Lynch”. Jornal Português de Gastrenterologia 15 (2): 54-55, 2008.
 
Carneiro F, Oliveira C, Leite M, Seruca R: Molecular targets and biological modifiers in gastric cancer. Seminars in Diagnostic Pathology 25:274-287, 2008.
 
Carneiro F, Oliveira C, Suriano G, Seruca R: Molecular pathology of familial gastric cancer, with an emphasis on Hereditary Diffuse Gastric Cancer (HDGC). Journal of Clinical Pathology61:25-30, 2008. doi:10.1136/jcp.2006.043679.
 
Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familiar gastric cancer. International Journal of Surgical Pathology. 18(3 Suppl):33S-36S, 2010. doi: 10.1177/1066896910366463.
 
Carneiro F. Molecular pathology tools in gastrointestinal pathology. International Journal of Surgical Pathology 18(3 Suppl):53S-55S, 2010. doi: 10.1177/1066896910368593.
 
Carneiro F, Charlton A, Huntsman DG: Hereditary Diffuse Gastric Cancer. In: WHO Classification of Tumours of the Digestive System, Fouth Edition. Bosman FT, Carneiro F, Hruban RH and Theise ND (eds), IARC Press: Lyon, 2010; Pp 59-63.
 
Carneiro F: Some pathways for keeping pathology alive and well in Europe. Rev Esp Patol, 2012. doi:10.1016/j.patol.2011.12.001.
 
Caroccia B, Fassina A, Seccia TM, Recarti C, Petrelli L, Belloni AS et al. Isolation of human adrenocortical aldosterone-producing cells by a novel immunomagnetic beads method. Endocrinology 2010 Mar;151(3):1375-1380.
 
Carrat F, Bedossa P, Lunel-Fabiani F, Morand P, Pialoux G, Piroth L, Salmon-Céron D, Bani-Sadr F, Perronne C, Cacoub P, Pol S. Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients. AIDS. 2008 Jul 31;22(12):1513-5.
 
Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo Ll, Martinez A, Hamoudi R, Howat W, Montserrat E, Campo E. High Numbers of Tumor Infiltrating PD-1-Positive Regulatory Lymphocytes Are Associated with Improved Overall Survival in Follicular Lymphoma. J Clin Oncol 2009 (E Published)
 
Castel V., Grau E., Noguera R., Martinez F.: Molecular biology of neuroblastoma”.Clin Transl Oncol. 9(8):478-83, 2007
 
Castel V, Villamón E, Cañete A, Navarro S, Ruiz A, Melero C, Herrero A, Yáñez Y, Noguera R. Neuroblastoma in adolescents: genetic and clinical characterisation. Clin Transl Oncol. 2010 Jan;12(1):49-54.
 
Castellano I, Sapino A, Arisio R, Viale G, Bussolati G, Bandelloni R, Barresi G, Bersiga A, Bordi C, Botti G, Cosimi F, D'Amore E, Doglioni C, Marchetti A, Nappi O, Romeo F, Roncalli M, Russo R, Santinelli A, Spagnoli LG, Tanda F, Tricomi P, Trentini G, Zanconati F, Iurlaro M. Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases. Oncol Rep. 2008 May;19(5):1271-5.
 
Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A. Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat. 2010 Feb 3. [Epub ahead of print] PubMed PMID: 20127405.
 
Castellano I, Marchiò C, Tomatis M, Ponti A, Casella D, Bianchi S, Vezzosi V, Arisio R, Pietribiasi F, Frigerio A, Mano MP, Ricardi U, Allia E, Accortanzo V, Durando A, Bussolati G, Tot T, Sapino A. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study. Mod Pathol. 2010 Feb;23(2):260-9. Epub 2009 Nov 13. PubMed PMID: 19915523.
 
Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J, Matías-Guiu X, Cano A, Oliva E, Palacios J. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol. 2011 Jan;223(1):72-80. doi: 10.1002/path.2802. Epub 2010 Oct 29. PubMed PMID: 21125666.
 
Cassoni P, Gaetano L, Senetta R, Bussolati B, Molinaro L, Bussolati G. Histology far away from Flatland: 3D roller-coasting into grade-dependent angiogenetic patterns in oligodendrogliomas. J Cell Mol Med. 2008 Apr;12(2):564-8. Epub 2007 Dec 20.
 
Catasus L, Gallardo A, Cuatrecasas M, Prat J. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrioid adenocarcinomas are associated with adverse prognostic parameters. Mod Pathol 2008; 21:131–139.
 
Catasus L, Gallardo A, Cuatrecasas M, Prat J. Concomitant PI3K/AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis. Modern Pathol 2009; 22:522–529.
 
Catasus L, Gallardo A, Prat J. Molecular genetics of endometrial carcinoma. Diagnostic Histopathology 2009; 15:554-563.
 
Catasus L, D'Angelo E, Pons C, Espinosa I, Prat J. Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations. Mod Pathol. 2010 May;23(5):694-702. Epub 2010 Feb 19. PubMed PMID: 20173732.
 
Cattaruzza L, Fregona D, Mongiat M, Ronconi L, Fassina A, Colombatti A et al. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xerografts. Int J Cancer 2011 Jan 1;128(1):206-215.
 
Cecchin D, Schiavi F, Fanti S, Favero M, Manara R, Fassina A et al. Peptide Receptor Radionuclide Therapy in a Case of Multiple Spinal Canal and Cranial Paragangliomas. J Clin Oncol. 2010 Dec 13.
 
Celià-Terrassa T, Meca-Cortés O, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, Ell B-J, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ,  Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella V, Paciucci R, Martínez-Balbás M, García de Herreros A, Gomis RR, Kang Y, Blanco J, Fernández PL and Thomson TM. Epithelial-mesenchymal transition can suppress major attributes of epithelial tumor-initiating cells.J Clin Invest   2012; 122:1849-68
 
Cerqueira L, Fernandes RM, Ferreira RM, Carneiro F, Dinis-Ribeiro M, Figueiredo C, Keevil CW, Azevedo NF, Vieira MJ: PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori. BMC Microbiol 11:101, 2011.
 
Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Engel P, Teucher B, Kaaks R, Floegel A, Boeing H, Trichopoulou A, Dilis V, Karapetyan T, Mattiello A, Tumino R, Grioni S, Palli D, Vineis P, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Lund E, Navarro C, Quirós JR, Sánchez-Cantalejo E, Gurrea AB, Dorronsoro M, Regnér S, Sonestedt E, Wirfält E, Khaw KT, Wareham N, Allen NE, Crowe FL, Rinaldi S, Slimani N, Carneiro F, Riboli E, González CA. Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Am J Clin Nutr 94:1304-1313, 2011.
 
Chandak PG, Obrowsky S, Radovic B, Doddapattar P, Aflaki E, Kratzer A, Doshi LS, Povoden S, Ahammer H, Hoefler G, Levak-Frank S, Kratky D. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. Biochim Biophys Acta. 2011; 1811(12):1011-1020. Listed in: [ISI:000298521700002]; [PMID:21924378] IF(2010): 5,084; IFnorm: 0,863; Citations (SCI): 0; last update: 16.04.2012. Doi:10.1016/j.bbalip.2011.08.010
 
Chifenti B, Morelli M, Zavaglia M, Coviello DA, Guerneri S, Santucci A, Paffetti A, Masetti M, Locci MT, Bertacca G, Capodanno A, Collecchi P, Campani D, Mosca F, Bevilacqua G, Cavazzana AO. Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines: Evidences of Different Tumor Phenotypes. Pancreas, 38: 184-196, 2009
 
Ciobotaru V, Heimburger M, Louedec L, Heymes C, Ventura-Clapier R, Bedossa P, Escoubet B, Michel JB, Mercadier JJ, Logeart D. Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats. J Pharmacol Exp Ther. 2008 Jan;324(1):43-9
 
Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS ONE journal. 2009;4:e7542
 
Codony-Servat J, Marín-Aguilera M, Visa L, Garciía-Albéniz X, Pineda E, Fernández PL, Filella X, Gascón P, Mellado B. Nuclear Factor-Kappa B and Interleukin- 6 RelatedDocetaxel Resistance in Castration-Resistant Prostate Cancer. Prostate. 2013 ;73:512-21
 
Comanescu M, Ardeleanu C: Biomarkers of apoptotic pathways in triple negative breast cancer. 22nd European Congress of Pathology, Florence, 4-9 september 2009, Virchows Archiv (2009) 455 (Suppl 1), ISSN 0945-6317, vol rez, pg. 105
 
Comper f, Antonello D, Beghelli S, Gobbo S, Montagna L, Pederzoli P, Chilosi M, Scarpa A. Expression Pattern of Claudins 5 and 7 Distinguishes Solid-pseudopapillary From Pancreatoblastoma, Acinar Cell and Endocrine Tumors of the Pancreas. AM J Surg Pathol, 2009.
 
Comperat E, Bieche I, Dargere D, Laurendeau I, Vieillefond A, Benoit G, Vidaud M, Camparo P, Capron F, Verret C, Cussenot O, Bedossa P, Paradis V. Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. Urology. 2008 Oct;72(4):873-7.
 
Conill C, Vargas M, Valduvieco I, Fernández PL, Cardesa A, Capurro S. Metastasis to the nasal cavity from primary rectal adenocarcinoma. Clin Transl Oncol. 2009 ;11:117-9.
 
Corbo V, Dalai I, Scardoni M, Barbi S, Beghelli S, Bersani S, Albarello L, Doglioni C, Schott C, Capelli P, Chilosi M, Boninsegna L, Becker KF, Falconi M, Scarpa A. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. Endocr Relat Cancer. 2010 Aug 16;17(3):771-83. IF 4.2
 
Corleto VD, Falconi M, Panzuto F, Milione M, De Luca O, Perri P, Cannizzaro R, Bordi C, Pederzoli P, Scarpa A, Delle Fave G. Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology, 89:223-230, 2009.
 
Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R. Oncogenic mutations in gastric cancer with microsatellite instability. European Journal of Cancer 47:443-451, 2011.
 
Couvelard A, Deschamps L, Ravaud P, Baron G, Sauvanet A, Hentic O, Colnot N, Paradis V, Belghiti J, Bedossa P, Ruszniewski P. Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol. 2009 Feb;22(2):273-81.
 
Couvelard A, Deschamps L, Rebours V, Sauvanet A, Gatter K, Pezzella F, Ruszniewski P, Bedossa P. Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Clin Cancer Res. 2008 Oct 15;14(20):6634-9.
 
Cretnik M, Poje G, Musani V, Krušlin B, Ozretic P, Tomas D, Šitum M, Levanat S. Involvement of p16 and PTCH in pathogenesis of melanoma and basal cell carcinoma. Int J Oncol 2009;34:1045-50 (CC)
 
Croner RS, Förtsch T, Brückl WM, Rödel F, Rödel C, Papadopoulos T, Brabletz T, Kirchner T, Sachs M, Behrens J, Klein-Hitpass L, Stürzl M, Hohenberger W, Lausen B. Molecular signature for lymphatic metastasis in colorectal carcinomas. Ann Surg. 2008 May;247(5):803-10.
 
Crusius JBA, Canzian F, Capellá G, Peña AS, Pera G, Sala N, Agudo A, Rico F, Del Giudice G, Palli D, Plebani M, Boeing H, Bueno-de-Mesquita H, Carneiro F, Pala V, Save VE, Vineis P, Tumino R, Panico S, Berglund G, Manjar J, Stenling R, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Binghan S, Caldas C, Linseisen J, Kaak R, Overvad K, Tjønneland A, Büchner FC, Peeters PHM, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Rinaldi S, Ferrari P, Riboli E, González CA: Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Annals of Oncology2008Jul 14. [Epub ahead of print]. doi: 10.1093/annonc/mdn400.
 
Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009; 33:556-567.
 
Czermak C, Wallner SJ, Kresse A, Schauer S, Aigner R, Hoefler G, Lehofer M, Liebmann PM. Baseline plasma epinephrine levels predict Wisconsin Card Sorting Test scores in healthy volunteers. Psychoneuroendocrinology. 2009; 34(4):625-628[Fulltext][PubMed][Fulltext MUG-login]
 
Dacic, S; Kothmaier, H; Land, S; Shuai, Y; Halbwedl, I; Morbini, P; Murer, B; Comin, C; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, P; Popper, H.: Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch. 2008; 453(6):627-635 [Fulltext] [PubMed] [Fulltext MUG-login] [Listed in ISI Web of Science]
 
da Cunha CB, Oliveira C, Wen X, Gomes B, Sousa S, Suriano G, Grellier M, Huntsman DG, Carneiro F, Granja PL, Seruca R. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Laboratory Investigation. 90:1604-1614, 2010. doi: 10.1038/labinvest.2010.155.
 
D’Angelo E, Spagnoli LG, Prat J. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. Hum Pathol 2009; 40: 1571-1585.  
 
D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010 Jan;116(1):131-9. Epub 2009 Oct 23. Review. PubMed PMID: 19853898.  
 
D'Angelo E, Dadmanesh F, Pecorelli S, Prat J. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type. Int J Gynecol Pathol. 2010 Nov;29(6):529-32. PubMed PMID: 20881861.
 
D'Angelo E, Prat J. Classification of ovarian carcinomas based on pathology and molecular genetics. Clin Transl Oncol. 2010 Dec;12(12):783-7. PubMed PMID: 21156408.
 
Daniele L, D’Armento G, Annaratone L, Allia E, Mariani S, Armando E, Bosco M, Macrì L, Cassoni P, Bussolati G, Cserni G, Sapino A: “Technical limits of comparison of Step-sectioning, Immunohistochemistry and RT-PCR on breast cancer sentinel nodes. A study on methacarn fixed tissue”. Under consideration
 
Daniele L, Macrì L, Schena M, Dongiovanni D, Bonello L, Armando E, Ciuffreda L, Bertetto O, Bussolati G, Sapino A.: “Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens”. Mol Cancer Ther. 2007 Apr;6(4):1223-9. Epub 2007 Apr 3.
 
Daniele L, Annaratone L, Allia E, Mariani S, Armando E, Bosco M, Macrì L,Cassoni P, D'Armento G, Bussolati G, Cserni G, Sapino A. Technical limits of comparison of step-sectioning, immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn fixed tissue. J Cell Mol Med. 2008 Jul 30. [Epub ahead of print]
 
Daniele L, Righi A, Ferraris A, Macrì L, Asioli S. Metastasis of Malignant Peritoneal Epithelioid Mesothelioma in Endoscopic Gastric Biopsy: A Diagnostic Pitfall. Int J Surg Pathol. 2008 Sep 14. [Epub ahead of print]
 
Daniele L, Sapino A.Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies. Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):9-18.
 
Darb-Esfahani S, Faggad A, Noske A, Weichert W, Buckendahl AC, Müller B, Budczies J, Röske A, Dietel M, Denkert C. Phospho-mTOR and phosphor-4EBP1 in endometrial adenocarcinoma: association with stage and gradein vivo and link with response to rapamycin treatment in vitro. J Cancer Res Clin Oncol. 2008 Dec 24. [Epub ahead of print]
 
Darb-Esfahani S, Wirtz RM, Sinn BV, Budczies J, Noske A, Weichert W, Faggad A, Scharff S, Sehouli J, Oskay-Ozcelik G, Zamagni C, De Iaco P, Martoni A, Dietel M, Denkert C. Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Endocr Relat Cancer. 2009 Dec;16(4):1229-39. Epub 2009 Aug 12.PMID: 19675076
 
Darlavoix T, Seelentag W, Yan P, Bachmann A, Bosman FT. Altered expression of CD44 and DKK1 in the progression of Barrett's esophagus to esophageal adenocarcinoma. Virchows Arch. 2009 Jun;454(6):629-37. Epub 2009 Apr 25. PubMed PMID: 19396460.
 
D'Armento G, Daniele L, Mariani S, Ottaviani D, Mussa A, Cassoni P, Sapino A, Bussolati G. Added Value of Combined Gene and Protein Expression of CK20 and CEA in Non-macroscopically Involved Lymph Nodes of Colorectal Cancer. Int J Surg Pathol. 2008 Dec 12. [Epub ahead of print]
 
Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan, KP, Kumari P, Trauner M, Zimmermann R, Vesely P, Haemmerle G, Zechner R, Hoefler G. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 2011; 333(6039):233-238. Listed in: [ISI:000292502700053]; [PMID:21680814] IF(2011): 31,377; IFnorm: 0,983; Citations (SCI): 14; last update: 16.04.2012. Doi:10.1126/science.1198973
 
D'assignies G, Couvelard A, Bahrami S, Vullierme MP, Hammel P, Hentic O, Sauvanet A, Bedossa P, Ruszniewski P, Vilgrain V. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009 Feb;250(2):407-16.
 
Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F, Esteller M. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 31:2062-2074, 2012. doi: 10.1038/onc.2011.383.
 
De Álava, Fernández PL, Morente M. “Bancos de tumores en España. Realidades y retos”. Oncología 2007; 30: 148-156.
 
de Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout EM, Lakeman A, Vandesompele J, Hoebeeck J, Van Maerken T, De Paepe A, Laureys G, Schulte JH, Schramm A, Van Den Broecke C, Vermeulen J, Van Roy N, Beiske K, Renard M, Noguera R, Delattre O, Janoueix-Lerosey I, Kogner P, Martinsson T, Nakagawara A, Ohira M, Caron H, Eggert A, Cools J, Versteeg R, Speleman F. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin Cancer Res. 2010 Sep 1;16(17):4353-62. Epub 2010 Aug 18.
 
de Bruin EC, van de Velde CJ, van Krieken JH, Marijnen CA, Medema JP. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients. Clin Cancer Res. 2008 Feb 15;14(4):1073-9. PMID: 18281539 [PubMed - indexed for MEDLINE]
 
de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A, Sander B, Thorns C, Campo E, Molina T, Hagenbeek A, Horning S, Lister A, Raemaekers J, Salles G, Gascoyne RD, Weller E. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium). J Clin Pathol. 2009 Feb;62(2):128-38
 
de Maat MF, van de Velde CJ, van der Werff MP, Putter H, Umetani N, Klein-Kranenbarg EM, Turner RR, van Krieken JH, Bilchik A, Tollenaar RA, Hoon DS. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol. 2008 May 10;26(14):2327-35. PMID: 18467724 [PubMed - indexed for MEDLINE]
 
De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, Bray I, Castel V, Chen C, Drozynska E, Eggert A, Hogarty MD, Izycka-Swieszewska E, London WB, Noguera R, Piqueras M, Bryan K, Schowe B, van Sluis P, Molenaar JJ, Schramm A, Schulte JH, Stallings RL, Versteeg R, Laureys G, Van Roy N, Speleman F, Vandesompele J. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples. Clin Cancer Res. 2011 Dec 15;17(24):7684-92. Epub 2011 Oct 26.
 
Demirovic A, Cesarec S, Spajic B, Tomas D , Bulimbašic S, Miloševic M, Marušic Z, Krušlin B. Can renal oncocytoma be distinguished from chromophobe renal cell carcinoma by the presence of fibrous capsule? Virchows Arch 2010;456:85-9 (CC)
 
Demirovic A, Džombeta T, Tomas D, Spajic B, Pavic I, Hudolin T, Miloševic M, Cupic H, Krušlin B. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma. Pathol Res Pract. 2010 Oct 15;206(10):695-9.
 
Demirovic A, Marusic Z, Lenicek T, Spajic B, Balicevic D, Tomas D, Krušlin B. CD138-positive plasmacytoid urothelial carcinoma of urinary bladder with focal micropapillary features. Tumori. 2010 Mar-Apr;96(2):358-60.
 
Demurtas A, Accinelli G, Pacchioni D, Godio L, Novero D, Bussolati G, Palestro G, Papotti M, Stacchini A. Utility of Flow Cytometry Immunophenotyping in Fine-needle Aspirate Cytologic Diagnosis of Non-Hodgkin Lymphoma: A Series of 252 Cases and Review of the Literature. Appl Immunohistochem Mol Morphol. 2009 Feb 25. [Epub ahead of print]
 
De Nicolò A, Tancredi M, Lombardi G, Flemma CC, Barbuti S, Di Cristofano C, Sobhian B, Bevilacqua G, Drapkin R, Caligo MA. A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function. Clin Cancer Res 14: 4672-4680, 2008
 
Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O. Metabolite profiling of human colon carcinoma—deregulation of TCA cycle and amino acid turnover. Mol Cancer. 2008 Sep 18;7:72.
 
Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R, Hanusch C, von Törne C, Weichert W, Engels K, Solbach C, Schrader I, Dietel M, von Minckwitz G. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010 Jan 1;28(1):105-13. Epub 2009 Nov 16. Erratum in: J Clin Oncol. 2010 Feb 1;28(4):708. PMID: 19917869
 
Denkert C, Kronenwett R, Schlake W, Bohmann K, Penzel R, Weber KE, Höfler H, Lehmann U, Schirmacher P, Specht K, Rudas M, Kreipe HH, Schraml P, Schlake G, Bago-Horvath Z, Tiecke F, Varga Z, Moch H, Schmidt M, Prinzler J, Kerjaschki D, Sinn BV, Müller BM, Filipits M, Petry C, Dietel M. Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay. Virchows Arch. 2012 Mar;460(3):251-9. Epub 2012 Feb 28.
 
Dekkers R, Verweij PE, Weemaes CM, Severijnen RS, Van Krieken JH, Warris A. Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease. Med Mycol. 2008 Aug;46(5):491-4. Epub 2008 Mar 10. PMID: 18608916 [PubMed - indexed for MEDLINE]
 
Dequeker E, Ligtenberg MJ, Vander Borght S, van Krieken JH. Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme. Virchows Arch. 2011 Aug;459(2):155-60.
 
De Vita S, Devoy A, Groet J, Krušlin B, Kuzmic-Prusac I, Nižetic D. Megakaryocyte hyperproliferation without GATA1 mutation in foetal liver in a case of Down syndrome with hydrops foetalis. BJ Haematol 2008;143:300-3 (CC)
 
Di Cristofano C., Minervini A., Menicagli M., Salnitri G., Bertacca G., Pefanis G., Masieri L., Lessi F., Collecchi P., Minervini R., Carini M., Bevilacqua C., Cavezzana A.: “Nuclear expression of hypoxia-inducible factor-1alpha in clear cell renal cell carcinoma is involved in tumor progression”. Am J Surg Pathol. 2007 Dec;31(12):1875-81. PMID: 18043042 [PubMed - indexed for MEDLINE]
 
Dietel M, Tannapfel A, Baretton G, Kreipe H, Kloor M, Gabbert H, Kirchner T. Molecular pathologic KRAS mutation analysis. A prerequisite of effective antibody treatment for metastasized colorectal cancer. Chirurg. 2008 Jun;79(6):576-9. German.
 
Dietel M. Post-mortems with organ and tissue retention Z Evid Fortbild Qual Gesundhwes. 2008;102(3):189-93.
 
Dietel M, Schäfer R. Systems pathology--or how to solve the complex problem of predictive pathology. Virchows Arch. 2008 Oct;453(4):309-12. Epub 2008 Sep 13. Review.
 
Dietel M, Schäfer R. Systems pathology--or how to solve the complex problem of predictive pathology.  Virchows Arch. 2009 Feb;454(2):237-8. No abstract available.   
 
Dietel M. Hormone replacement therapy (HRT), breast cancer and tumor pathology. Maturitas. 2010 Mar;65(3):183-9. Epub 2009 Dec 14.PMID: 20005648
 
Dietel M. [Opening address of the president of the German Society of Pathology e.V]. Pathologe. 2011 Nov;32 Suppl 2:156. German. No abstract available.
 
Dietel M, Schirmacher P. Deficits in the management of patients with adrenocortical carcinoma in Germany. Statements cannot be substantiated. Dtsch Arztebl Int. 2011 May;108(19):339; author reply 339-40. Epub 2011 May 13. No abstract available.
 
Dietel M, Häfner N, Jansen L, Dürst M, Runnebaum IB. Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis. J Mol Med (Berl). 2011 Jun;89(6):621-30. Epub 2011 Mar 23.
 
Dijkstra JR, Opdam FJ, Boonyaratanakornkit J, Schönbrunner ER, Shahbazian M, Edsjö A, Hoefler G, Jung A, Kotsinas A, Gorgoulis VG, López-Ríos F, de Stricker K, Rouleau E, Biesmans B, van Krieken JH. Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis. J Mol Diagn. 2012 May-Jun;14(3):187-91.
 
Dijkstra JR, van Krieken JHJM, Opdam FJM, Boonyaratanakornkit J, Schonbrunner ER, Shahbazian M, Edsjo A, Hoefler G, Jung A, Kotsinas A, Gorgoulis VG, Lopez-Rios, F, de Stricker K, Rouleau E, Biesmans B. Do Pre-Analytical Parameters Explain KRAS Test Sensitivity Disparities? Reply. J MOL DIAGN. 2012; 14(6): 632-633.
 
di Meo N, Bergamo S, Vidimari P, Bonin S, Trevisan G. Analysis of diagnostic criteria in adamantiades-behcet disease: a retrospective study. Indian journal of dermatology. 2013;58(4):275-7.
 
Dinis-Ribeiro M, Areia M, de Vries A, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O’Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 460:19-46, 2012. [Epub ahead of print]. doi: 10.1007/s00428-011-1177-8.
 
Dinis-Ribeiro M, Areia M, de Vries A, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O’Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 44:74-94, 2012. doi: 10.1055/s-0031-1291491.
 
Domingo J, Fernández PL, Filella X, Gallardo E, Fernández E, Alcaraz A, Gascón P, Mellado B. “Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel”. Ann Oncol 19:269-75,2008
 
Donada M, Nardon E, Bonin S, De Pellegrin A, Decorti G and Stanta G. Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability. Journal of Cancer Research and Clinical Oncology: Volume 137:201-210;2011
 
Donada M, Bonin S, Barbazza R, Pettirosso D, Stanta G. Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision. BMC gastroenterology. 2013;13:36.
 
Donadelli M, Dalla Pozza E, Scupoli MT, Costanzo C, Scarpa A, Palmieri M. Intracellular zing increas inhibits p53 (-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis. Biochim Biophys Acta, 1793:273-280, 2009.
 
Dongiovanni D, Daniele L, Barone C, Dongiovanni V, Fissore C, Sapino A, Macrì L, Bussolati G, Buffoni L, Gaspari F, Grillo R, Birocco N, Addeo A, Ciuffreda L, Schena M. Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)? Lung Cancer. 2008 Jul;61(1):73-81. Epub 2008 Feb 19.
 
Dotti I, Bonin S, Basili G, Nardon E, Balani A, Siracusano S, Zanconati F, Palmisano S, De Manzini N and Stanta G. Effects of formalin, methacarn and FineFIX fixatives on RNA preservation. Diagnostic Molecular Pathology. 2010 (in print)
 
Duch J, Fuster D, Muñoz M, Fernández PL, Paredes P, Fontanillas M, Guzmán F, Rubí S,Lomeña FJ,Pons F. 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer . Eur J Nucl Med Mol Imaging. 2009;36:1551-7.
 
Duch J., Fuster D., Muñoz M., Fernández P. L., Paredes P., Fontanillas M., Skaltsa K., Domènech B., Lomeña F., Pons F. PET/CT with [18F] fluorodeoxyglucose in the assessment of metabolic response to neoadjuvant chemotherapy in locally advanced breast cancer. Q J Nucl Med Mol Imaging. 2012;56:291-8
 
Duell EJ, Travier N, Lujan-Barroso L, Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Krogh V, Mattiello A, Tumino R, Sacerdote C, Rodriguez L, Sanchez-Cantalejo E, Navarro C, Barricarte A, Dorronsoro M, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Bueno-de-Mesquita HB, Jeurnink SM, Numans ME, Peeters PH, Lagiou P, Valanou E, Trichopoulou A, Kaaks R, Lukanova-McGregor A, Bergman MM, Boeing H, Manjer J, Lindkvist B, Stenling R, Hallmans G, Dahm CC, Overvad K, Olsen A, Tjonneland A, Bakken K, Lund E, Jenab M, McCormack V, Rinaldi S, Michaud D, Mouw T, Nesi G, Carneiro F, Riboli E, González CA. Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the european prospective investigation into cancer and nutrition. American Journal of Epidemiology 172:1384-1393, 2010. doi: 10.1093/aje/kwq321.
 
Dzombeta T, Krajacic-Jagarcec G, Tomas D, Kraus O, Ruzic B, Kruslin B. Urothelial carcinoma with an inverted growth pattern: a report of 4 cases. Acta Med Croatica. 2010 Mar;64(1):47-50. Croatian.
 
Ebelt K, Babaryka G, Figel AM, Pohla H, Buchner A, Stief CG, Eisenmenger W, Kirchner T, Schendel DJ, Noessner E. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. Prostate 2008 Jan 1;68(1):1-10.
 
Ebelt K, Babaryka G, Frankenberger B, Stief CG, Eisenmenger W, Kirchner T, Schendel DJ, Noessner E. Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters. Eur J Cancer. 2009 Jun;45(9):1664-72. Epub 2009 Mar 21. PubMed PMID: 19318244.
 
Eferl, R; Hasselblatt, P; Rath, M; Popper, H; Zenz, R; Komnenovic, V; Idarraga, MH; Kenner, L; Wagner, EF.: Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A. 2008; 105(30):10525-10530 [Fulltext] [PubMed] [Fulltext MUG-login] [Listed in ISI Web of Science]
 
Egevad L, Algaba F, Berney DM, Boccon-Gibod L, Griffiths DF, Lopez-Beltran A, Mikuz G, Varma M, Montironi R; European Network of Uropathology. Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology. 2008 Sep;53(3):333-9. Epub 2008 Jul 15.
 
Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A. Are the Clinical and Pathological Features of Differentiated Thyroid Carcinoma Really Changed over the Last 35 Years? Study on 4187 Patients from a Single Italian Institution to Answer this Question. J Clin Endocrinol Metab. Epub ahead of print 2010
 
Eloy C, Lopes JM, Faria G, Moreira H, Brandão A, Silva T, Carneiro F: Clear Cell Change in Colon Polyps. International Journal of Surgical Pathology 2008 Jul 8. [Epub ahead of print]. doi: 10.1139/y08-031.
 
Enache S, Stoicea M, Georgescu A, Terzea D, Arsene D, Mihai M, Iosif C, Andrei F, Enache V, Cionca F, Ardeleanu C: DOG1 and D2-40 in GISTs diagnosis. 22nd European Congress of Pathology, Florence, 4-9 september 2009, Virchows Archiv (2009) 455 (Suppl 1), ISSN 0945-6317, vol rez, pg. 133
 
Endri M, Cartei G, Zustovich F, Serino FS, Fassina A. Differential diagnosis of lung nodules: breast cancer metastases and lung tuberculosis. Infez Med. 2010 Mar;18(1):39-42.
 
Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Álvarez S, Reina O, Ardanaz M, Jares P, García-Orad A, Pujana M, Montserrat E, De Sanjose S, Campo E. Genetic Variants in Apoptosis and Immunoregulation-Related Genes are Associated with Risk of Chronic Lymphocytic Leukemia. Cancer Res 2008; 68(24):10178-88
 
Ensari A, Bosman FT, Offerhaus GJ. The serrated polyp: getting it right! J Clin Pathol. 2010;63:665-8.
 
Ergin B, Meding S, Langer R, Kap M, Viertler C, Schott C, Ferch U, Riegman P, Zatloukal K, Walch A, Becker KF. Proteomic Analysis of PAXgene-Fixed Tissues. J Proteome Res. 2010 Oct 1;9(10):5188-96. IF 5.1
 
Esclapez P, Garcia-Granero E, Flor B, García-Botello S, Cervantes A, Navarro S, Lledó S. Prognostic heterogeneity of endosonographic T3 rectal cancer. Dis Colon Rectum. 2009 Apr;52(4):685-91.
 
Esgueva R, Perner S, J Lafargue C, Scheble V, Stephan C, Lein M, Fritzsche FR, Dietel M, Kristiansen G, Rubin MA. Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Mod Pathol. 2010 Jan 29. [Epub ahead of print]PMID: 20118910
 
Espinosa I, José Carnicer M, Catasus L, Canet B, D'angelo E, Zannoni GF, Prat J. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Am J Surg Pathol. 2010 Nov;34(11):1708-14. PubMed PMID: 20962622.
 
Eussen SJ, Vollset SE, Hustad S, Midttun Ø, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Ferrari P, Agudo A, Sala N, Capellá G, Del Giudice G, Palli D, Boeing H, Weikert C, Bueno-de-Mesquita HB, Büchner FL, Carneiro F, Berrino F, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martínez C, Arrizola L, Barricarte A, Navarro C, Rodriguez L, Bingham S, Linseisen J, Kaaks R, Overvad K, Tjønneland A, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Trichopoulou A, Lund E, Plebani M, Riboli E, González CA. Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers & Prevention 19:28-38, 2010. doi: 10.1158/1055-9965.EPI-08-1096.
 
Faber C, Kirchner T, Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch. 2009 Apr;454(4):359-67. Epub 2009 Mar 14. Review. PubMed PMID: 19288129.
 
Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Weichert W, Noske A, Budczies J, Müller BM, Buckendahl AC, Röske A, Eldin Elwali N, Dietel M, Denkert C. Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Mod Pathol. 2009 Mar 6.
 
Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Noske A, Weichert W, Buckendahl AC, Budczies J, Müller BM, Elwali NE, Dietel M, Denkert C. Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology. 2009 May;54(6):657-66.PMID: 19438741]
 
Faggad A, Budczies J, Tchernitsa O, Darb-Esfahani S, Sehouli J, Müller BM, Wirtz R, Chekerov R, Weichert W, Sinn B, Mucha C, Elwali NE, Schäfer R, Dietel M, Denkert C. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J Pathol. 2010 Feb;220(3):382-91.PMID: 19960504 [PubMed - in process] Related articles
 
Falconi M, Crippa S, Dominguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Ann Surg Oncol, 2008.
 
Faoro V, Barbazza R, Bonin S, Brunetti D, Sulfaro S, Stanta G. Detection of HPV E7 Oncoviral Protein in Cervical Lesions by a New Antibody. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 2013;21(4):341-50.
 
Fassina A, Cappellesso R, Schiavi F, Fassan M. Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland. J Surg Oncol. 2011 Jan 1;103(1):103-104.
 
Fassina A, Corradin M, Zardo D, Cappellesso R, Corbetti F, Fassan M. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology 2010 Aug 25.
 
Fassina A, Fabbro M, Cappellesso R, Fassan M. Seeding of tumour cells after fine needle aspiration cytology in liver nodules: myth or reality? Citopathology 2010 Dec;21(6):413-414.
 
Fassina A, Olivotto A, Cappellesso R, Vendraminelli R, Fassan M. Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocystosis. Cancer Cytopathol. 2010 Dec 17.
 
Faus C, Roda D, Frasson M, Roselló S, García-Granero E, Flor-Lorente B, Navarro S. The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment. Clin Transl Oncol. 2010 May;12(5):339-45. Review.
 
Fernandes S, Carneiro F, Oliveira C, Seruca R: Colorectal Cancer and RASSF family - A special emphasis on RASSF1A. Int J Cancer (in press).
 
Fernàndez V, Jares P, Salaverria I, Giné E, Beà S, Aymerich M, Colomer D, Villamor N, Bosch F, Montserrat E, Campo E. Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia. Haematologica. 2008 Jan;93(1):132-6.
 
Fernandez  P L. Palaeopathology: the study of disease in the past. Pathobiology 2012; 79:221-7.
 
Ferreira AC, Gomes L, Máximo V, Amil J, Carneiro F, Machado JC, Tavarela-Veloso F: GRIM-19 mutations are not associated with Crohn's disease. Inflammatory Bowel Diseases 14:434-435, 2008. doi: 10.1002/ibd.20313.
 
Ferreira AC, Suriano G, Mendes N, Gomes B, Wen X, Carneiro F, Seruca R, Machado JC. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Hum Mol Genet 21:334-343, 2012. doi: 10.1093/hmg/ddr469.
 
Ferreira RM, Machado JC, Leite M, Carneiro F, Figueiredo C. The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and gastric carcinoma development. Histopathology 60:992-998, 2012. doi: 10.1111/j.1365-2559.2012.04190.x.
 
Ferrer A, Bosch F, Villamor N, Rozman M, Gutierrez G, mercadal S, Campo E, Rozman C, López-Guillermo A, Montserrat E. Central nervous system involvement in mantle cell lymphoma. Ann Oncol 2008:19:135-141.
 
Fieuw A, Kumps C, Schramm A, Pattyn F, Menten B, Antonacci F, Sudmant P, Schulte JH, Van Roy N, Vergult S, Buckley PG, De Paepe A, Noguera R, Versteeg R, Stallings R, Eggert A, Vandesompele J, De Preter K, Speleman F. Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas. Int J Cancer. 2012 Jun 1;130(11):2599-606. doi: 10.1002/ijc.26317. Epub 2011 Aug 29.
 
Filipits M, Haddad V, Schmid K, Huynh A, Dunant A, André F, Brambilla E, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Pirker R. “Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program”. Clin Cancer Res. 2007 Jul 1;13(13):3892-8.
 
Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Brambilla E. “Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program”. J Clin Oncol. 2007 Jul 1;25(19):2735-40.
 
Fisang C, Bastian PJ, Mikuz G, Oberpenning F, Müller SC. Malignant mixed mullerian tumor of the urinary bladder in a 73 year old woman. Eur J Med Res. 2008 May 26;13(5):215-7.
 
Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C; on behalf of the International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. Journal of Medical Genetics 47: 436-444, 2010. doi: 10.1136/jmg.2009.074237.
 
Frasson M, Garcia-Granero E, Roda D, Flor-Lorente B, Roselló S, Esclapez P, Faus C, Navarro S, Campos S, Cervantes A. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer. 2011 Jan 24.
 
Fried I, Wölfler A, Quehenberger F, Hoefler G, Sill H Zebisch A. Mutations in DNMT3A and loss of RKIP are independent events in acute monocytic leukemia. Haematologica. 2012; 97(12):1936-1937
 
Friederich P, de Jong AE, Mathus-Vliegen LM, Dekker E, Krieken HH, Dees J, Nagengast FM, Vasen HF. Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008 Nov;6(11):1237-42. Epub 2008 Oct 10. PMID: 18848811 [PubMed - indexed for MEDLINE]
 
Fritzsche FR, Weichert W, Röske A, Gekeler V, Beckers T, Stephan C, Jung K, Scholman K, Denkert C, Dietel M, Kristiansen G. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer. 2008 Dec 19;8:381.
 
Fritzsche FR, Riener MO, Dietel M, Moch H, Jung K, Kristiansen G. GOLPH2 expression in renal cell cancer. BMC Urol. 2008 Nov 11;8:15.
 
Fritzsche FR, Wassermann K, Rabien A, Schicktanz H, Dankof A, Loening SA, Dietel M, Jung K, Kristiansen G. CD146 protein in prostate cancer: revisited with two different antibodies. Pathology. 2008 Aug;40(5):457-64.
 
Fritzsche FR, Wassermann K, Jung M, Tölle A, Kristiansen I, Lein M, Johannsen M, Dietel M, Jung K, Kristiansen G. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer. 2008 Jun 26;8:179.
 
Fritzsche FR, Kristiansen G, Riener MO, Dietel M, Oelrich B. GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urol. 2010 Feb 25;10(1):4. [Epub ahead of print]PMID: 20184749
 
Frulloni L, Scattolini C, Graziani R, Cavestro GM, Pravadelli C, Amodio A, Manfredi R, Scarpa A, Vantini I. Clinical and radiological outcome of patients suffering from chronic pancreatitis associated with gene mutations. Pancreas, 37:371-376, 2008.
 
Fuchs M, Hermannstädter C, Hutzler P, Häcker G, Haller F, Höfler H, Luber B.: Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage. Exp Cell Res. 2008 Jan 1;314(1):153-63.
 
Fuchs H, Gailus-Durner V, Adler T, Pimentel JA, Becker L, Bolle I, Brielmeier M, Calzada-Wack J, Dalke C, Ehrhardt N, Fasnacht N, Ferwagner B, Frischmann U, Hans W, Hölter SM, Hölzlwimmer G, Horsch M, Javaheri A, Kallnik M, Kling E, Lengger C, Maier H, Mossbrugger I, Mörth C, Naton B, Nöth U, Pasche B, Prehn C, Przemeck G, Puk O, Racz I, Rathkolb B, Rozman J, Schäble K, Schreiner R, Schrewe A, Sina C, Steinkamp R, Thiele F, Willershäuser M, Zeh R, Adamski J, Busch DH, Beckers J, Behrendt H, Daniel H, Esposito I, Favor J, Graw J, Heldmaier G, Höfler H, Ivandic B, Katus H, Klingenspor M, Klopstock T, Lengeling A, Mempel M, Müller W, Neschen S, Ollert M, Quintanilla-Martinez L, Rosenstiel P, Schmidt J, Schreiber S, Schughart K, Schulz H, Wolf E, Wurst W, Zimmer A, Hrabé de Angelis M. The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr Pharm Biotechnol. 2009 Feb;10(2):236-43.
 
Funel N, Giovannetti E, Del Chiaro M, Mey V, Pollina LE, Nannizzi S, Boggi U, Ricciardi S, Del Tacca M, Bevilacqua G, Mosca F, Danesi R, Campani D. Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. Lab Invest 88: 773-784, 2008
 
Gale N, Michaels L, Luzar B, Poljak M, Zidar N, Fischinger J, Cardesa A. Current review on squamous intraepithelial lesions of the larynx. Histopathology. 2008 Aug 25. [Epub ahead of print] PMID: 18752537 [PubMed - as supplied by publisher]
 
Gale N, Zidar N. Benigne und potentiell maligne Läsionen des Plattenepithels und Platenepithelkarzinom. In: Cardesa A, Mentzel Th, Rudolph P, Slootweg P PJ. Pathologie. Kopf-Hals-Regionen Weichgewebstumoren Haut. Springer Berlin, 2009: 4-46.
 
Gale N, Cardesa A, Zidar N. Larynx und Hypopharynx. In: CardesaA, Mentzel Th, Rudolph P, Slootweg PJ Pathologie. Kopf-Hals-Region, Weichgewebstumoren, Haut. Springer, Berlin 2009, pp: 238-282.
 
Gale N, Michaels L. Luzar B, Poljak M, Zidar N, Fischinger J: Cardesa A.Current review on squamous intraepithelial lesions of the larynx.Histopathology 2009; 54; 639-656.
 
Gallardo A, Prat J. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases. Am J Surg Pathol 2009; 33:278-288.
 
García-Granero E, Faiz O, Muñoz E, Flor B, Navarro S, Faus C, García-Botello SA, Lledó S, Cervantes A. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer. 2009 Aug 1;115(15):3400-11.
 
Garcia-Herrera A, Colomo L, Camós M, Carreras J, Balague O, Martinez A, Lopéz-Guillermo A, Estrach T, Campo E. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol. 2008 Jul 10;26(20):3364-71.
 
García-Palomares S, Navarro S, Pertusa JF, Hermenegildo C, García-Pérez MA, Rausell F, Cano A, Tarín JJ. Delayed Fatherhood in Mice Decreases Reproductive Fitness and Longevity of Offspring. Biol Reprod. 2009 Feb;80(2):343-9
 
Gardiol D., Zacchi A., Petrera F., Stanta G., Banks L.: “Human disc large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissues architecture during malignant progression.” Int J Cancer, 2007
 
Gaviraghi M, Caricasole A, Costanzo C, Diamanti D, Dandrea M, Donadelli M, Scarpa A, Palmieri M. Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene. BMC Mol Biol, 9:56, 2008.
 
Gazquez C, Ribal MJ, Marín-Aguilera M, Kayed H, Fernández PL, Mengual L, Alcaraz A.Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement? BJU Int. 2012 ;110:1310-6.
 
Georgescu A, Stoicea M, Enache S, Andrei F, Vasilescu F, Dobrea C, Ceausu M, Cionca F, Comanescu M, Butur G, Ardeleanu C: AKT and TRAIL status in young women with breast cancer. Implications in therapy resistance. 22nd European Congress of Pathology, Florence, 4-9 september 2009, Virchows Archiv (2009) 455 (Suppl 1), ISSN 0945-6317, vol rez, pg. 94
 
Gerhardt J, Steinbrech C, Büchi O, Behnke S, Bohnert A, Fritzsche F, Liewen H, Stenner F, Wild P, Hermanns T, Müntener M, Dietel M, Jung K, Stephan C, Kristiansen G. The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro. Am J Pathol. 2011 Apr;178(4):1847-60.
 
Ghilusi M, Plesea IE, Comanescu M, Enache SD, Bogdan F.Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas. Rom J Morphol Embryol.; 50 (2): 195-202, 2009
 
Gilje B, Nordgård O, Tjensvoll K, Janssen EA, Søiland H, Smaaland R, Baak JP. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients. Breast Cancer Res Treat. 2011 Jul;128(1):137-46.
 
Gilks CB, Prat J. Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol 2009; 40:1213-23.
 
Giner F, Machado I, Noguera R, Villamon E, Pellin A, Calabuig-Fariñas S, Peydro-Olaya A, Navarro S, Llombart-Bosch A. The epithelial mesenchymal transition process in wilms tumor: a study based on a xenograft model. Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):369-75. Erratum in: Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):483.
 
Gladkowska-Dura M, Dzierzanowska-Fangrat K, Dura WT, van Krieken JH, Chrzanowska KH, van Dongen JJ, Langerak AW. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation. J Pathol. 2008 Nov;216(3):337-44. PMID: 18788073 [PubMed - indexed for MEDLINE]
 
Godic A., Korošec B., Miljkovic J., Kansky A., Glavac D. Four novel ATP2A2 mutations in Slovenian patients with Darier disease. J. Am. Acad. Dermatol., 2009, [in press, 5 str.]. ISSN 0190-9622
 
Gómez-Mateo Mdel C, Piqueras M, Påhlman S, Noguera R, Navarro S. Prognostic value of SOX2 expression in neuroblastoma. Genes Chromosomes Cancer. 2011 May;50(5):374-7. doi: 10.1002/gcc.20859. Epub 2011 Feb 8. No abstract available.
 
González CA, Megraud F, Buissoniere A, Lujan Barroso L, Agudo A, Duell EJ, Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Krogh V, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Sanchez-Cantalejo E, Navarro C, Barricarte A, Dorronsoro M, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Bas Bueno-de-Mesquita H, Jeurnink SM, Numans ME, Peeters PH, Lagiou P, Valanou E, Trichopoulou A, Kaaks R, Lukanova-McGregor A, Bergman MM, Boeing H, Manjer J, Lindkvist B, Stenling R, Hallmans G, Mortensen LM, Overvad K, Olsen A, Tjonneland A, Bakken K, Dumeaux V, Lund E, Jenab M, Romieu I, Michaud D, Mouw T, Carneiro F, Fenge C, Riboli E. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol 23:1320-1324, 2012. Epub 2011 Sep 14. doi: 10.1093/annonc/mdr384.
 
Gosens MJ, Dresen RC, Rutten HJ, Nieuwenhuijzen GA, van der Laak JA, Martijn H, Tan-Go I, Nagtegaal ID, van den Brule AJ, van Krieken JH. Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours. Ann Oncol. 2008 Dec;19(12):2026-32. Epub 2008 Jul 29. PMID: 18664561 [PubMed - indexed for MEDLINE]
 
Gottardo F, Cesari M, Morra A, Gardiman M, Fassina A, Dal Bianco M. A kidney tumor in an adolescent with severe hypertension and hypokalemia: an uncommon case-report and review of the literature on reninoma. Urol Int. 2010 Jul;85(1):121-124.
 
Grassilli E, Narloch R, Federzoni E, Ianzano L, Pisano F, Giovannoni R, Romano G, Masiero L, Leone BG, Bonin S, Donada M, Stanta G Helin K, and ML Lavitrano, Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013.
 
Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients. J Cancer Res Clin Oncol. 2010 Sep;136(9):1415-21. Epub 2010 Feb 7.
 
Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease. Mol Carcinog. 2011 Mar;50(3):153-62. doi: 10.1002/mc.20700. Epub 2010 Nov 23.
 
Grauer O.M., Wesseling P., Adema G.J. Immunotherapy of diffuse gliomas: biological background, current status and future developments. Brain Pathology, 2009, 19(4), 674-93.
 
Graulich T, Das SK, Krasteva G, Ruppert C, Wessels L, Hoefler G, Muhlfeld C. Cancer cachexia alters intracellular surfactant metabolism but not total alveolar surface area. Histochem Cell Biol. 2012; 138(5):803-813
 
Graziano SL, Azougagh S, Vollmer R, Kratzke R, Popper H, Filipits M, Tsao M, Seymour L, Rosell R, Taron M, Pignon JP. Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA J THORAC ONCOL. 2009; 4(9):S506-S506. [Oral Communication]
 
Grbeša I, Marinkovic M, Ivkic M, Krušlin B, Pegan B, Bogdanovic O, Bedekovic V, Gall-Trošelj K. Loss of imprinting of IGF2 and H19, loss of heterozigosity of IGF2R and Helicobacter pylori infection in laryngeal squamous cell carcinoma. J Mol Med 2008;86:1057-66 (CC)
 
Grill M, Heinemann A, Hoefler G, Peskar BA, Schuligoi R: Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors. J Neurochem. 2008; 104(5):1345-1357 [Fulltext] [PubMed] [Fulltext MUG-login] [Listed in ISI Web of Science] [Pressetext]
 
Grill C, Guelly C, Ebner B, Leuschner I, Hauser-Kronberger C, Hoefler G, Guertl B. Loss of PTEN/MMAC1 activity is a rare and late event in the pathogenesis of nephroblastomas. Hum Pathol. 2010; 41(8): 1172-1177.
 
Grill C, Sunitsch S, Hatz M, Hauser-Kronberger C, Leuschner I, Hoefler G, Guertl B. Activation of beta-catenin is a late event in the pathogenesis of nephroblastomas and rarely correlated with genetic changes of the APC gene. Pathology. 2011; 43(7): 702-706. Listed in: [ISI:000298489700005]; [PMID:22081130] IF(2011): 2,168; IFnorm: 0,605; Citations (SCI): 0; last update: 16.04.2012. Doi:10.1097/PAT.0b013e32834bf65c
 
Grimstad T, Bjørndal B, Cacabelos D, Aasprong OG, Janssen EA, Omdal R, Svardal A, Hausken T, Bohov P, Portero-Otin M, Pamplona R, Berge RK. Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scand J Gastroenterol. 2012 Jan;47(1):49-58.
 
Grimstad T, Berge RK, Bohov P, Skorve J, Gøransson L, Omdal R, Aasprong OG, Haugen M, Meltzer HM, Hausken T. Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study. Scand J Clin Lab Invest. 2011 Feb;71(1):68-73. PMID: 21142420.
 
Groenen PJ, Blokx WA, Diepenbroek C, Burgers L, Visinoni F, Wesseling P, van Krieken JH. Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase. Histopathology. 2011 Jul;59(1):1-7. doi: 10.1111/j.1365-2559.2010.03711.x.
 
Grubišic I, Lenicek T, Tomas D, Džombeta T, Trnski D, Tomaškovic I, Krušlin B. Primary osteosarcoma of bladder diverticulum mimicking intradiverticular calculus: a case report. Diagn Pathol 2011;6:37 (CC)
 
Gudlaugsson E, Skaland I, Janssen EA, van Diest PJ, Voorhorst FJ, Kjellevold K, Hausen AZ, Baak JP. Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer. Breast Cancer Res Treat. 2010 May;121(1):35-40. 
 
Gudlaugsson E, Skaland I, Undersrud E, Janssen EA, Søiland H, Baak JP. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients. Mod Pathol. 2011 Apr;24(4):502-11.
 
Guertl B, Kratky D, Guelly C, Zhang LF, Gorkiewicz G, Das SK, Tamilarasan KP, Hoefler G. Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy INT J EXP PATHOL. 2009; 90(3): 338-346. [Fulltext][Fulltext MUG-login]
 
Guertl B, Leuschner I, Guelly C, Ebner B, Kronberger C, Hoefler G. Is Predisposition for Nephroblastoma Linked to Polymorphisms of the WTX Gene? Pathol Oncol Res. 2010; 16(2):189-191
 
Guertl B, Senanayake U, Nusshold E, Leuschner I, Mannweiler S, Ebner B, Hoefler G. Lim1, an embryonal transcription factor, is absent in multicystic renal dysplasia, but reactivated in nephroblastomas. Pathobiology. 2011; 78(4):210-219. Listed in: [ISI:000292875700004]; [PMID:21778788] IF(2011): 2,291; IFnorm: 0,645; Citations (SCI): 0; last update: 16.04.2012. Doi:10.1159/000326769
 
Guillou L, Hogendoorn PC, Bosman FT. Soft tissue sarcomas: introduction to theVirchows Archiv review issue. Virchows Arch. 2010 Feb;456(2):107-9. Epub 2010 Feb 18. PubMed PMID: 20165867; PubMed Central PMCID: PMC2828557.
 
Gunia S, May M, Scholmann K, Störkel S, Hoschke B, Koch S, Dietel M, Kristiansen G. Expression of alpha-methylacyl-CoA racemase correlates with histopahologic grading in noninvasive bladder cancer. Virchows Arch. 2008 Aug;453(2):165-70. Epub 2008 Jul 22.
 
Gunia S, May M, Koch S, Dietel M, Erbersdobler A. MUC1 Expression in Incidental Prostate Cancer Predicts Staging and Grading on the Subsequent Radical Prostatectomy. Pathol Oncol Res. 2009 Nov 27. [Epub ahead of print]
 
Gunia S, May M, Koch S, Dietel M, Erbersdobler A. Expression of CD44s in incidental prostate cancer is more strongly associated with Gleason scores on subsequent radical prostatectomies than conventional prognostic parameters. Pathobiology. 2009;76(6):286-92. Epub 2009 Nov 30.PMID: 19955840
 
Guo H, Liu JX, Xu L, Madebo T, Baak JP. Traditional chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined target therapy and chemotherapy. Integr Cancer Ther. 2010 Dec 8.
 
Guo H, Liu L, Baak JP. Is the improvement of prognosis of patients with metastatic pulmonary adenocarcinoma treated with TCM herbal medicine due to lag time to treatment bias? Integr Cancer Ther. 2011 Sep;10(3):234-9. doi: 10.1177/1534735411418112. Epub 2011 Aug 23. PubMed PMID: 21862517.
 
Guo H, Liu JX, Xu L, Madebo T, Baak JP. Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy. Integr Cancer Ther. 2011 Jun;10(2):127-37. Epub 2010 Dec 8. PubMed PMID: 21147812.
 
Haemmerle G, Moustafa T, Woelkart G, Büttner S, Schmidt A, van de Weijer T, Hesselink M, Jaeger D, Kienesberger PC, Zierler K, Schreiber R, Eichmann T, Kolb D, Kotzbeck P, Schweiger M, Kumari M, Eder S, Schoiswohl G, Wongsiriroj N, Pollak NM, Radner FP, Preiss-Landl K, Kolbe T, Rülicke T, Pieske B, Trauner M, Lass A, Zimmermann R, Hoefler G, Cinti S, Kershaw EE, Schrauwen P, Madeo F, Mayer B, Zechner R. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med. 2011; 17(9):1076-1085. Listed in: [ISI:000294605100027]; [PMID:21857651] IF(2011): 25,43; IFnorm: 1; Citations (SCI): 8; last update: 16.04.2012. Doi:10.1038/nm.2439
 
Hager M, Haufe H, Kemmerling R, Hitzl W, Mikuz G, Moser PL, Kolbitsch C. Increased Activated Akt Expression in Renal Cell Carcinomas and Prognosis. J Cell Mol Med. 2008 Sep 4. [Epub ahead of print] PMID: 18774962 [PubMed - as supplied by publisher]
 
Hager M, Mikuz G, Haufe H, Kolbitsch C, Moser KB, Moser PL. Association between atherosclerosis and urothelial tumors of the renal pelvis. World J Urol. 2008 Aug;26(4):375-9. Epub 2008 May 16.
 
Hager M, Mikuz G, Kolbitsch C, Moser PL. Association between local atherosclerosis and renal cell carcinomas. Nutr Cancer. 2008;60(3):364-7.
 
Hainaut P., Bevilacqua G, Bosman F, Dassesse T, Höfler H, Janin A, Langer R, Larsimont D, Morente MM, Riegman P, Schirmacher P, Stanta G, Zatloukal K, Caboux E. “The role of the pathologist in tissue banking: European Consensus Expert Group Report”. Virchows Arch. 2010 Feb 16. [Epub ahead of print] PubMed PMID: 20157825.
 
Halon A, Materna V, Drag-Zalesinska M, Nowak-Markwitz E, Gansukh T, Donizy P, Spaczynski M, Zabel M, Dietel M, Lage H, Surowiak P. Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival. Pathol Oncol Res. 2011 Sep;17(3):511-8. DOI: 10.1007/s12253-010-9340-0, IF=1,483, KBN=20
 
Halon A, Nowak-Markwitz E, Maciejczyk A, Pudelko M, Gansukh T, Györffy B, Donizy P, Murawa D, Matkowski R, Spaczynski M, Lage H, Surowiak P. Loss of estrogen receptor Beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients. Anticancer Res. 2011 Feb;31(2):711-8. IF=1,656, KBN=20
 
Halon A, Nowak-Markwitz E, Donizy P, Matkowski R, Maciejczyk A, Gansukh T, Györffy B, Spaczynski M, Zabel M, Lage H, Surowiak P. Enhanced Immunoreactivity of TIMP-2 in the Stromal Compartment of Tumor as a Marker of Favorable Prognosis in Ovarian Cancer Patients. J Histochem Cytochem. 2012 Apr 17 [Epub ahead of print]
 
Hartmann E, Fernández V, Moreno V, Valls J, Hernández L, Bosch F, Abrisqueta P, Klapper W, Dreyling M, Hoster E, Müller-Hermelink HK, Ott G, Rosenwald A, Campo E. Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue. J Clin Oncol. 2008;26(30):4966-72
 
Hartmann C., Meyer J., Balss J., Capper D., Mueller W., Christians A., Felsberg J., Wolter M., Mawrin C., Wick W., Weller M., Herold-Mende C., Unterberg A., Jeuken J.W.M., Wesseling P., Reifenberger G., von Deimling A. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathologica, 2009, 118(4), 469-74.
 
Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I, Doring C, Cogliatti S, Parrens M, Merlio JP, Kwiecinska A, Porwit A, Piccaluga PP, Pileri S, Hoefler G, Kuppers R, Siebert R, Hansmann ML. High resolution SNP array genomic profiling of peripheral T celllymphomas, not otherwise specified, identifies a subgroup withchromosomal aberrations affecting the REL locus. Brit J Haematol. 2010; 148(3): 402-412. [Fulltext][PubMed][Fulltext MUG-login]
 
Hebbard PC, MacMillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, Kwan A, Boone D, Bursey F, Green J, Fernandez B, Fontaine D, Wirtzfeld DA: Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): The Newfoundland experience with 23 patients. Annals of Surgical Oncology,16:1890-1895, 2009. doi: 10.1245/s10434-009-0471-z.
 
Hebeda K.M., van Altena M.C., Rombout P., van Krieken J.H.J.M., Groenen P.J.T.A. PCR clonality detection in Hodgkin lymphoma. J Hematopathology, 2009, 2(1), 34-41.
 
Heinemann V, Stintzing S, Kirchner T, Boeck S, Jung A. Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. Cancer Treat Rev. 2009 May;35(3):262-71. Epub 2008 Dec 30. Review. PubMed PMID: 19117687.
 
Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre-Millo M, Poitou C, Basdevant A, Stich V, Viguerie N, Langin D, Bedossa P, Zucker JD, Clement K.. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008 Jan 21;9(1):R14
 
Herrmann K, Walch A, Balluff B, Tänzer M, Höfler H, Krause BJ, Schwaiger M, Friess H, Schmid RM, Ebert MP. Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers. Nat Clin Pract Gastroenterol Hepatol. 2009 Mar;6(3):170-83.
 
Hipp S, Walch A, Schuster T, Höfler H, Becker KF Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin Exp Metastasis. 2008; 25(6):679-83.
 
Hipp S, Berg D, Ergin B, Schuster T, Hapfelmeier A, Walch A, Avril S, Schmalfeldt B, Höfler H, Becker KF. Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients. Virchows Arch. 2010 Dec;457(6):705-713. IF 2.3
 
Hoel Lende T, Janssen EA, Gudlaugsson E, Voorhorst F, Smaaland R, van Diest P, Søiland H, Baak JP. In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant! J Clin Oncol. 2010 Dec 28.  
 
Hofstetter B, Niemierko A, Forrer C, Benhattar J, Albertini V, Pruschy M, Bosman FT, Catapano CV, Ciernik IF. Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:1512-9.
 
Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Pahlman S., “Recruitment of HIF-1 alpha and HIF-2 alpha to common target genes is differentially regulated in neuroblastoma: HIF-2 alpha promotes an aggressive phenotype”. Cancer Cell 10(5):413-23, 2006.
 
Horst D, Kriegl L, Engel J, Kirchner T, Jung A. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer. 2008 Oct 21;99(8):1285-9. Epub 2008 Sep 9.
 
Horst D, Budczies J, Brabletz T, Kirchner T, Hlubek F. Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer. Cancer. 2009 Nov 1;115(21):4946-58. PubMed PMID: 19658179.
 
Horst D, Kriegl L, Engel J, Kirchner T, Jung A. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest. 2009 Oct;27(8):844-50. PubMed PMID: 19626493.
 
Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol. 2009 Dec;219(4):427-34. PubMed PMID: 19621338.
 
Horst D, Kriegl L, Engel J, Jung A, Kirchner T. CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer. 2009 Jul;45(11):2034-40. Epub 2009 May 4. PubMed PMID: 19403300.
 
Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer. Cancer. 2009 May 15;115(10):2063-70. PubMed PMID: 19298008.
 
Hrabar D, Aralica G, Gomercic M, Ljubicic N, Kruslin B, Tomas D. Epithelial and stromal expression of syndecan-2 in pancreatic carcinoma. Anticancer Res. 2010 Jul;30(7):2749-53.
 
Huerta JM, Navarro C, Chirlaque MD, Tormo MJ, Steindorf K, Buckland G, Carneiro F, Johnsen NF, Overvad K, Stegger J, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Boeing H, Kaaks R, Rohrmann S, Vigl M, Lagiou P, Trichopoulos D, Trichopoulou A, Bas Bueno-de-Mesquita H, Monninkhof EM, Numans ME, Peeters PH, Mattiello A, Pala V, Palli D, Tumino R, Vineis P, Agudo A, Ardanaz E, Arriola L, Molina-Montes E, Rodríguez L, Lindkvist B, Manjer J, Stenling R, Lund E, Crowe FL, Key TJ, Khaw KT, Wareham NJ, Jenab M, Norat T, Romaguera D, Riboli E, González CA. Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort. Cancer Causes & Control 21:657-669, 2010. doi: 10.1007/s10552-009-9493-x.
 
Ihrler S, Schwarz S, Zengel P, Guntinas-Lichius O, Kirchner T, Weiler C. [Pleomorphic adenoma: pitfalls and clinicopathological forms of progression]. Pathologe. 2009 Nov;30(6):446-56. German. PubMed PMID: 19844715.
 
Ihrler S, Rath C, Zengel P, Kirchner T, Harrison JD, Weiler C. Pathogenesis of sialadenosis: possible role of functionally deficient myoepithelial cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):218-23.
 
Illueca C, Machado I, Cruz J, Almenar S, Noguera R, Navarro S, Llombart-Bosch A. Pleomorphic hyalinizing angiectatic tumor: a report of 3 new cases, 1 with sarcomatous myxofibrosarcoma component and another with unreported soft tissue palpebral location. Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):96-101. 
 
Iosif C I, Georgescu A, Ceausu M, Vasilescu F, Arsene D, Mihai M, Terzea D, Dobrea C, Enache S, Visan A, Butur G, Ardeleanu C: CD117 expression with molecular analysis of muations in ISH-EBV positive undifferentiated nasopharyngeal carcinomas, 22nd European Congress of Pathology, Florence, 4-9 september 2009, Virchows Archiv (2009) 455 (Suppl 1), ISSN 0945-6317, vol rez, pg. 322
 
Jahn S, Minai-Pour MB, Speicher MR, Reiner-Concin A, Hoefler G. Comprehensive screening for Lynch syndrome: who can be the driving force in daily clinical practice? J Clin Oncol. 2009; 27(13):2292-2292[Fulltext][PubMed][FulltextMUG-login]
 
Jahn SW, Winter G, Stacher E, Halbwedl I, Gattenlöhner S, Stockinger R, Spreitzer S, Waldispuehl-Geigl J, Geigl JB, Offner F, Hoefler G. Multiple intratumoral KRAS mutations can clonally segregate to different lymph node metastases in colon cancer. Histopathology. 2011; 59(2):342-345. Listed in: [ISI:000294786300023]; [PMID:21884216] IF(2011): 3,569; IFnorm: 0,816; Citations (SCI): 1; last update: 16.04.2012. Doi:10.1111/j.1365-2559.2011.03902.x
 
Jakovljevic G, Nakic M, Rogosic S, Kardum-Skelin I, Mrsic-Davidovic S, Zadro R, Krušlin B. Pre-B cell acute lymphoblastic leukemia with bulk extramedullary disease and chromosome 22 (EWSR1) rearrangement masquerading as Ewing's sarcoma. Pediatr Blood Cancer 2010;54:606-9 (CC)
 
Jansen C, Hebeda KM, Linkels M, Grefte JM, Raemaekers JM, van Krieken JH, Groenen PJ. Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol. 2008;30(1):27-38. PMID: 18219108 [PubMed - indexed for MEDLINE]
 
Jansen C, Feuth T, Raemaekers JM, Rijntjes J, Meijer JW, Westenend PJ, van Baarlen J, van Krieken JH, Hebeda KM, Groenen PJ. Protein profiling in pathology: analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas. Proteomics Clin Appl. 2010 May;4(5):519-27.
 
Janssen EA, Øvestad IT, Skaland I, Søiland H, Gudlaugsson E, Kjellevold KH, Nysted A, Søreide JA, Baak JP. LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer. Cell Oncol. 2009;31(5):335-43.
 
Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, Baak JP. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol. 2010 Dec;23(12):1567-76. Epub 2010 Sep 3.
 
Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol. 2008 Apr 10. [Epub ahead of print]
 
Jenab M, McKay JD, Ferrari P, Biessy C, Laing S, Capella Munar GM, Sala N, Peña S, Crusius JB, Overvad K, Jensen MK, Olsen A, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Georgila C, Psaltopoulou T, Mattiello A, Vineis P, Pala V, Palli D, Tumino R, Numans ME, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Sánchez MJ, Dorronsoro M, Navarro Sanchez C, Quirós JR, Hallmans G, Stenling R, Manjer J, Régner S, Key T, Bingham S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Carneiro F, Riboli E, Gonzalez C:  CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). European Journal of Cancer 44:774-780, 2008. doi: 10.1016/j.ejca.2008.02.003.
 
Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, Bonetti F, Kingswood C, Review Panel of the ERS LAM Task Force. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010; 35(1):14-26
 
Jöhrens K, Franke A, Dietel M, Anagnostopoulos I. Non-neoplastic TdT-positive cells in bone marrow trephines with acute myeloid leukaemia before and after treatment express myeloid molecules. Pathobiology. 2011;78(1):35-40. Epub 2011 Apr 5.
 
Jöhrens K, Dietel M, Anagnostopoulos I. Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2012 Jan;53(1):152-5. Epub 2011 Sep 19.
 
Jukic Z, Tomas D, Mijic A, Krušlin B. Expression of growth hormone receptor and growth hormone in colorectal carcinoma. Hepatogastroenterology 2009;56:85-8 (CC)
 
Jukic Z, Ledinsky I, Ulamec M, Ledinsky M, Krušlin B, Tomas D. Primary acantholytic squamous cell carcinoma of the cecum: a case report. Diagn Pathol. 2011 Jan 11;6(1):5.
 
Jukic Z, Ledinsky M, Ledinsky M, Krušlin B, Tomas D. Primary acantholytic squamous cell carcinoma of the cecum: a case report. Diagn Pathol 2011;6:5 (CC)
 
Jung A, Jaitner S, Schäffauer AJ, Kirchner T. [mRNA quantification. The next challenge in routine diagnostics]. Pathologe. 2010 Oct;31 Suppl 2:280-4. German.
 
Juric I, Pogorelic Z, Kuzmic-Prusac I, Biocic M, Jakovljevic G, Stepan J, Zupancic B, Culic S, Kruslin B. Expression and prognostic value of the Ki-67 in Wilms' tumor: experience with 48 cases. Pediatr Surg Int. 2010 May;26(5):487-93.
 
Kamal NS, Soria JC, Mendiboure J, Planchard D, Olaussen KA, Rousseau V, Popper H, Pirker R, Bertrand P, Dunant A, Le Chevalier T, Filipits M, Fouret P; International Adjuvant Lung Trial-Bio Investigators. MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer. Clin Cancer Res. 2010; 16(4): 1206-1215. [Fulltext][PubMed][Fulltext MUG-login]
 
Kamphues C, Wittschieber D, Klauschen F, Kasajima A, Dietel M, Schmidt SC, Glanemann M, Bahra M, Neuhaus P, Weichert W, Stenzinger A. Prolyl hydroxilase domain 2 protein is a strong prognostic marker in human gastric cancer. Pathobiology. 2012;79(1):11-7. Epub 2012 Jan 12.
 
Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B,
Viertler C, Groelz D, Becker KF, Zatloukal K, Langer R, Slotta-Huspenina J, Bodo K, de Jong B, Oelmuller U, Riegman P. Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS One. 2011;6(11):e27704. IF 4.4
 
Karam R, Carvalho J, Bruno I, Graziadio C, Senz J, Hunstman D, Carneiro F, Seruca R, Wilkinson MF, Oliveira C: The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers. Oncogene 27: 4255-4260, 2008. doi: 10.1038/onc.2008.62.
 
Kasajima A, Pavel M, Darb-Esfahani S, Noske A, Stenzinger A, Sasano H, Dietel M, Denkert C, Röcken C, Wiedenmann B, Weichert W. mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2011 Jan 13;18(1):181-92. Print 2011 Feb.
 
Kempkensteffen C, Fritzsche FR, Johannsen M, Weikert S, Hinz S, Dietel M, Riener MO, Moch H, Jung K, Krause H, Miller K, Kristiansen G. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer. 2009 Aug 8;9:276.PMID: 19664236
 
Kets CM, Hoogerbrugge N, van Krieken JH, Goossens M, Brunner HG, Ligtenberg MJ. Compound heterozygosity for two MSH2 mutations suggests mild consequences of the  initiation codon variant c.1A>G of MSH2. Eur J Hum Genet. 2009 Feb;17(2):159-64. Epub 2008 Sep 10. PMID: 18781192 [PubMed - indexed for MEDLINE]
 
Kets CM, van Krieken JH, van Erp PE, Feuth T, Jacobs YH, Brunner HG, Ligtenberg MJ, Hoogerbrugge N. Is early-onset microsatellite and chromosomally stable colorectal cancer a hallmark of a genetic susceptibility syndrome? Int J Cancer. 2008 Feb 15;122(4):796-801. PMID: 17957798 [PubMed - indexed for MEDLINE]
 
Kirchner T, Jung A. Pathological diagnosis for individualized therapy of colorectal cancer. Pathologe. 2010 Feb;31(1):16-21. Review. German.
 
Klauschen F, von Winterfeld M, Stenzinger A, Sinn BV, Budczies J, Kamphues C, Bahra M, Wittschieber D, Weichert W, Striefler J, Riess H, Dietel M, Denkert C. High nuclear poly-(ADP-ribose)-polymerase expression in prognostic of improved survival in pancreatic cancer. Histopathology. 2012 Mar 2. doi: 10.1111/j.1365-2559.2012.04225.x. [Epub ahead of print]
 
Klöppel G, Couvelard A, Perren A, Komminoth P, Mc Nicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Rindi G, Plockinger U. ENETS Guidelines for the Standards of Care in Patients with Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification. Neuroendocrinology, 2008.
 
Knösel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn’s disease. Pathol Res Pract. 2009 Jan 29. [Epub ahead of print]
 
Kocjan BJ, Poljak M, Cimerman M, Gale N, Potocnik M, Bogovac Z, Seme K.Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6). Virology. 2009 Sep 1;391(2):274-83
 
Kocjan G, Cochand-Priollet B, de Agustin PP, Bourgain C, Chandra A, Daneshbod Y et al. Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology 2010 Apr;21(2):86-92.
 
Kocjan Bj, GaleN, Hocevar Boltežar I, Seme K, Fujs Komloš K, Hošnjak L, Maver PJ, Jelen MM, Zupanic Pajnic I, Balažic J, Poljak M. Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. J Infect Dis. 2013; 207:583-587.
 
Kocjan Bj, Maver PJ, Hošnjak L, Zidar N, Odar K, Gale N, Pojak M. Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers. Acta Dermatovenerol Alp Panonica Adriat. 2012; 21:73-75.
 
Kojc N, Zidar N, Gale N, Poljak M, Fujs Komlos K, Cardesa A, Höfler H, Becker KF. Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2009 May;454(5):549-55.
 
Komloš KF, Kocjan BJ, Košorok P, Luzar B, Meglic L, Potocnik M, Hocevar Boltežar I, Gale N, Seme K, Poljak M. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol. 2012; 84:1233-1241.
 
Koopman M, Kortman GA, Mekenkamp L, Ligtenberg MJ, Hoogerbrugge N, Antonini NF, Punt CJ, van Krieken JH. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009 Jan 27;100(2):266-73. PMID: 19165197 [PubMed - indexed for MEDLINE]
 
Korošec B., Glavac D., Volavšek M., Ravnik-Glavac M. ATP2A3 gene is involved in cancer susceptibility. Cancer Genet Cytogenet. 2009 Jan 15;188(2):88-94. ISSN 0165-4608
 
Korosec B, Glavac D, Volavsek M, Ravnik-Glavac M. Alterations in genes encoding sacroplasmatic-endoplasmatic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma. Cancer Genet Cytogenet. 2008 Mar;181(2):112-8.  
 
Kothmaier H, Quehenberger F, Halbwedl I, Morbini P, Demirag F, Zeren H, Comin CE, Murer B, Cagle PT, Attanoos R, Gibbs AR, Gallateau- Salle F, Popper HH.”EGFR And PDGFR Differentially Promote Growth In Malignant Epitheloid Mesothelioma Of Short- And Long-term Survivors”. Thorax. 2007 Dec 17; [Epub ahead of print]
 
Kothmaier H, Faoro V, Daniele L, Zamò A, Rossoni R, Schott C, Bussolati G, Stanta G, Popper HH, Becker KF. Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues Virchows Archiv. 2009; 455: 23-23. [Oral Communication]
 
Kothmaier H, Rohrer D, Stacher E, Quehenberger F, Becker KF, Popper HH. Comparison of formalin-free tissue fixatives: a proteomic study testing their application for routine pathology and research. Arch Pathol Lab Med. 2011. Jun;135(6):744-52.  IF 2.5
 
Koussis H, Maruzzo M, Scola A, Ide EC, Fassina A, Marioni G et al. A case of anaplastic thyroid cancer with long-term survival. Anticancer Res. 2010 Apr;30(4):1273-1278.
 
Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D: Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res. 2009; 50(2):312-326 [Fulltext] [PubMed] [FulltextMUG-login] [Listed in ISI Web of Science]
 
Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res. 2009; 50(2): 312-326. [Fulltext][PubMed][Fulltext MUG-login][Cited by (Google scholar)]
 
Kriegl L, Horst D, Reiche JA, Engel J, Kirchner T, Jung A. LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J Transl Med. 2010 Nov 22;8:123.
 
Kriegl L, Jung A, Engel J, Jackstadt R, Gerbes AL, Gallmeier E, Reiche JA, Hermeking H, Rizzani A, Bruns CJ, Kolligs FT, Kirchner T, Göke B, De Toni EN. Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma. Clin Cancer Res. 2010 Nov 15;16(22):5529-38.
 
Kristiansen G, Fritzsche FR, Wassermann K, Jäger C, Tölls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer. 2008 Sep 16;99(6):939-48.
 
Kroll J, Becker KF, Kuphal S, Hein R, Hofstädter F, Bosserhoff AK. “Isolation of high quality protein samples from punches of formalin fixed and paraffin embedded tissue blocks”. Histol Histopathol. 2008 Apr;23(4):391-5.
 
Kruse AJ, Slangen B, Dunselman GA, Pirens T, Bakers FC, Baak JP, de Vijver KV. Neoplastic transformation of endocervicosis into an extraovarian mucinous cystadenocarcinoma. Hum Pathol. 2011 May;42(5):743-8. Epub 2011 Jan 15. PubMed PMID: 21237491.
 
Krušlin B. Apoptoza u patološkim procesima prostate. Acta med Croat 2009;63:49-52. (Suppl 2) (IM)
 
Krušlin B, Tomas D, Mikuz. Periacinar retraction artifact of the prostate. G.Front Biosci (Schol Ed). 2011 Jan 1;3:226-35.
 
Krušlin B, Tomas D, Spajic B. Pathohistological diagnosis of prostatic carcinoma in needle core biopsies. Lijec Vjesn. 2010 May-Jun;132(5-6):155-61. Review. Croatian.
 
Krušlin B, Tomas D, Mikuz G. Periacinar retraction artifact of the prostate. Front Biosci 2011;1:226-35 (CC)
 
Kuhn KA, Knoll A, Mewes HW, Schwaiger M, Bode A, Broy M, Daniel H, Feussner H, Gradinger R, Hauner H, Höfler H, Holzmann B, Horsch A, Kemper A, Krcmar H, Kochs EF, Lange R, Leidl R, Mansmann U, Mayr EW, Meitinger T, Molls M, Navab N, Nüsslin F, Peschel C, Reiser M, Ring J, Rummeny EJ, Schlichter J, Schmid R, Wichmann HE, Ziegler S. Informatics and medicine--from molecules to populations. Methods Inf Med. 2008;47(4):283-95.
 
Kumps C, Van Roy N, Heyrman L, Goossens D, Del-Favero J, Noguera R, Vandesompele J, Speleman F, De Preter K. Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma. BMC Genomics. 2010 May 12;11:298. 
 
Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merke O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, Hofler G, Piva R, Medico E, Ruggeri BA, Cheng MG, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L. PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med. 2012; 18(11):1699-1704.
 
Lambert J, Halfon P, Penaranda G, Bedossa P, Cacoub P, Carrat F. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem. 2008 Aug;54(8):1372-8.
 
Lauwers GY, Carneiro F, Graham DY, Curado M-P, Franceschi S, Montgomery E, Tatematsu M, Hattori T: Gastric Carcinoma. In: WHO Classification of Tumours of the Digestive System, Fouth Edition. Bosman FT, Carneiro F, Hruban RH and Theise ND (eds), IARC Press: Lyon, 2010; Pp 48-58.
 
Lazar N, Manara C, Navarro S, Bleau AM, Llombart-Bosch A, Scotlandi K, Planque N, Perbal B. “Domain-specific CCN3 antibodies as unique tools for structural and functional studies”. J Cell Communication & signaling, 2007. In press.
 
Lehmann A, Denkert C, Budczies J, Buckendahl AC, Darb-Esfahani S, Noske A, Müller BM, Bahra M, Neuhaus P, Dietel M, Kristiansen G, Weichert W. High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo. BMC Cancer. 2009 Nov 13;9:395.PMID: 19912635
 
Lehmann A, Schewe C, Hennig G, Denkert C, Weichert W, Budczies J, Dietel M. Applicability of a System for Fully Automated Nucleic Acid Extraction from Formalin-fixed Paraffin-embedded Sections for Routine KRAS Mutation Testing. Diagn Mol Pathol. 2012 May 1. [Epub ahead of print]
 
Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, Manuel Soares J, Castedo S, Carneiro F, Roviello F, Oliveira C, Seruca R. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer 128:1606-1613, 2011. doi: 10.1002/ijc.25495.
 
Leitner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy. Lung Cancer. 2009; 65(1): 98-104. [Fulltext] [PubMed] [FulltextMUG-login]
 
Lenassi E., Jarc-Vidmar M., Glavac D., Hawlina M. Pattern electroretinography of larger stimulus field size and spectral-domain optical coherence tomography in patients with stargardt disease. Br. j. ophthalmol., 2009; 93(12): 1600-1605. ISSN 0007-1161
 
Lende TH, Janssen EA, Gudlaugsson E, Voorhorst F, Smaaland R, van Diest P, Søiland H, Baak JP. In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant! J Clin Oncol. 2011 Mar 1;29(7):852-8.
 
Lenicek T, Serda F, Demirovic A, Mijic A, Kruslin B, Tomas D. “Pleomorphic ductal carcinoma of the breast with predominant micropapillary features”. Pathol Int 2007;57:694–7.
 
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar 21;319(5870):1676-9.
 
Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5.
 
Le Renard PE, Buchegger F, Petri-Fink A, Bosman F, Rüfenacht D, Hofmann H,Doelker E, Jordan O. Local moderate magnetically induced hyperthermia using animplant formed in situ in a mouse tumor model. Int J Hyperthermia. 2009May;25(3):229-39. PubMed PMID: 19437238.
 
Le Renard PE, Jordan O, Faes A, Petri-Fink A, Hofmann H, Rüfenacht D, BosmanF, Buchegger F, Doelker E. The in vivo performance of magnetic particle-loadedinjectable, in situ gelling, carriers for the delivery of local hyperthermia.Biomaterials. 2010 Feb;31(4):691-705. Epub 2009 Oct 29. PubMed PMID: 19878991.
 
Lerma E, Romero M, Gallardo A, Pons C, Muñoz J, Fuentes J, Lloveras B, Catasus L, Prat J. Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma. Virchows Arch 2008; 452:65-74.
 
Lerma E, Catasus L, Gallardo A, Peiro G, Alonso C, Aranda I, Barnadas A, Prat J. Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas. Virchows Arch. 2008; 453:133-139.
 
Lerma E, Barnadas A, Prat J. Triple negative breast carcinomas: similarities and differences with
basal like carcinomas. Appl Immunohisto M M (in press).
 
Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H, Leoncini L. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol. 2008 Dec;216(4):440-50. PMID: 18802929 [PubMed - indexed for MEDLINE]
 
Li H, Shen X, Ying J, Zhao L, Jin M, Thu S, Sun C, Voorhorst F, Soiland H, Lende T, Baak JP. Patients with clinical/radiological hyperplasia of mammary glands show pathological persistence of temperature of skin points. Anticancer Res. 2009 Nov;29(11):4697-702.
 
Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet. 2009 Jan;41(1):112-7. Epub 2008 Dec 21. PMID: 19098912 [PubMed - indexed for MEDLINE]
 
Limbäck-Stokin C., Glavac D., Popovic M. A case of haemangioblastoma of the fourth ventricle presenting with depression. Br. med. j. (Clin. res. ed. 1981), 2009, [Str. 1-3]. ISSN 0959-8138
 
Llombart-Bosch A, Machado I, Navarro S, Bertoni F, Bacchini P, Alberghini M, Karzeladze A, Savelov N, Petrov S, Alvarado-Cabrero I, Mihaila D, Terrier P, Lopez-Guerrero JA, Picci P. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch. 2009 Nov;455(5):397-411.
 
Löfstedt T, Fredlund E, Noguera R, Navarro S, Holmquist-Mengelbier L, Beckman S, Påhlman S, Axelson H. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells. Exp Cell Res. 2009 Jul 1;315(11):1924-36.
 
López-Guerrero JA, Machado I, Scotlandi K, Noguera R, Pellín A, Navarro S, Serra M, Calabuig-Fariñas S, Picci P, Llombart-Bosch A. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors. Int J Cancer. 2011 Mar 1;128(5):1139-50. doi: 10.1002/ijc.25424.
 
Lorenzen S, Brücher B, Zimmermann F, Geinitz H, Riera J, Schuster T, Roethling N, Höfler H, Ott K, Peschel C, Siewert JR, Molls M, Lordick F. Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Br J Cancer. 2008 Oct 7;99(7):1020-6.
 
Lovric E, Gatalica Z, Eyzaguirre E, Kruslin B. Expression of maspin and glutathionine-S- transferase-pi in normal human prostate and prostatic carcinomas. Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):429-32.
 
Lovric E, Hizak DB, Balja MP, Lenicek T, Kruslin B. An unusual mixed germ cell tumor of the testis consisting of rhabdomyosarcoma, mature teratoma and yolk sac tumor. Asian J Androl. 2010 May;12(3):451-2.
 
Lumachi F, Fabbro M, Tregnaghi A, Antunovic L, Bui F, Cecchin D et al. Fine-needle aspiration cytology and (99m) Tc-pertechnetate scintigraphy together in patients with differentiated thyroid carcinoma. Anticancer Res. 2010 Jul;30(7):3083-3086.
 
Lundberg G, Sehic D, Länsberg JK, Ora I, Frigyesi A, Castel V, Navarro S, Piqueras M, Martinsson T, Noguera R, Gisselsson D. Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas. Genes Chromosomes Cancer. 2011 Apr;50(4):250-62. doi: 10.1002/gcc.20850. Epub 2011 Jan 14.
 
Lupi I, Manetti L, Caturegli P, Menicagli M, Cosottini M, Iannelli A, Acerbi G, Bevilacqua G, Bogazzi F, Martino E. Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab 95: 289-296, 2010.
 
Machado I, Giner F, Mayordomo E, Carda C, Nacarro S, Llombart-Bosch A. Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study. Diagn Pathol. 15(3) Suppl1: 25, 2008.
 
Machado AM, Figueiredo C, Touati E, Máximo V, Sousa S, Michel V, Carneiro F, Nielsen FC, Seruca R, Rasmussen LJ: Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clinical Cancer Research, 15:2995-3002, 2009. doi: 10.1158/1078-0432.CCR-08-2686.
 
Machado I, Noguera R, Pellin A, Lopez-Guerrero JA, Piqueras M, Navarro S, Llombart-Bosch A. Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR. Diagn Mol Pathol. 2009 Dec;18(4):189-99.
 
Machado I, Noguera R, Santonja N, Donat J, Fernandez-Delgado R, Acevedo A, Baragaño M, Navarro S. Immunohistochemical Study as a Tool in Differential Diagnosis of Pediatric Malignant Rhabdoid Tumor. Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):150-8.
 
Machado I, Navarro S, Giner F, Alberghini M, Bertoni F, Llombart-Bosch A. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors. Virchows Arch. 2010 Jul;457(1):87-9. Epub 2010 Jun 16.
 
Machado I, Noguera R, Mateos EA, Calabuig-Fariñas S, López FI, Martínez A, Navarro S, Llombart-Bosch A. The many faces of atypical Ewing's sarcoma. A true entity mimicking sarcomas, carcinomas and lymphomas. Virchows Arch. 2011 Mar;458(3):281-90. Epub 2010 Dec 23.
 
Machado I, Alberghini M, Giner F, Corrigan M, O'Sullivan M, Noguera R, Pellin A, Bertoni F, Llombart-Bosch A. Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases. Histopathology. 2010 Jul;57(1):162-7. Epub 2010 Jun 14.
 
Mache, CJ; Gamillscheg, A; Popper, HH; Haworth, SG.: Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1. Thorax. 2008; 63(1):85-86 [Fulltext] [PubMed] [Fulltext MUG-login] [Listed in ISI Web of Science].
 
Maciejczyk A, Szelachowska J, Szynglarewicz B, Szulc R, Szulc A, Wysocka T, Jagoda E, Lage H, Surowiak. P. CD46 expression is an unfavorable prognostic factor in breast cancer cases. Appl.Immunohistochem.Mol.Morphol. 2011 Dec;19(6):540-6.; DOI: 10.1097/PAI.0b013e31821a0be9, IF=1.411, KBN=27.000.
 
Maciejczyk A, Jagoda E, Wysocka T, Matkowski R, Györffy B, Lage H, Surowiak P. ABCC2 (MRP2, cMOAT) Localized in the Nuclear Envelope of Breast Carcinoma Cells Correlates with Poor Clinical Outcome. Pathol Oncol Res. 2012 Apr;18(2):331-42.,   IF=1,483, KBN=20.
 
Mæland Nilsen M, Uleberg KE, Janssen EA, Baak JP, Andersen OK, Hjelle A. From SELDI-TOF MS to protein identification by on-chip elution. J Proteomics. 2011 Nov 18;74(12):2995-8.
 
Magnowska M, Surowiak P, Nowak-Markwitz E, Michalak M, Magnowski P, Rokita W, Kedzia H, Zabel M, Spaczynski M. Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.Ginekol Pol. 2008 Dec;79(12):826-34.
 
Malcic A, Jukic S, Anic I, Pavelic B, Kapitanovic S, Krušlin B, Pavelic K. Alterations of FHIT and p53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst. J Oral Pathol Med 2008;37:294-301 (CC)
 
Malinowsky K, Wolff C, Ergin B, Berg D, Becker KF. Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J. Cell. Physiol. 225: 364–370, 2010. DOI: 10.1002/jcp.22307 IF 4.5
 
Malinowsky K, Böllner C, Hipp S, Berg D, Schmitt M, Becker KF. UPA and PAI-1 analysis from fixed tissues - new perspectives for a known set of predictive markers. Curr Med Chem. 2010;17(35):4370-7 IF 4.8
 
Malinowsky K, Wolff C, Gündisch S, Berg D, Becker KF. Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues. J Cancer 2011; 2:26-35
 
Malinowsky K, Wolff C, Berg D, Schuster T, Walch A, Bronger H, Mannsperger H,  Schmidt C, Korf U, Höfler H, Becker KF. uPA and PAI-1-Related Signaling Pathways  Differ between Primary Breast Cancers and Lymph Node Metastases. Transl Oncol. 2012 Apr;5(2):98-104.
 
Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, De Ledinghen V, Beaugrand M. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009 Feb;29(2):242-7
 
Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Di Coscio G, Pinchera A, Bevilacqua G. A Morpho-Molecular Diagnosis of Papillary Thyroid Carcinoma: BRAF V600E Detection as an Important Tool in Preoperative Evaluation of Fine-Needle Aspirates.Thyroid 19: 837-842, 2009
 
Marchiò C, Iravani M, Natrajan R, Lambros MB, Savage K, Tamber N, Fenwick K, Mackay A, Senetta R, Di Palma S, Schmitt FC, Bussolati G, Ellis LO, Ashworth A, Sapino A, Reis-Filho JS. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol. 2008 Aug;215(4):398-410.
 
Marchiò C, Lambros MB, Gugliotta P, Di Cantogno LV, Botta C, Pasini B, Tan DS, Mackay A, Fenwick K, Tamber N, Bussolati G, Ashworth A, Reis-Filho JS, Sapino A. Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis. J Pathol. 2009 Sep;219(1):16-24. PubMed PMID: 19670217.
 
Marchiò C, Iravani M, Natrajan R, Lambros MB, Geyer FC, Savage K, Parry S, Tamber N, Fenwick K, Mackay A, Schmitt FC, Bussolati G, Ellis I, Ashworth A, Sapino A, Reis-Filho JS. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. J Pathol. 2009 Jul;218(3):301-15. PubMed PMID: 19479727.
 
Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Machado JC, Figueiredo C, Reis CA, Ferreira J, Areias J. First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies? Fam Cancer 11:137-143, 2012. doi: 10.1007/s10689-011-9488-0.
 
Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Wen X, Lopes C, Figueiredo C, Machado JC, Ferreira R, Reis C, Canedo P, Durães C, Ferreira J, Pedroto I, Areias J: First Degree Relatives of Early-Onset Gastric Cancer Patients show a high risk for gastric cancer: phenotype and genotype profile. Alimentary Pharmacology & Therapeutics 2012 May 2 [Epub ahead of print]. doi: 10.1111/j.1365-2036.2012.05111.x.
 
Marín-Aguilera M, Codony-Servat J, Kalko SG, Fernandez PL, Bermudo R, Buxo E, Ribal MJ, Gascón P, Mellado B. Identification of docetaxel resistance genes in castration-resistant prostate cancer. Mol Cancer Ther. 2012;11:329-39
 
Mariniello B, Finco I, Sartorato P, Patalano A, Iacobone M, Guzzardo V et al. Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells. J Endocrinol Invest. 2010 Oct 27.
 
Marques M, Magro F, Cardoso H, Carneiro F, Portugal R, Lopes J, Costa Santos C: Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis. Inflammatory Bowel Diseases 14:723-725, 2008. doi: 10.1002/ibd.20293.
 
Marroni F, Cipollini G, Peissel B, D’Andrea E, Pensabene M, Radice P, Caligo MA, Presciuttini S, Bevilacqua G. Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic Analysis. Ann Hum Genet 72: 310-318, 2008
 
Martelli MP, Sozzi G, Hernandez L, Pettirossi V, Navarro A, Conte D, Gasparini P, Perrone F, Modena P, Pastorino U, Carbone A, Fabbri A, Sidoni A, Nakamura S, Gambacorta M, Fernández PL, Ramirez J, Chan JK, Grigioni WF, Campo E, Pileri SA, Falini B. EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. Am J Pathol. 2009 Feb;174(2):661-70
 
Martinez-Rodriguez M, Sumramaniam MM, Calatayud AM, Ramos D, Navarro S, Llombart-Sosch A. Ossifying fibromyxoid tumor of soft parts mimicking a shwannoma with uncommon histology: a potential diagnosis pitfall. J Cutan Pathol. 36(1):71-3, 2009
 
Marušic Z, Stastny T, Kirac I, Stojcevic D, Krušlin B, Tomas D. Subcutaneous Dirofilariasis caused by Dirofilaria repens diagnosed by histopathologic and polymerase chain reaction analysis. Acta Dermatovenerol Croat 2008;16:222-5 (IM)
 
Marušic Z, Zhang D, Krušlin B.Bladder Cancer Therapy Related Histopathologic Changes.The Open Pathology Journal, 2009;3:74-80.
 
Marušic Z, Cupic H, Krušlin B, Tomas D,  Miloševic M, Mikuz G.Tumor-associated tissue eosinophilia and inflammation in pTa and pT1 papillary urothelial carcinoma of the bladder. AnalytQuantCytolHistol 2009;31:239 (CC)
 
Marušic Z, Zovak M, Hagenkord JM, Kash S, Koul MS, Sanger W, Gatalica Z, Kruslin B, Tomas D. Papillary renal cell-like carcinoma in a retroperitoneal teratoma. Pathol Int. 2010 Aug;60(8):581-5.
 
Mateo F, Fernández PL, Thomson TM. Stem cells in prostate cancer. Arch Esp Urol 2013; 66: 475-486.
 
Matkovic B, Juretic A, Šeparovic V, Novosel I, Šeparovic R, Gamulin M, Krušlin B. Immunohistochemical analysis of ER, PR and HER-2 antigen expression in medullary breast cancer. Tumori 2008;94:838-44 (CC)
 
Matkovic B, Juretic A, Spagnoli GC, Šeparovic V, Gamulin M, Šeparovic R, Šaric N, Bašic-Koretic M, Novosel I, Krušlin B. Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: a retrospective immunohistochemical study. Croat Med J 2011;52:171-7. (CC)
 
Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology. 2008 Sep;135(3):821-9.
 
Mayordomo E, Machado I, Giner F, Kresse SH, Myklebost O, Carda C, Navarro S, Llombart-Bosch A. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models. Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):453-61.
 
Mayr D, Heim S, Werhan C, Zeindl-Eberhart E, Kirchner T. Comprehensive immunohistochemical analysis of Her-2/neu oncoprotein overexpression in breast cancer: HercepTest (Dako) for manual testing and Her-2/neuTest 4B5 (Ventana) for Ventana BenchMark automatic staining system with correlation to results of fluorescence in situ hybridation (FISH). Virchows Arch. 2009 Mar;454(3):241-8. Epub 2009 Jan 24.
 
Mayr D, Heim S, Weyrauch K, Zeindl-Eberhart E, Kunz A, Engel J, Kirchner T. Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization. Histopathology. 2009 Dec;55(6):716-23. Epub . PubMed PMID: 19922593.
 
Mazzeo S., Cappelli C., Caramella D., Del Chiaro M., Campani D., Pollina L., Caproni G., Battaglia V., Belcari A., Funel N., Di Candio G., Forasassi F., Boggi U., Bevilacqua G., Mosca F., Bartolozzi C.: “Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology”. Abdom Imaging. 2007 Mar 27; [Epub ahead of print]. PMID: 17387543 [PubMed - as supplied by publisher]
 
Mejia C, Navarro S, Llombart-Bosch A. ,“Apoptosis in peripheral neuroblastic tumors. Immunohistochemical expression of bcl-2 and p53 is related to DNA fragmentation”. Histol Histopathol 22: 1365-1370, 2007
 
Mejia C, Navarro S, “Focus on Neuroblastoma Research: Expression of apoptotic molecules and telomerase subunits in peripheral neuroblastic tumors”. ISBN: 1-60021-484-3. Nova ed. Nova Science Publishers, Inc. Hauppauge, NY, 2007
 
Mellado B, Font A,Alcaraz A, Aparicio LA, Veiga FJG, Areal J, Gallardo E, Hannaoui N, Lorenzo JRM, Sousa A, Fernandez PL, Gascon P. Phase II trial of short term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate carcinoma. Br J Cancer. 2009;101:1248-52.
 
Melo S, Ropero S, Moutinho C, Aaltonen L, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu C-G, Villanueva A, Capella G, Schwartz Jr S, Shiekhattar R, Esteller M: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nature Genetics 41:365-370, 2009.doi:10.1038/ng.317.
 
Mendoza-Maldonado R, Faoro V, Bajpai S, Berti M, Odreman F, Vindigni M, Ius T, Ghasemian A, Bonin S, Skrap M, Stanta G, Vindigni A. The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation. Molecular Cancer. 10:83;2011.
 
Mengual et al. Validation study of a noninvasive test for diagnosis and prognosis assessment of bladder cancer. J of Urol 2013 (in press)
 
Mestdagh P, Fredlund E, Pattyn F, Schulte JH, Muth D, Vermeulen J, Kumps C, Schlierf S, De Preter K, Van Roy N, Noguera R, Laureys G, Schramm A, Eggert A, Westermann F, Speleman F, Vandesompele J. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene. 2010 Mar 4;29(9):1394-404. Epub 2009 Nov 30.
 
Mestdagh P, Fredlund E, Pattyn F, Rihani A, Van Maerken T, Vermeulen J, Kumps C, Menten B, De Preter K, Schramm A, Schulte J, Noguera R, Schleiermacher G, Janoueix-Lerosey I, Laureys G, Powel R, Nittner D, Marine JC, Ringnér M, Speleman F, Vandesompele J. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene. 2010 Jun 17;29(24):3583-92. Epub 2010 Apr 12.
 
Michelucci A, Di Cristofano C, Lami A, Collecchi P, Caligo A, Decarli N, Leopizzi M, Aretini P, Bertacca G, Prosperi Porta R, Ricci S, Della Rocca C, Stanta G, Bevilacqua G, Cavazzana A. “PIK3CA in Brest Carcinoma. A Mutational Analysis of Sporadic and Hereditary Cases.” Diagn Mol Pathol, 18: 200-205, 2009
 
Miglino B, Viana M, Zavattaro E, Bonin S, Valente G, Colombo E. Localized scleroderma unius lateri and Borrelia burgdoferi infection. Indian J Dermatol Ve. 2012;78(3):383-U254.
 
Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Làszló F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian-Sarlissian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.Neurobiol Aging. 2008 Oct 16. [Epub ahead of print]
 
Milne AN, Carneiro F, O’Morain C, Offerhaus GJA: Nature Meets Nurture: Molecular Genetics of Gastric Cancer. Human Genetics, 126:615–628, 2009. doi: 10.1007/s00439-009-0722-x.
 
Milne AN, Offerhaus GJA, Carneiro F: Histopathology of familial and early onset gastric cancer. Diagnostic Histopathology 17: 62-68, 2011.
 
Minervini A, di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol 180: 1284-1289  2008.
 
Minervini A, Di Cristofano C, Lapini A, Marchi M, Lanzi F, Giubilei G, Tosi N, Tuccio A, Mancini M, Della Rocca C, Serni S, Bevilacqua G, Carini M. Histopathologic Analysis of Peritumoral Pseudocapsule and Surgical Margin Status after Tumor Enucleation for Renal Cell Carcinoma. Eur Urol 55: 1410-1418, 2009
 
Mlakar V., Berginc G., Volavšek M., Štor Z., Rems M., Glavac D. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. BMC Cancer, 2009, vo. 9, p. 282 [1-25]. ISSN 1471-2407
 
Mlakar V., Todorovic V., Cemažar M., Glavac D., Serša G. Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma cells. BMC Cancer, 2009, vol. 9, p. 299 [1-8] ISSN 1471-2407
 
Mlakar V., Stražišar M., Sok M., Glavac D. Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1. Cancer Investig., 2009. ISSN 0735-7907
 
Moch H, Blank PR, Dietel M, Elmberger G, Kerr KM, Palacios J, Penault-Llorca F, Rossi G, Szucs TD. Personalized cancer medicine and the future of pathology. Virchows Arch. 2012 Jan;460(1):3-8. Epub 2011 Dec 6. Review.
 
Molina R, Auge J M, Farrus B, Zanon G, Pahisa J, Munoz M, Torne A, Filella X, Escudero J M, Fernandez P, Velasco M. Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer.
Clinical Chemistry 56:1148–1157 (2010).
 
Montanic S, Terdoslavich M, Rajcevic U, De Leo L, Bonin S, Serbec VC, et al. Development and characterization of a novel mAb against bilitranslocase - a new biomarker of renal carcinoma. Radiology and oncology. 2013;47(2):128-37.
 
Montironi R, Cheng L, Scarpelli M, Mazzucchelli R, Mikuz G, Lopez-Beltran A. “Pathological” reflection on European urology: extended, saturation and systematic prostate biopsies. Eur Urol. 2008 Jun;53(6):1111-4. Epub 2008 Mar 24. No abstract available.
 
Montoto S, Moreno C, Domingo-Doménech E, Estany C, Oriol A, Altés A, Besalduch J, Pedro C, Gardella S, Escoda L, Asensio A, Vivancos P, Galán P, de Sevilla AF, Ribera JM, Briones J, Colomer D, Campo E, Montserrat E, López-Guillermo A; Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB) Spain. High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. Haematologica. 2008 Feb;93(2):207-14.
 
Montserrat N, Gallardo A, Escuin D, Catasus L, Prat J, Gutiérrez-Avignó FJ, Peiró G, Barnadas A, Lerma E. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort? Hum Pathol. 2011 Jan;42(1):103-10. Epub 2010 Oct 20. PubMed PMID: 20970163.
 
Morawietz L, Floore A, Stork-Sloots L, Folprecht G, Buettner R, Rieger A, Dietel M, Huebner G. Comparison of histopathological and gene expression-based typing of cancer of unknown primary. Virchows Arch. 2010 Jan;456(1):23-9. Epub 2009 Dec 10.PMID: 20012089
 
Moreira H, Pinto-de-Sousa J, Carneiro F, Rodrigues J, Cardoso-de-Oliveira M, Pimenta A: Early onset gastric cancer no longer presents as an advanced disease with ominous prognosis. Digestive Surgery, 26:215-221, 2009. doi: 10.1159/000219331.
 
Morente M. de Álava E, Fernández PL. “Tumor banking: the Spanish design”. Pathobiology
74:245-250,2007.
 
Morente M, Fernández PL, de Álava E. Biobanking: old activity or young discipline? Semin Diagnost Pathol 25:317-22, 2008.
 
Morresi-Hauf A, Wöckel W, Kirchner T. Thymic cyst with initial malignant transformation Pathologe. 2008 Jul;29(4):308-10. German.
 
Moslavac S, Dzidic I, Kejla Z, Tomas D. “Hemodialysis-associated amyloidosis with cervical spinal cord compression and incomplete tetraplegia: a case report”. Spinal Cord 2007;45:799-801.
 
Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, Martinot-Peignoux M, Dauvergne A, Asselah T, Boyer N, Bedossa P, Valla D, Vidaud M, Nicolas-Chanoine MH, Marcellin P. Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology. 2008 Nov 19. [Epub ahead of print]
 
Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008 Feb;134(2):416-23.
 
Moulin AP, Clément G, Bosman FT, Zografos L, Benhattar J. Methylation of CpG island promoters in uveal melanoma.Br J Ophthalmol. 2008 Feb;92:281-5.
 
Moustafa T, Fickert P, Magnes C, Guelly C, Thueringer A, Frank S, Kratky D, Sattler W, Reicher H, Sinner F, Gumhold J, Silbert D, Fauler G, Höfler G, Lass A, Zechner R, Trauner M. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology. 2012; 142(1):140-151.
 
Moutinho C, Mateurs AR, Milanezi F, Carneiro F, Seruca R, Suriano G: EGFR structural alterations in gastric cancer. BMC Cancer8:10, 2008. doi:10.1186/1471-2407-8-10.
 
Mozos A, Sole M, Miquel R,Petit P, Nadal A,Fernandez PL.Usefulness and limitations of Alpha-Methylacyl-CoA Racemase expression in the hepatobiliary system and pancreas: a wide tissuemicroarray analysis of normal and neoplastic epithelia. Ana Quant Cytol 2010;32:261-268
 
Muhlfeld C, Das SK, Heinzel FR, Schmidt A, Post H, Schauer S, Papadakis T, Kummer W, Hoefler G. Cancer Induces Cardiomyocyte Remodeling and Hypoinnervation in the Left Ventricle of the Mouse Heart PLOS ONE. 2011; 6(5): e20424. Listed in: [ISI:000291052200063] IF(2011): 4,411; IFnorm: 0,872; Citations (SCI): 1; last update: 16.04.2012. Doi:10.1371/journal.pone.0020424
 
Müller BM, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, Weichert W, Altmann G, Roth C, Winzer KJ, Kristiansen G, Petry C, Dietel M, Denkert C. Quantitative determination of estrogen receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer. Diagn Mol Pathol. 2011 Mar;20(1):1-10.
 
Müller BM, Brase JC, Haufe F, Weber KE, Budzies J, Petry C, Prinzler J, Kronenwett R, Dietel M, Denkert C. Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections. J Clin Pathol. 2012 Mar 23. [Epub ahead of print]
 
Munkácsy G, Abdul-Ghani R, Mihály Z, Tegze B, Tchernitsa O, Surowiak P, Schäfer R, Györffy B. PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer. Br J Cancer. 2010 Jan 19;102(2):361-8.
 
Muradyan, A; Boldt, V; Steininger, A; Stabentheiner, S; Tebel, K; Kreutzberger, J; Müller, I; Madle, H; Popper, HH; Ullmann, R.: An integrative approach for analyzing the interplay of genetic and epigenetic changes in tumors. Arch Pathol Lab Med. 2008; 132(10): 1557-1561. [Fulltext] [PubMed]
 
Nadal A, Jares P, Pinyol M, Conde L, Romeu C, Fernández PL, Campo E, Cardesa A.: “Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification”. Virchows Arch 450: 161-167, 2007
 
Nagel JM, Kriegl L, Horst D, Engel J, Gautam S, Mantzoros CS, Kirchner T, Göke B, Kolligs FT. γ-Catenin is an independent prognostic marker in early stage colorectal cancer. Int J Colorectal Dis. 2010 Nov;25(11):1301-9.
 
Nardon E., Donada M., Bonin S., Dotti I., Stanta G. Higher random oligo concentration improves reverse transcription yield of cDNA from bioptic tissues and quantitative RT-PCR reliability. Experimental and Molecular Pathology, 2009, 87: 146–151
 
Nardon E., Glavac D., Benhattar J., Groenen P., Höfler G., Höfler H., Jung A., Keller G., Kirchner T., Lessi F., Ligtenberg M., Mazzanti M., Winter G., and Stanta G. A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of Five Quasimonomorphic Mononucleotide Repeats. Diagnostic Molecular Pathology, accepted March 1, 2010
 
Navarro S, Llombart-Bosch A, Pellin A, Burgues O, Ruiz A, Piqueras M, Noguera R., “Patologia de los tumores neuroblasticos: evaluacion pronostica: Experiencia del centro español de referencia de la SEOP para estudios biopatologicos del neuroblastoma (1992-2005)”. Rev Esp Patol 40 /2): 79-90, 2007.
 
Navarro S, Giraudo P, AI Karseladze, Smirnov A, Petrovichev N, Savelov N, Alvarado-Cabrero I, Llombart-Bosch A., “Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing´s family of tumors (EFT) and their therapeutic implications”. Anticancer Res 27 (48):2457-2463, 2007.
 
Nemolato S, Fanni D, Naccarato AG, Ravarino A, Bevilacqua G, Faa G. Lymphoepitelioma-like hepatocellular carcinoma: A case report and a review of the literature.World J Gastroenterol. 14: 4694-6, 2008.
 
Neumann J, Zeindl-Eberhart E, Kirchner T, Jung A. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Pathol Res Pract. 2009;205(12):858-62. Epub 2009 Aug 12. PubMed PMID: 19679400.
 
Noguera R, Subramaniam MM, Cruz J, Piqueras M, Llombart-Bosch A, Navarro S, “Focus on Neuroblastoma Research: Immunophenotypic diversity in the normal development of human sympathetic nervous system”. (Chapter X ; pp163-186). ISBN: 1-60021-484-3. Nova ed. Nova Science Publishers, Inc. Hauppauge, NY, 2007.
 
Noguera R, “El neuroblastoma como enfoque multidisciplinar y otras aplicaciones de la MIBG: Genética de los tumores neuroblásticos. Importancia en la estratificación terapéutica y el pronóstico”. (Capitulo 2; pp15-34).ISBN: 978-84-611-9464-3. Editores: Luis Diez y Victoria Castel. Ed. SIMED SOFTWARE SL Madrid. 2007.
 
Noguera R, Machado I, Piqueras M, Lopez-Guerrero JA, Navarro S, Mayordomo E, Pellin A, Llombart-Bosch A. Tissue microarrays: applications in study of p16 and p53 alterations in Ewing’s cell lines. Diagn Pathol.15(3) Suppl 1: 27, 2008.
 
Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, Påhlman S. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res. 2009 Dec 1;15(23):7130-6.
 
Noguera R, Villamón E, Berbegall A, Machado I, Giner F, Tadeo I, Navarro S, Llombart-Bosch A. Gain of MYCN Region in a Wilms Tumor-derived Xenotransplanted Cell Line. Diagn Mol Pathol. 2010 Mar;19(1):33-39.
 
Nordgård O, Oltedal S, Janssen EA, Gilje B, Kørner H, Tjensvoll K, Smaaland R. Comparison of a PNA Clamp PCR and an ARMS/Scorpion PCR Assay for the Detection of K-ras Mutations. Diagn Mol Pathol. 2012 Mar;21(1):9-13.
 
Noske A, Lindenberg JL, Darb-Esfahani S, Weichert W, Buckendahl AC, Röske A, Sehouli J, Dietel M, Denkert C. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis. Oncol Rep. 2008 Dec;20(6):1409-17.
 
Noske A, Faggad A, Wirtz R, Darb-Esfahani S, Sehouli J, Sinn B, Nielsen FC, Weichert W, Buckendahl AC, Röske A, Müller B, Dietel M, Denkert C. IMP3 expression in human ovarian cancer is associated with improved survival. Int J Gynecol Pathol. 2009 May;28(3):203-10.PMID: 19620937
 
Noske A, Pahl S, Fallenberg E, Richter-Ehrenstein C, Buckendahl AC, Weichert W, Schneider A, Dietel M, Denkert C. Flat epithelial atypia is a common subtype of B3 breast lesions and associated with noninvasive cancer but not with invasive cancer in final excision histology. Hum Pathol. [Epub ahead of print]PMID: 20004938
 
Noske A, Schwabe M, Weichert W, Darb-Esfahani S, Buckendahl AC, Sehouli J, Braicu EI, Budczies J, Dietel M, Denkert C. An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas. BMC Cancer. 2011 Jul 14;11:294.
 
Nowak-Markwitz E, Maciejczyk A, Pudelko M, Tserenchunt G, Balázs G, Spaczynski M, Zabel M, Dietel M, Lage H, Surowiak P. Influence of tamoxifen on cisplatin-sensitivity and estrogen receptors expression in ovarian carcinoma cell lines. Ginekol Pol. 2010 Mar;81(3):183-7.
 
Nitta H, Hauss-Wegrzyniak B, Lehrkamp M, Murillo AE, Gaire F, Farrell M, Walk E, Penault-Llorca F, Kurosumi M, Dietel M, Wang L, Loftus M, Pettay J, Tubbs RR, Grogan TM. Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH). Diagn Pathol. 2008 Oct 22;3:41.
 
Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y, Asgharzadeh S, Seeger R, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Vermeulen J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Weber A, Christiansen H, Grundy RG, Schardt K, Schwab M, Eils R, Warnat P, Kaderali L, Simon T, Decarolis B, Theissen J, Westermann F, Brors B, Fischer M. Prognostic impact of gene expression-based classification for neuroblastoma. J Clin Oncol. 2010 Jul 20;28(21):3506-15. Epub 2010 Jun 21.
 
Odar K, Boštjancic E, Gale N, Glavac D, Zidar N. Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck. Histopathology. 2012; 61:257-265.
 
Odar K, Zidar N, Bonin S, Gale N, Cardesa A and Stanta G. Desmosomes in verrucous carcinoma of the head and neck. Histol Histopathol. 27: 467-474; 2012
 
Odar K, Gale N, Zidar N. Desmosomal proteins and microRNAs-markers for hybrid tumors (verrucous carcinoma with foci of squamous cell carcinoma). Ann Diagn Pathol. 2012;16:157-158.
 
Odze RD, Riddell RH, Bosman FT, Carneiro F, Fléjou J-F, Geboes K, Genta RM, Hattori T, Hruban RH, van Krieken JHJM, Lauwers GY, Offerhaus GJA, Rugge M, Shimizu M, Shimoda T, Theise ND, Vieth M: Premalignant lesions of the digestive system. In: WHO Classification of Tumours of the Digestive System, Fouth Edition. Bosman FT, Carneiro F, Hruban RH and Theise ND (eds), IARC Press: Lyon, 2010; Pp 10-12.
 
Oliveira C, Seruca R, Carneiro F: Hereditary gastric cancer. Best Practice & Research Clinical Gastroenterology (2009). doi:10.1016/j.bpg.2009.02.003.
 
Oliveira C, Sousa S, Pinheiro H, Karam R, Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Yokota J, Carneiro F, Huntsman D, Seruca R: Quantification of epigenetic and genetic second hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009 Mar 6. [Epub ahead of print]. doi: 10.1053/j.gastro.2009.02.065. 
 
Oltedal S, Aasprong OG, Møller JH, Kørner H, Gilje B, Tjensvoll K, Birkemeyer EM, Heikkilä R, Smaaland R, Nordgård O. Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. Int J Colorectal Dis. 2011 Oct;26(10):1271-7. Epub 2011 May 15. PubMed PMID:21573767.
 
O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, Gascoyne RD, Wright G, Staudt LM, Lister TA, Fitzgibbon J. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and a poorer overall survival. Blood. 2008;112(8):3126-9
 
O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, Gribben J, Rosenwald A, Ott G, Rimsza LM, Holte H, Cazier JB, Johnson NA, Campo E, Chan WC, Gascoyne RD, Young BD, Staudt LM, Lister TA, Fitzgibbon J. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood. 2009 Jan 13. [Epub ahead of print]
 
Osterheld MC, Laurini RN, Saraga EP, Bosman FT. Evaluation of DNA-ploidy heterogeneity in gastric cancers. Cell Oncol. 2008;30:511
 
Ott K, Lordick F, Becker K, Ulm K, Siewert J, Höfler H, Keller G. Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients. Int J Colorectal Dis. 2008 Aug;23(8):773-82.
  
Overbeek LI, Ligtenberg MJ, Willems RW, Hermens RP, Blokx WA, Dubois SV, van der Linden H, Meijer JW, Mlynek-Kersjes ML, Hoogerbrugge N, Hebeda KM, van Krieken JH. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008 Aug;32(8):1246-51. PMID: 18677806 [PubMed - indexed for MEDLINE]
 
Overbeek LI, Hoogerbrugge N, van Krieken JH, Nagengast FM, Ruers TJ, Ligtenberg MJ, Hermens RP; MIPA Study Group. Most patients with colorectal tumors at young age do not visit a cancer genetics clinic. Dis Colon Rectum. 2008 Aug;51(8):1249-54. PMID: 18536968 [PubMed - indexed for MEDLINE]
 
Overes IM, de Rijke B, van Horssen-Zoetbrood A, Fredrix H, de Graaf AO, Jansen JH, van Krieken JH, Raymakers RA, van der Voort R, de Witte TM, Dolstra H. Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis. Br J Haematol. 2008 Jun;141(6):799-807. Epub 2008 Apr 10. PMID: 18410452 [PubMed - indexed for MEDLINE]
 
Øvestad IT, Gudlaugsson E, Skaland I, Malpica A, Kruse AJ, Janssen EA, Baak JP. Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Mod Pathol. 2010 Sep;23(9):1231-40. Epub 2010 May 28.
 
Øvestad IT, Janssen E, Kjellevold K, Baak J. HPV tests at Stavanger University Hospital. Tidsskr Nor Laegeforen. 2010 Nov 18;130(22):2219. Norwegian.
 
Øvestad IT, Vennestrøm U, Andersen L, Gudlaugsson E, Munk AC, Malpica A, Feng W, Voorhorst F, Janssen EA, Baak JP. Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3. Gynecol Oncol. 2011 Nov;123(2):278-83.
 
Øvestad IT, Gudlaugsson E, Skaland I, Malpica A, Munk AC, Janssen EA, Baak JP. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3. J Clin Pathol. 2011 Apr;64(4):303-7. PubMed PMID: 21421698.
 
Pacchioni D, Bosco M, Allia E, Mussa B, Mikuz G, Bussolati G. Microcystic urothelial cell carcinoma with neuroendocrine differentiation arising in renal pelvis. Report of a case. Virchows Arch. 2009 Feb;454(2):223-7. Epub 2008 Nov 11.
 
Paciucci R et al. "Regulation of protein translation and c-Jun expression by Prostate Tumor Overexpressed 1 (PTOV1)"  . Oncogene (in press)
 
Pallares J, Velasco A, Eritja N, Santacana M, Dolcet X, Cuatrecasas M, Palomar-Asenjo V, Catasus L, Prat J, Matias-Guiu X. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. Mod Pathol 2008; 21:691-699.
 
Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis. Hepatology. 2008 Dec 29;49(3):851-859.
 
Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Caldeira J, Ribeiro AS, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis C, Leite M, Fernandes S, Figueiredo C, Schmitt F, Carneiro F, Oliveira C, Seruca R: Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta (in press).
 
Pascale M, Pracella D, Barbazza R, Marongiu B, Roggero E, Bonin S and G Stanta Is Human Papillomavirus Associated with Prostate Cancer Survival? Disease Markers. 2013;35(6):7.
 
Passeri G, Vescovini R, Sansoni P, Galli C, Franceschi c, Passeri M, Motta M, Framceschi C, Motta L, Capurso A, Panza F, Solfrizzi V, D’Introno A, Colacicco AM, Capurso S, Capri M, Salvioli S, Valensin S, Bennati E, Malaguarnera M, Maugeri D, Rapisarda R, Franzone A, Ferlito L, De Benedictis G, Berardelli M, Masotti G, Petruzzi E, Petruzzi I, Pinzani P, Monti D, Antonini FM, Capurso C, Nicita-Mauro V, Lo Balbo C, Mento A, Nicita-Mauro C, Maltese G, Basile G, Mari D, Coppola R, Provenzano R, Salvioli G, Baldelli MV, Mussi C, Varricchio M, Barbieri M, Gambardella A, Paolisso G, Caruso C, Candore G, Colonna-Romano G, Lio D, Sansoni P, Vescovini R, Galli C, Basini C, Telera A, Passeri G, Passeri M, Ferrari E, Cravello L, Barili L, Solerte SB, Fioravanti M, Magri F, Fagnoni F, Senin U, Mecocci P, Cherubini A, Marigliano V, Tafaro L, Cicconetti P, Tombesi F, Tombolillo MT, Ettore E, Forconi S, Boschi S, Righi GA, Guerrini M, Giarelli L, Stanta G, Ferrucci L, Ble A, Metter EJ, Guaralnik JM, Pacifici R, Zuccaro P, Palmi I, Branca S, Fradà G, Motta F, Crimi G; Italian Multicentric Study on Centenarians (IMUSCE), “Calcium metabolism and vitamin D in the extreme longevity.” Exp Gerontol. 43:79-87;2008
 
Patankar JV, Chandak PG, Obrowsky S, Pfeifer T, Diwoky C, Uellen A, Sattler W, Stollberger R, Hoefler G, Heinemann A, Battle M, Duncan S, Kratky D, Levak-Frank S. Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2011; 300(3):E478-E488.
 
Patankar JV, Obrowsky S, Doddapattar P, Hoefler G, Battle M, Levak-Frank S, Kratky D. Intestinal GATA4 deficiency protects from diet-induced hepatic steatosis. J Hepatol. 2012; 57(5):1061-1068
 
Pavic I, Marusic Z, Mijic A, Balicevic D, Kruslin B, Tomas D. A case of signet-ring cell carcinoma of the gallbladder: immunohistochemistry and differential diagnosis. Acta Clin Croat. 2010 Jun;49(2):159-62.
 
Pavlidis N, Stanta G, Audisio R. Cancer Prevalence and Mortality in Centenarians: a systematic review. Critical Reviews in Oncology/Hematology. (2012) 83 (1): 145-152.
 
Pažanin L, Vucic M, Cupic H, Plavec D, Krušlin B. IGFBP-2 expression, angiogenesis and pseudopallisades in glioblastoma. Translational Neuroscience 2011;2.219-224
 
Pecina Slaus N, Nikuseva Martic T, Beros V, Tomas D. “Genetic alteration of E-cadherin and beta-catenin in germinoma and teratoma. Report of two central nervous system cases“. Pathol Oncol Res 2007;13:370-4.
 
Pecina Slaus N, Nikuseva Martic T, Tomas D, Beros V, Zeljko M, Cupic H. “Meningiomas exhibit loss of heterozygosity of the APC gene“. J Neurooncol 2008;87:63-70.
 
Peleteiro B, Lunet N, Wen X, Afonso LP, Mendes N, Barros R, Carneiro F, Almeida R, Barros H. Association between environmental factors and CDX2 expression in gastric cancer patients. Eur J Cancer Prev Dec 12. [Epub ahead of print]. doi: 10.1097/CEJ.0b013e32834ef1aa.
 
Pensabene M, Spagnoletti I, Capuano I, Condello C, Pepe S, Contegiacomo A, Lombardi G, Bevilacqua G, Caligo MA. Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol 20: 874-878, 2009
 
Penzel R, Sers C, Chen Y, Lehmann-Mühlenhoff U, Merkelbach-Bruse S, Jung A, Kirchner T, Büttner R, Kreipe HH, Petersen I, Dietel M, Schirmacher P. EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch. 2011 Jan;458(1):95-8.
 
Pérez-Galán P, Roué G, López-Guerra M, Nguyen M, Villamor N, Montserrat E, Shore GC, Campo E, Colomer D. BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. Leukemia. 2008 Sep;22(9):1712-20.
 
Périgny M, Hammel P, Corcos O, Larochelle O, Giraud S, Richard S, Sauvanet A, Belghiti J, Ruszniewski P, Bedossa P, Couvelard A. Pancreatic Endocrine Microadenomatosis in Patients With von Hippel-Lindau Disease: Characterization by VHL/HIF Pathway Proteins Expression. Am J Surg Pathol. 2009 Feb 20. [Epub ahead of print]
 
Peters E, Nagtegaal ID, van de Velde CJ, van Krieken JH. Lymph node examination rate, survival rate, and quality of care in colon cancer. JAMA. 2008 Feb 27;299(8):896-7; author reply 897-8. No abstract available. PMID: 18314429 [PubMed - indexed for MEDLINE]
 
Petersen I, Kotb WF, Friedrich KH, Schlüns K, Böcking A, Dietel M. Core classification of lung cancer: Correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer. 2009 Jan 23. [Epub ahead of print]
 
Petrov SV, Machado I, Boulytcheva IV, Noguera R, Pellin A, Bacchini P, Bertoni F, Llombart-Bosch A. New approaches in the diagnosis of small-cell round tumors of bone and soft tissue. Arkh Patol. 2009 Jan-Feb;71(1):34-40.
 
Pichler M, Balic M, Stadelmeyer E, Ausch C, Wild M, Guelly C, Bauernhofer T, Samonigg H, Hoefler G, Dandachi N: Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors. J Mol Diagn. 2009; 11(2):140-147 [Fulltext] [PubMed] [Fulltext MUG-login]
 
Pichler M, Beckendorf J, Winter E, Kleinert R, Kniepeiss D, Hoefler G. Quantitative short-tandem repeat analysis of recipient-derived cells as an additional tool for diagnosing cardiac allograft rejection. Transplantation. 2010; 89(6):749-755
 
Pichler M, Rainer PP, Schauer S, Hoefler G. Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J Am Coll Cardiol. 2012; 59(11):1008-1016.
 
Pichler M, Winter E, Stotz M, Eberhard K, Samonigg H, Lax S, Hoefler G. Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer. Br J Cancer. 2012. 106(11):1826-1832.
 
Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Eberhard K, Hoefler G, Pummer K, Zigeuner R. Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010. J Clin Pathol. 2012; 65(8):721-724
 
Pietras A, Gisselsson D, Øra, Noguera R, Beckman S, Navarro S, Påhlman S,“High Levels of HIF-2α Highlight an Immature Neural Crest-like Neuroblastoma Cell Cohort Located in a Perivascular Niche”. J. Pathol 214 (4):482-88, 2007
 
Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjölund J, Gisselsson D, Rehn M, Beckman S, Noguera R, Navarro S, Cammenga J, Fredlund E, Kaplan DR, Påhlman S. HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16805-10.
 
Pifferi M, Maggi F, Cristofano CD, Cangiotti AM, Nelli LC, Bevilacqua G, Maccia P, Bendinelli M, Boner AL. Torquetenovirus Infection and Ciliary Dysmotility in Children With Recurrent Pneumonia. Pediatr Infect Dis J 27: 413-418, 2008
 
Pinent M, Prokesch A, Hackl H, Voshol PJ, Klatzer A, Walenta E, Panzenboeck U, Kenner L, Trajanoski Z, Hoefler G, Bogner-Strauss JG. Adipose Triglyceride Lipase and Hormone-Sensitive Lipase Are Involved in Fat Loss in JunB-Deficient Mice. Endocrinology. 2011; 152(7):2678-2689. Listed in: [ISI:000291925700017]; [PMID:21540289] IF(2011): 4,993; IFnorm: 0,836; Citations (SCI): 0; last update: 16.04.2012. Doi:10.1210/en.2010-1477
 
Pinho SS, Reis C, Paredes J, Magalhães AM, Ferreira AC, Figueiredo J, Wen X, Carneiro F, Gärtner F, Seruca R: The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Human Molecular Genetics, 18:2599-2608 2009. doi: 10.1093/hmg/ddp194.
 
Piqueras Franco M, Noguera Salva R, Cruz Mojarrieta J, Subramanian MM, Castel Sanchez V, Llombart-Bosch A, Navarro Fos S. “Expresion inmunohistoquimica de la proteina mycN y el estado del gen MYCN en tumores neuroblasticos”. Rev Esp Patol 40(2):97-102, 2007.
 
Piqueras M, Navarro S, Castel V, Cañete A, Llombart-Bosch A, Noguera R. Analysis of biological prognostic factors using tissue microrrays in neuroblastic tumors. Pediatr Blood Cancer.52(2):209-14, 2009
 
Piqueras M, Navarro S, Cañete A, Castel V, Noguera R. Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content. Histopathology. 2011 Jul;59(1):22-30. doi: 10.1111/j.1365-2559.2011.03899.x. Epub 2011 Jun 13.
 
Pircher A, Ploner F, Popper H, Hilbe W. Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients.Lung Cancer. 2010; 134(3) [Fulltext][PubMed][Fulltext MUG-login]
 
Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, Fornari A, Martinoglio B, Medico E, Zamò A, Facchetti F, Ponzoni M, Geissinger E, Rosenwald A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010 Mar 20;28(9):1583-90. Epub 2010 Feb 16. PubMed PMID: 20159827.
 
Popovic A, Demirovic A, Spajic B, Krušlin B, Tomas D. Expression and prognostic role of syndecan-2 in prostate cancer. Prostate Cancer Prostatic Dis 2010;13:78-82 (CC)
 
Popper HH. European Working Groups for Molecular Pathology and Pulmonary Pathology.: Molecular signatures of lung and pleural tumors: joint symposium of the European Working Groups for Molecular Pathology and Pulmonary Pathology, 21st European Congress of Pathology. Arch Pathol Lab Med. 2008; 132(10): 1549-1550. [Fulltext] [PubMed] [Listed in ISI Web of Science]
 
Popper HH, Kothmaier H. Proteomics--tissue and protein microarrays and antibody array: what information is provided? Arch Pathol Lab Med. 2008; 132(10): 1570-1572. [PubMed]
 
Popper HH. Introduction to continuing special series.Arch Pathol Lab Med. 2010; 134(1): 23-23. [PubMed]
 
Postma C, Koopman M, Buffart TE, Eijk PP, Carvalho B, Peters GJ, Ylstra B, van Krieken JH, Punt CJ, Meijer GA. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann Oncol. 2009 Jan 15. [Epub ahead of print] PMID: 19150955 [PubMed - as supplied by publisher]
 
Potocnik U, Glavac D, Dean M. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability. Cancer Genet Cytogenet. 2008 May;183(1):28-34.
 
Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, Mcgarrity T, Heathcote Ej, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; epic study group. Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon-alfa/Ribavirin Therapy. Gastroenterology. 2009 Jan 22. [Epub ahead of print]
 
Pozzi Mucelli S., Zamunera M., Tormen M., Stanta G., Ugo P., “Nanoelectrode ensembles as recognition platform for electrochemical immunosensors” Biosensors and Bioelectronics 2008, Mar 8-Epub
 
Pracella D, Bonin S, Barbazza R, Sapino A, Castellano I, Sulfaro S and G Stanta.. Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up? Disease Markers. 2013;35(6):11.
 
Prat J. FIGO staging for uterine sarcoma. Int J Gynecol Obstet 2009; 104: 177-178.
 
Prat J. Subclassification of ovarian cancer based on pathology and genetics. Eur J Cancer 2009; 45 Suppl 1:427-428.
 
Prat J. Classification and staging of endometrial sarcomas: one disease or two different tumor types? Gynecol Oncol. 2010 Jul;118(1):1-2. PubMed PMID: 20542153.
 
Prats-Muñoz G, Malgosa A, Armentano N, Galtés I,  Esteban J, Bombi JA, Tortosa M, Fernández E, Jordana X, Isidro A, Fullola JM, Petit MA, Guerrero VM, Calvo M, Fernández PL. A paleoneurohistological study of 3000-year-old mummified brain tissue from the Mediterranean Bronze Age. Pathobiology 2012; 79:239-46.
 
Prats-Muñoz G, Galtés I, Armentano N, Cases S, Fernández PL. Malgosa A .eservation in the Cova des Pas site (Minorca Bronze Age). J Arch Science 2013;40:4701-10.
 
Primoz S, Oblak I, Gale N, Smid L, Kos J. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study. Histopathology. 2008 Nov;53(5):612-4.
 
Provenza, C, Young, RH, Prat J. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcoma-like mural nodules. Am J Surg Pathol 2008; 32:383–389.
 
Prunotto M, Bosco M, Daniele L, Macri' L, Bonello L, Schirosi L, Rossi G,Filosso P, Mussa B, Sapino A. Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta. Lung Cancer. 2008 Nov 26. [Epub ahead of print]
 
Pupulim LF, Felce-Dachez M, Paradis V, Vullierme MP, Zappa M, Bedossa P, Vilgrain V. Algorithm for immediate cytologic diagnosis of hepatic tumors. AJR Am J Roentgenol. 2008 Mar;190(3):W208-12.
 
Rabien A, Fritzsche F, Jung M, Diamandis EP, Loening SA, Dietel M, Jung K, Stephan C, Kristiansen G. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse. Tumour Biol. 2008;29(1):1-8. Epub 2008 May 23.
 
Radner FP, Streith IE, Schoiswohl G, Schweiger M, Kumari M, Eichmann TO, Rechberger G, Koefeler HC, Eder S, Schauer S, Theussl HC, Preiss-Landl K, Lass A, Zimmermann R, Hoefler G, Zechner R, Haemmerle G. Growth Retardation, Impaired Triacylglycerol Catabolism, HepaticSteatosis, and Lethal Skin Barrier Defect in Mice Lacking ComparativeGene Identification-58 (CGI-58). J Biol Chem. 2010; 285(10):7300-7311[Fulltext][PubMed][Fulltext MUG-login]
 
Radulovic P, Pavic I, Marušic Z, Peric-Balja M, Znaor A, Kraus O, Krušlin B. [Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma] Lijec Vjesn 2008;130:1-3.
 
Rainer PP, Doleschal B, Kirk JA, Sivakumaran V, Saad Z, Groschner K, Maechler H, Hoefler G, Bauernhofer T, Samonigg H, Hutterer G, Kass DA, Pieske B, von Lewinski D, Pichler M. Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes. BJU Int. 2012. 110(10):1455-1462.
 
Ralmer N, Hoefler G, Hogenauer C, Lackner C, Steinke V, Sengteller M, Friedl W, Aretz, S; Propping, P; Mangold, E; Walldorf, C: Compound heterozygosity for two MSH6 mutations in a patient with early onset colorectal cancer, vitiligo and systemic lupus erythematosus. Am J Med Genet A. 2008; 146A(10):1314-1319 [Fulltext] [PubMed] [Fulltext MUG-login] [Listed in ISI Web of Science]
 
Ramon Y Cajal T, Torres A, Alonso C, Fisas D, Ojeda B, Boguña I, Prat J, Baiget M, Barnadas A. Risk factors associated with the occurrence of breast cancer after bilateral salpingo-oophorectomy in high-risk women. Cancer Epidemiol. 2010 Jul 16. [Epub ahead of print] PubMed PMID: 20638925.
 
Rautou PE, Cazals-Hatem D, Moreau R, Francoz C, Feldmann G, Lebrec D, OGIER-Denis E, Bedossa P, Valla D, Durand F. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology. 2008 Sep;135(3):840-8
 
Regalo G, Resende C, Wen X, Gomes B, Durães C, Seruca R, Carneiro F, Machado JC. C/EBPalpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Laboratory Investigation 90:1132-1139, 2010. doi: 10.1038/labinvest.2010.79.
 
Reiner-Concin A, Regitnig P, Dinges HP, Höfler G, Lax S, Müller-Holzner E, Obrist P, Rudas M: Practice of HER-2 Immunohistochemistry in Breast Carcinoma in Austria. Pathol Oncol Res. 2008; 14(3): 253-259. [Fulltext] [PubMed] [Fulltext MUG-login] [Listed in ISI Web of Science]
 
Reinacher-Schick A, Arnold D, Trarbach T, Ridwelski K, Bruch HP, Kirchner T, Kubicka S, Schmoll HJ. [Adjuvant therapy in colon cancer]. Onkologie. 2010;33 Suppl 4:2-7. Review. German.
 
Reiter R, Gais P, Steuer-Vogt MK, Boulesteix AL, Deutschle T, Hampel R, Wagenpfeil S, Rauser S, Walch A, Bink K, Jutting U, Neff F, Arnold W, Höfler H, Pickhard A. Centrosome abnormalities in head and neck squamous cell carcinoma (HNSCC). Acta Otolaryngol. 2008 Jun 2:1-9.
 
Renaud S, Loukinov D, Alberti L, Vostrov A, Kwon YW, Bosman FT, Lobanenkov V, Benhattar J. BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells. Nucleic Acids Res. 2010 Sep 28. [Epub ahead of print]
 
Rimsza LM, Leblanc ML, Unger JM, Miller TP, Grogan TM, Persky DO, Martel RR, Sabalos CM, Seligmann B, Braziel RM, Campo E, Rosenwald A, Connors JM, Sehn LH, Johnson N, Gascoyne RD. Gene expression predicts overall survival in paraffin embedded tissues of diffuse large B cell lymphoma treated with R-CHOP. Blood. 2008; 112(8):3425-33
 
Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP. CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression. Haematologica. 2009 Feb 19. [Epub ahead of print]
 
Rigo A, Gottardi M, Zamò A, Mauri P, Bonifacio M, Krampera M, Damiani E, Pizzolo G, Vinante F. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer. 2010 Oct 14;9:273. PubMed PMID: 20946648; PubMed Central PMCID: PMC2964621.
 
Rissech C, Roberts C, Tomas-Batlle X, Tomas-Gimeno X, Fuller B, Fernandez PL, Botella M. A Roman Skeleton with Possible Treponematosis in the North-East of the Iberian Peninsula: A Morphological and Radiological Study. Int. J. Osteoarchaeol 2011, DOI: 10.1002/oa.129
 
Rodrigues M, Vitó I, Santos R, Paiva J, Pontes P, Silva P, Carneiro F:Establishment of a Tumour Bank: The experience of the Department of Pathology of Hospital S.João (Porto, Portugal). Cell and Tissue Banking 10:75–77, 2009. doi: 10.1007/s10561-008-9102-3
 
Rodríguez Pinilla SM, Roncador G, Rodríguez-Peralto JL, Mollejo M, García JF, Montes-Moreno S, Camacho FI, Ortiz P, Limeres-González MA, Torres A, Campo E, Navarro-Conde P, Piris MA. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol. 2009 Jan;33(1):81-90
 
Rodrigues S, Pereira P, Magro F, Lopes S, Albuquerque A, Lopes J, Carneiro F, Macedo G:  Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification. Journal of Crohn's and Colitis 5: 54-56, 2011.
 
Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, Corrin B, Franks TJ, Galateau-Salle F, Galvin J, Hasleton PS, Henderson DW, Honma K. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society.Arch Pathol Lab Med. 2010; 134(3): 462-480. [PubMed]
 
Romero-Sánchez M, Peiper SC, Evans B, Wang Z, Catasus Ll, Ribe A, Prat J, Giri JG. Expression profile of heptahelical putative membrane progesterone receptors (mPRs) in epithelial ovarian tumors. Hum Pathol 2008; 39:1026-1033.
 
Rokavec M, Schroth W, Amaral SM, Fritz P, Antoniadou L, Glavac D, Simon W, Schwab M, Eichelbaum M, Brauch H. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer. Cancer Res. 2008 Dec 1;68(23):9799-808.
 
Rosai J, Forteza-Vila J, Sobrinho-Simões M, Carneiro F, Cameselle-Teijeiro J. Second International Pathology Meeting, May 21-29, 2010: along the way to Santiago. International Journal of Surgical Pathology 18 (3 Suppl):7S-9S, 2010. doi: 10.1177/1066896910364412.
 
Rosai J, Forteza-Vila J, Sobrinho-Simões M, Carneiro F, Cameselle-Teijeiro J. Travelogue. International Journal of Surgical Pathology 18 (3 Suppl): 20S-26S, 2010. doi: 10.1177/1066896910365215.
 
Rosenberg R, Nekarda H, Zimmermann F, Becker K, Lordick F, Höfler H, Molls M, Siewert JR. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol. 2008 Jan 1;97(1):8-13
 
Roth AD, Tejpar S, Delorenzi M, Yan P, Fiocca R, Klingbiel D, Dietrich D, Biesmans B, Bodoky G, Barone C, Aranda E, Nordlinger B, Cisar L, Labianca R, Cunningham D, Van Cutsem E, Bosman F. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol. 2010 Jan 20;28(3):466-74. Epub 2009 Dec 14. PubMed PMID: 20008640.
 
Ruffini E, Asioli S, Filosso PL, Lyberis P, Bruna MC, Macrì L, Daniele L, Oliaro A. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg. 2009 Feb;87(2):365-71; discussion 371-2.
 
Rustemovic N, Berkovic MC, Zjacic-Rotkvic V, Ostojic R, Hrabar D, Sertic J, Jakic-Razumovic J, Kruslin B, Stern-Padovan R, Tezak S, Kovacic K, Vrbanec D, Belev B, Skegro M. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic neuroendocrine tumors. Lijec Vjesn. 2010 May-Jun;132(5-6):127-33. Croatian.
 
Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, Galaup A, Maier-Redelsperger M, Vandermeersch S, Scarpa A, Janin A, Levy B, Girot R, Beuzard Y, Leboeuf C, Henri A, Germain S, Dussaule JC, Tharaux PL. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest, 118:1924-1933, 2008.
 
Saccardi C, Ludwig K, Cosmi E, D’Antona D, Salmaso R, Fassina A. Tracheal agenesis with bifurcating common airway arising from midesophagus. Pediatr Dev Pathol. 2010 May-Jun;13(3):252-254.
 
Sakr WA, Gale N, Gnepp DR, Crissman JD. Squamous intraepithelial neoplasia of the upper aerodigestive tract. In GneppDR (ed): Diagnostic surgical pathology of the head and neck. Saunders, Elsevier, Philadelphia. 2009: 1-44.
 
Salaverria I, Beà S, Lopez-Guilleromo A, Lespinet V, Pinyol M, Burkhardt B, Lamant L, Zettl A, Horsman D, Gascoyne R, Ott G, Siebert R, Delsol G, Campo E. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Brit J Haematol 2008:140;516-526
 
Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A; Leukemia and Lymphoma Molecular Profiling Project (LLMPP).Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma. Haematologica. 2008 Sep;93(9):1327-34.
 
Salaverria I, Espinet B, Carrió A, Costa D, Astier L, Slotta-Huspenina J, Quintanilla-Martinez L, Fend F, Solé F, Colomer D, Serrano S, Miró R, Beà  S, Campo E. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques. Genes Chromosomes Cancer. 2008 Aug 15;47(12):1086-1097
 
Sandmeier D, Bosman F, Fiche M. Learning in the working place: the educational potential of a multihead microscope in pathology postgraduate training. Virchows Arch. 2009 Mar;454(3):257-61. Epub 2009 Jan 14. PubMed PMID: 19142659.
 
Sanjuán A, Escaramís G, Vidal-Sicart S, Illa M, Zanón G, Pahisa J, Rubí S, Velasco M, Santamaría G, Farrús B, Muñoz M, García Y, Fernández PL, Pons F.Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems. Breast J. 2010 Mar;16(2):134-40.
 
Santamaría G, Velasco M, Bargalló X, Caparrós X, Farrús B, Fernández PL. Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images. Radiographics 2010 ;30:533-48
 
Santamaría G, Velasco M,  Farrús B,  Caparrós FX  Fernández . Dynamic contrast-enhanced mri reveals the extent and the microvascular pattern of breast ductal carcinoma in situ . The Breast Journal (in press)
 
Sanz-Pamplona R, Aragüés R, Driouch K, Martín B, Oliva B, Gil M, Boluda S, Fernández PL, Martínez A, Moreno V, Acebes JJ, Lidereau R, Reyal F, Van de Vijver MJ, Sierra A. Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB2-positive and -negative primary breast tumors. Am J Pathol. 2011;179:564-79
 
Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD; International Peripheral T-Cell Lymphoma Project. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008 Jun 15;111(12):5496-504.
 
Scaggiante B., Bonin S. et al.: “Prostate Tumour-Inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection”. Cancer Investigation 26: 800-808; 2008.
 
Scaggiante B, Dapas B, Bonin S, Grassi M, Zennaro C, Farra R, et al. Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression. British journal of cancer. 2012;106(1):166-73.
 
Scheel SK, Porzner M, Pfeiffer S, Ormanns S, Kirchner T, Jung A. Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.  BMC Cancer. 2010 Aug 9;10:413.
 
Schildhaus HU, Mikuz G, Fisang C, Steiner S, Büttner R, Wardelmann E. [Malignant mixed Müllerian tumor of the urinary bladder.] Pathologe. 2008 Sep;29(5):375-8.
 
Schipf A, Mayr D, Kirchner T, Diebold J. Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study. Virchows Arch. 2008 Mar;452(3):259-68.
 
Schlick K, Aigelsreiter A, Pichler M, Reitter S, Neumeister P, Hoefler G, Beham-Schmid C, Linkesch W Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases. Onkologie. 2012; 35(7-8):447-450
 
Schoiswohl G, Schweiger M, Schreiber R, Gorkiewicz G, Preiss-Landl K, Taschler U, Zierler KA, Radner FP, Eichmann TO, Kienesberger PC, Eder S, Lass A, Haemmerle G, Alsted TJ, Kiens B, Hoefler G, Zechner R, Zimmermann R. Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids. J Lipid Res. 2010; 51(3):490-499[Fulltext][PubMed][Fulltext MUG-login] 2009 Originalarbeit (Zeitschrift)
 
Schraders M, Oeschger S, Kluin PM, Hebeda K, Schuuring E, Groenen PJ, Hansmann ML, van Krieken JH. Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol. 2009 Mar;22(3):416-25. Epub 2009 Jan 9. PMID: 19136929 [PubMed - in process]
 
Schraders M, Jares P, Bea S, Schoenmakers EF, van Krieken JH, Campo E, Groenen PJ. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. Br J Haematol. 2008 Oct;143(2):210-21. Epub 2008 Aug 10. PMID: 18699851 [PubMed - indexed for MEDLINE]
 
Schraders M., van Reijmersdal S.V., Kamping E.J., van Krieken J.H., van Kessel A.G., Groenen P.J., Hoogerbrugge P.M., Kuiper R.P. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genetics and Cytogenetics, 2009, 191(1), 27-33.
 
Schuller-Petrovic S, Wolkart G, Hofler G, Neuhold N, Freisinger F, Brunner F: Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer DERMATOL SURG. 2008; 34(4): 529-543. [Listed in ISI Web of Science]
 
Schuster C, Budczies J, Faber C, Kirchner T, Hlubek F. MicroRNA expression profiling of specific cells in complex archival tissue stained by immunohistochemistry. Lab Invest. 2011 Jan;91(1):157-65.
 
Schuster C, Malinowsky K, Liebmann S, Berg D, Wolff C, Tran K, Schott C, Reu S, Neumann J, Faber C, Höfler H, Kirchner T, Becker KF, Hlubek F. Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues. Histopathology. 2012 May;60(6B):E37-E50. doi: 10.1111/j.1365-2559.2012.04184.x.
 
Schuurhuis D.H., Verdijk P., Schreibelt G., Aarntzen E.H.J.G., Scharenborg N., de Boer A., van de Rakt M.W., Kerkhoff M., Gerritsen M.J., Eijckeler F., Bonenkamp J.J., Blokx W., van Krieken J.H., Boerman O.C., Oyen W.J.G., Punt C.J.A., Figdor C.G., Adema G.J., de Vries I.J.M. In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients. Cancer Research, 2009, 69(7), 2927-34.
 
Scupoli MT, Donadelli M, Cioffi F, Rossi M, Perbellini O, Malpeli G, Corbioli S, Vinante F, Krampera M, Palmieri M, Scarpa A, Ariola C, Foa R, Pizzolo G. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia trhourgh the CXCL 12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways. Haematologica, 93:524-532, 2008.
 
Senanayake U, Das S, Vesely P, Alzoughbi W, Fröhlich LF, Chowdhury P, Leuschner I, Hoefler G, Guertl B. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis. 2012; 33(5):1014-1021.
 
Serafini M, Jakszyn P, Luján-Barroso L, Agudo A, Bueno-de-Mesquita HB, van Duijnhoven FJ, Jenab M, Navarro C, Palli D, Boeing H, Wallström P, Regnér S, Numans ME, Carneiro F, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Grioni S, Panico S, Tumino R, Sacerdote C, Quirós JR, Molina-Montes E, Huerta Castaño JM, Barricarte A, Amiano P, Khaw KT, Wareham N, Allen NE, Key TJ, Jeurnink SM, Peeters PH, Bamia C, Valanou E, Trichopoulou A, Kaaks R, Lukanova A, Bergmann MM, Lindkvist B, Stenling R, Johansson I, Dahm CC, Overvad K, Jensen M, Olsen A, Tjonneland A, Lund E, Rinaldi S, Michaud D, Mouw T, Riboli E, González CA. Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study. Int J Cancer 2011 Nov 9. [Epub ahead of print]. doi: 10.1002/ijc.27347.
 
Sergi C, Mikuz G. External quality assurance as a revalidation method for pathologists in pediatric histopathology: Comparison of four international programs. BMC Clin Pathol. 2008 Nov 12;8:11.
 
Sgambato A, Camerini A, Collecchi P, Graziani C, Bevilacqua G, Capodanno A, Migaldi M, Masciullo V, Scambia G, Rossi G, Cittadini A, Amoroso D. Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy. Cancer Sci 100: 1026-1033, 2009
 
Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, Koswig S, Budach V, Schlag PM. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomized study of the Berlin Cancer Society. BMC Cancer. 2009 Feb 6;9:50.
 
Šimic G, Mladinov M, Šešo Simic D, Jovanov Miloševic N, Islam A, Pajtak A, Barišic N, Sertic J, Lucassen PJ, Hof PR, Krušlin B. Abnormal motoneuron migration, differentiation and axon overgrowth in spinal muscular atrophy. Acta Neuropathol 2008;115:313-26 (CC).
 
Simkens L, Tol J, Koopman M, Mol L, Antonini N, van Krieken H, Punt C. Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group. Clin Colorectal Cancer. 2008 Mar;7(2):105-9. Review. PMID: 18501069 [PubMed - indexed for MEDLINE]
 
Sinn BV, Darb-Esfahani S, Wirtz RM, Faggad A, Weichert W, Buckendahl AC, Noske A, Müller BM, Budczies J, Sehouli J, Braicu EI, Dietel M, Denkert C. Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue. Virchows Arch. 2009 Dec;455(6):461-7. Epub 2009 Nov 13.PMID: 19911196
 
Sinn BV, Darb-Esfahani S, Wirtz RM, Budczies J, Sehouli J, Chekerov R, Dietel M, Denkert C. Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue. Histopathology. 2011 Nov;59(5):918-27. doi: 10.1111/j.1365-2559.2011.04028.x.
 
Šitic S, Mirt Dabic M, Brcic L, Juroš Z, Hutinec Z, Krušlin B. DNA ploidy in thymoma and associated multiple primary malignancies in the same patient. Acta clin Croat 2008;47:155-9 (EM)
 
Skaland I, Janssen EA, Gudlaugsson E, Hui Ru Guo L, Baak JP. The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer. Cell Oncol. 2009;31(4):261-71.
 
Skaland I, Janssen EA, Gudlaugsson E, Klos J, Kjellevold KH, Søiland H, Baak JP. Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age. Breast Cancer Res Treat. 2009 Mar;114(1):39-45. Epub 2008 Mar 29.
 
Skaland I, Nordhus M, Gudlaugsson E, Klos J, Kjellevold KH, Janssen EA, Baak JP. Evaluation of 5 different labeled polymer immunohistochemical detection systems. Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):90-6
 
Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncol. 2009;48(4):514-21.
 
Soler M, Mancini F, Meca-Cortés O, Sánchez-Cid L, Rubio N, López-Fernández S, Lozano JJ, Blanco J, Fernández PL, Thomson TM.HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells. Int J Cancer. 2009 ;125:2565-75
 
Sopel M, Surowiak P, Berdowska I. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. Folia Morphol (Warsz). 2010;69(4):204-12.
 
Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, Kirchner T, Behrens J, Brabletz T. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 2008 Jan 15;68(2):537-44.
 
Spajic B, Cupic H, TomasD, Stimac G, Kruslin B, Kraus O. “The incidence of hyperechoic prostate cancer in transrectal guided biopsy specimens”. Urology 2007;70:734-7.
 
Spajic B, Grubisic I, Spajic M, Marusic Z, Demirovic A, Mijic A, Kruslin B, Tomas D. Synchronous rectal adenocarcinoma and bilateral clear cell renal carcinoma. Acta Clin Croat. 2010 Jun;49(2):169-72.
 
Specht K, Harbeck N, Smida J, Annecke K, Reich U, Nährig J, Langer R, Mages J, Busch R, Kruse E, Klein-Hitpass L, Schmitt M, Kiechle M, Höfler H. Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy. Breast Cancer Res Treat. 2008 Oct 17. [Epub ahead of print]
 
Speetjens FM, de Bruin EC, Morreau H, Zeestraten EC, Putter H, van Krieken JH, van Buren MM, van Velzen M, Dekker-Ensink NG, van de Velde CJ, Kuppen PJ. Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother. 2008 May;57(5):601-9. Epub 2007 Sep 15. PMID: 17874100 [PubMed - indexed for MEDLINE]
 
Štabuc-Šilih M., Ravnik-Glavac M., Glavac D., Hawlina M., Stražišar M. Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. Mol. vis., 2009, letn. 15, str. 2848-2860. ISSN 1090-0535
 
Štabuc-Šilih M., Stražišar M., Hawlina M., Glavac D. Absence of pathogenic mutations in VSX1 and SOD1 genes in patients with keratoconus. Cornea, 2010, letn. 29, št. 2, str. 172-176. ISSN 0277-3740
 
Stadler TC, Jung A, Schlenker B, Nuhn P, Ellinger J, Kirchner T, Stief CG, Bastian PJ. [Pyrosequencing in uro-oncology: applications in prostate cancer]. Urologe A. 2010 Nov;49(11):1356-64. German.
 
Stanic G, Cupic H, Žarkovic K, Tomas D, Krušlin B. C-myc expression in the microvessels of medulloblastomas. Coll Antropol 2011;35:39-42 (CC)
 
Stanta G., Cescato A., Bonin S., Barbazza R.: “Bioethics considerations for medical research in human archive tissues: the point of view of the researcher.” Virchows Arch 2008, June 13 Epub
 
Stanta G, Cescato A., Barbazza R “Bioethical considerations on medical research using human tissues: the researcher’s viewpoint” Pathologica 100:72-75;2008
 
Stanta G, Bonin S, Machado I and Llombart-Bosch A. Models of Biobanking and Tissue Preservation: RNA Quality in Archival Samples in Pathology Laboratories and ‘‘In Vivo Biobanking’’ by Tumor Xenografts in Nude Mice— Two Models of Quality Assurance in Pathology. Biopreservation and Biobanking. 9(2): 149-155; 2011 doi:10.1089/bio.2011.0010.
 
Stanta G (editor), Guidelines for Molecular Analysis in Archive Tissues, Springer Verlag, Berlin, Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-17890-0
 
Stacher, E; Gruber-Mösenbacher, U; Halbwedl, I; Tos, AP; Cavazza, A; Papotti, M; Carvalho, L; Huber, M; Ermert, L; Popper, HH.: The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: New potential therapeutic targets? Lung Cancer. 2008; [Fulltext] [PubMed] [Fulltext MUG-login]
 
Steinbakk A, Malpica A, Slewa A, Skaland I, Gudlaugsson E, Janssen EA, Løvslett K, Fiane B, Kruse AJ, Feng W, Yinhua Y, Baak JP. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma. Mod Pathol. 2011 Sep;24(9):1262-71.
 
Steinbakk A, Malpica A, Slewa A, Gudlaugsson E, Janssen EA, Arends M, Kruse AJ, Yinhua Y, Feng W, Baak JP. High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases. Cell Oncol (Dordr). 2011 Oct;34(5):457-65.
 
Steinbakk A, Gudlaugsson E, Aasprong OG, Skaland I, Malpica A, Feng W, Janssen EA, Baak JP. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am J Obstet Gynecol. 2011 Apr;204(4):357.e1-12.
 
Steiner H, Bergmeister M, Verdorfer I, Granig T, Mikuz G, Bartsch G, Stoehr B, Brunner A. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int. 2008 Aug;102(3):291-6. Epub 2008 Mar 11.
 
Steinmuller T, Kianmanesh R, Falconi M, Scarpa A, Taal B, Kwekkeboom DJ, Lopes JM, Perren A, Nikou G, Yao J, Delle Fave GF, O’TooleD. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology, 87:47-62, 2008.
 
Stenzinger A, von Winterfeld M, Aulmann S, Warth A, Weichert W, Denkert C, Rüschoff J, Dietel M, Klauschen F. Quantitative Analysis of Diagnostic Guidelines for HER2-Status Assessment. J Mol Diagn. 2012 May;14(3):199-205.
 
Stenzinger A, Wittschieber D, von Winterfeld M, Goeppert B, Kamphues C, Weichert W, Dietel M, Rabien A, Klauschen F. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer. Hum Pathol. 2012 Mar 12. [Epub ahead of print]
 
Stenzinger A, von Winterfeld M, Rabien A, Warth A, Kamphues C, Dietel M, Weichert W, Klauschen F, Wittschieber D. Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer. Hum Pathol. 2012 Mar 5. [Epub ahead of print]
 
Sterlacci W, Veits L, Moser P, Steiner HJ, Rüscher S, Jamnig H, Mikuz G. Idiopathic Systemic Anyloidosis Primarily Affecting the Lungs with Fatal Pulmonary Haemorrhage due to Vascular Involvement. Pathol Oncol Res. 2008 Jun 14. [Epub ahead of print]
 
Štimac G, Katušic J, Sucic M, Ledinsky M, Krušlin B, Trnski D. A giant hemorrhagic adrenal pseudocyst: case report and review of the literature. Med Princ Pract 2008;17:419-21 (CC)
 
Štimac G, Dimanovski J, Spajic B, Babic N, Krušlin B, Kraus O. Seminal vesicle cyst with ectopic ureteral insertion and ipsilateral renal dysplasia – an unexpected diagnosis. Acta clin Croat 2008;47:101-4. (EM)
 
Stintzing S, Heinemann V, Moosmann N, Hiddemann W, Jung A, Kirchner T. The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status. Dtsch Arztebl Int. 2009 Mar;106(12):202-6. Epub 2009 Mar 20. Review. PubMed PMID: 19471640; PubMed Central PMCID: PMC2680580.
 
Stražišar M, Rott T, Glavac D. K-RAS and P53 mutations in association with COX-2 and hTERT expression and clinic-pathological status of NSCLC patients. Dis Markers. 2008;25(2):97-106.
 
Stražišar M, Rott T, Glavac D. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer. Lung Cancer. 2009 Mar;63(3):354-9. ISSN 0169-5002
 
Stražišar M., Mlakar V., Glavac D. LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma. Lung cancer. [Print ed.], 2009; 64 (3): 257-262. ISSN 0169-5002
 
Stražišar M., Mlakar V., Rott T., Glavac D. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous Cell (SCC) and large cell (LCC) lung carcinoma. Cancer investig., 2009; 27(4): 407-416. ISSN 0735-7907
 
Stražišar M., Mlakar V., Glavac D. The expression of Cox-2, hTERT, MDM2, LATS2 and S100A2 in different types ofnon-small cell lung cancer (NSCLC). Cell. Mol. Biol. Lett., 2009; 14 (3): 442-456. ISSN 1425-8153
 
Strojan P, Oblak I, Gale N, Smid L, Kos J. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study. Histopathology. 2008 Nov;53(5):612-4.  
 
Subramanian MM, Noguera R , Piqueras M, Navarro S, Carda C, Pellin A, Lopez Guerrero JA, Llombart Bosch A, “Evaluation of genetic stability of the SYT gene rearrangement by break-apart FISH in primary and xenotransplanted synovial sarcomas”. Cancer Genet Cytogenet 172(1): 23-28, 2007.
 
Subramaniam M, Lazar N, Navarro S, Perbal B, Llombart-Bosch A. “Expression of CCN3 protein in human Wilm´s tumors: Immunohistochemical detection of CCN3 variants using domain-specific antibodies”. Virchovs Arch 452:33-39 , 2007
 
Subramaniam MM, Piqueras M, Navarro S, Noguera R. Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas. Hum Pathol. 2009 Nov;40(11):1638-42.
 
Surowiak P, Materna V, Maciejczyk A, Pudelko M, Suchocki S, Kedzia W, Nowak-Markwitz E, Dumanska M, Spaczynski M, Zabel M, Dietel M, Lage H. Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor.Histol Histopathol. 2008 May;23(5):531-8.
 
Surowiak P, Pawelczyk K, Maciejczyk A, Pudelko M, Kolodziej J, Zabel M, Murawa D, Drag M, Gansukh T, Dietel M, Lage H. Positive correlation between cyclooxygenase 2 and the expression of ABC transporters in non-small cell lung cancer.Anticancer Res. 2008 Sep-Oct;28(5B):2967-74.
 
Surowiak P. Mezoterapia versus osocze bogatoplytkowe. Acad.Aesthet.Anti-Aging Med. 2011 nr 2; s.7-10
 
Šverko A, Tripalo-Batoš A, Marotti M, Mustapic M, Bekavac Bešlin M, Krušlin B. Correlation between magnetic resinance imaging and histopathology in differentiation of pancreatic diseases. Acta clin Croat 2011;50:137.44 (IM, SCI)
 
Szczuraszek K, Mazur G, Jelen M, Dziegiel P, Surowiak P, Zabel M.Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.Anticancer Res. 2008 Mar-Apr;28(2A):1113-8.
 
Szczuraszek K, Materna V, Halon A, Mazur G, Wróbel T, Kuliczkowski K, Maciejczyk A, Zabel M, Drag M, Dietel M, Lage H, Surowiak P. Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin’s lymphomas. Oncol Rep. 2009 Dec;22(6):1315-23.PMID: 19885582
 
Szczuraszek K, Halon A, Materna V, Mazur G, Wrobel T, Kuliczkowski K, Donizy P, Holm PS, Lage H, Surowiak P. Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas. Anticancer Res. 2011 Sep;31(9):2963-70.
 
Tamilarasan KP, Temmel H, Das SK, Al Zoughbi W, Schauer S, Vesely PW, Hoefler G (2012) Skeletal muscle damage and impaired regeneration due to LPL-mediated lipotoxicity. Cell Death Dis. 2012; 3(17):e354-e354
 
Tavano F, Bonin S, Pinato G, Stanta G and Cojoc D. Custom-built optical tweezers for locally probing the viscoelastic properties of cancer cells. International Journal of Optomechatronics 2011;5(3):234.
 
Tejpar S, Bertagnolli M, Bosman F, Lenz HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D, Hahn H, Harkin DP, Kennedy R, Ilyas M, Morreau H, Proutski V, Swanton C, Tomlinson I, Delorenzi M, Fiocca R, Van Cutsem E, Roth A. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist. 2010;15:390-404.
 
Theodosiou Z., Kasampalidis I., Karayannopoulou G., Kostopoulos I., Bobos M., Bevilacqua G., Aretini P., Starita A., Lyroudia K., Pitas I.: Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. Breast 17: 80-84, 2008
 
Thiel C, Kessler K, Giessl A, Dimmler A, Shalev SA, von der Haar S, Zenker M, Zahnleiter D, Stöss H, Beinder E, Abou Jamra R, Ekici AB, Schröder-Kress N, Aigner T, Kirchner T, Reis A, Brandstätter JH, Rauch A. NEK1 mutations cause short-rib polydactyly syndrome type majewski. Am J Hum Genet. 2011 Jan 7;88(1):106-14.
 
Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, Erdkamp FL, Vos AH, van Groeningen CJ, Sinnige HA, Richel DJ, Voest EE, Dijkstra JR, Vink-Börger ME, Antonini NF, Mol L, van Krieken JH, Dalesio O, Punt CJ. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009 Feb 5;360(6):563-72. PMID: 19196673 [PubMed - indexed for MEDLINE]
 
Tol J, Cats A, Mol L, Koopman M, Bos MM, van der Hoeven JJ, Antonini NF, van Krieken JH, Punt CJ. Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation. Invest New Drugs. 2008 Aug;26(4):393-7. Epub 2008 Mar 12. PMID: 18335169 [PubMed - indexed for MEDLINE]
 
Tol J, Dijkstra JR, Klomp M, Teerenstra S, Dommerholt M, Vink-Börger ME, van Cleef PH, van Krieken JH, Punt CJ, Nagtegaal ID. Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. Eur J Cancer. 2010 Jul;46(11):1997-2009. Epub 2010 Apr 21.
 
Tomas D, Bujas T, Stajduhar E, Kirac P, Mijic A, Kruslin B. “Malignant phyllodes tumor with associated osteosarcomatous, chondrosarcomatous, and liposarcomatous overgrowth”. APMIS 2007;115:367-70.
 
Tomas D, Vucic M, Šitum M, Krušlin B. The expression of syndecan-1 in psoriatic epidermis. Arch Dermatol Res 2008;300:393-5 (CC)
 
Tomas D, Franjic DB, Mijic A, Krušlin B. Malignant peripheral nerve sheath tumor with numerous signet-ring and lipoblast-like cells. J Cut Pathol 2009;36:77-9 (CC)
 
Tomas D, Jankovic D, Franceschi A, Mijic A, Krušlin B. Low-grade periductal stromal sarcoma of the breast with myxoid features: an immunohistochemical study. Pathol Int 2009;59:588-91 (CC)
 
Tomas D, Lenicek T, Tuckar N, Puljiz Z, Ledinsky M, Krušlin B. Primary ovarian leiomyoma associated with endometriotic cyst presenting with symptoms of acute appendicitis: a case report. Diagn Pathol 2009;4:25. (CC)
 
Tomas D, Spajic B, Milosevic M, Demirovic A, Marusic Z, Kruslin B. Intensity of stromal changes predicts biochemical recurrence-free survival in prostatic carcinoma. Scand J Urol Nephrol. 2010 Nov;44(5):284-90.
 
Tomas D, Spajic B, Miloševic M, Demirovic A, Marušic Z, Krušlin B. Extensive retraction artefact predicts biochemical recurrence-free survival in prostatic carcinoma. Histopathology 2011;58:447-54 (CC)
 
Tomic K, Mladinov D, Batelja-Vuletic L, Spajic B, Mijic A, Tomas D, Belicza M, Kruslin B. “Morphometric analysis of renal arteries in patients with renal cell carcinoma“. Pathol Res Pract 2007;203:647-52.
 
Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannagé-Yared MH, Bedossa P, Paradis V. Serum proteomic profiling of obese patients: correlation with pathology and evolution after bariatric surgery. Gut. 2008 Apr 10. [Epub ahead of print]
 
Trbušic M, Riederer M, Vucic M, Lovricevic I, Krušlin B, Gauster M, Mohrenz S, Berghold A, Tiran B, Degoricija V, Frank S. Increased expression of endothelial lipase in symptomatic and unstable carotid plaques. J Neurol 2012;259:448-56 (CC).
 
Trevisan G, Padovan C, Scaini MT, Cinco M, Floris R, Bonin S. Anetoderma associated with lyme disease: a case report. Acta Derm Venereol. 88(5):536-8; 2008.
 
Trindade E, Pissarra S, Carneiro F, Amil Dias J: Esofagite eosinofílica: causa de disfagia persistente. ENDOnews 22:11-12, 2008.
 
Turbiner J, Moreno-Bueno G, Dahiya S, Sanches-Estevez C, Hardisson D, Prat J, Oliva E, Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen. Mod Pathol 2008; 21:925-936.
 
Ulamec M, Stimac G, Kraus O, Kruslin B.“Bilateral renal cell carcinoma and concomitant urothelial carcinoma of the renal pelvis and ureter: case report“ Lijec Vjesn 2007;129:70-3.
 
Ulamec M, Tomas D, Ensinger C, Cupic H, Belicza M, Mikuz G, Kruslin B. “Periacinar retraction clefting in proliferative prostatic atrophy and prostatic carcinoma“. J Clin Pathol 2007;60:1098-1101.
 
Ulamec M, Soldo-Belic A, Vucic M, Buljan M, Krušlin B, Tomas D. Melanoma with second myxoid stromal changes after personally applied prolonged phototherapy. Am J Dermatopathol 2008;30:185-7 (CC)
 
Ulamec M, Tomas D, Peric-Balja M, Spajic B, Hes O, Krušlin B. Neuroendocrine breast carcinoma metastatic to renal cell carcinoma and ipsilateral adrenal gland. Pathol Res Pract 2008;204:851-5 (CC)
 
Ulamec M, Tomaškovic I, Murgic J, Krušlin B. Leiomiomatozni karcinom bubrežnih stanica: prikaz bolesnika. Lijec Vjesn 2011;133:190-3 (IM)
 
Uleberg KE, Munk AC, Brede C, Gudlaugsson E, van Diermen B, Skaland I, Malpica A, Janssen EA, Hjelle A, Baak JP. Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies. Proteome Sci. 2011 Jun 28;9:36.
 
Uleberg KE, Munk AC, Skaland I, Furlan C, van Diermen B, Gudlaugsson E, Janssen EA, Malpica A, Feng W, Hjelle A, Baak JP. A protein profile study to discriminate CIN lesions from normal cervical epithelium. Cell Oncol (Dordr). 2011 Oct;34(5):443-50.
  
Valbuena A, Suárez-Gauthier A, López-Rios F, López-Encuentra A, Blanco S, Fernández PL, Sánchez-Céspedes M, Lazo PA. “Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas”. Lung Cancer58:303-9, 2007.
 
Valbuena C, Carvalho E, Bustorff M, Ganhão M, Relvas S, Nogueira R, Carneiro F, Paulo Oliveira J: Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Archiv, 454:721-722, 2009. doi: 10.1007/s00428-009-0779-x.
 
Valbuena C, Oliveira JP, Carneiro F, Relvas S, Ganhão M, Sá-Miranda MC, Rodrigues LG. Kidney histologic alterations in α-Galactosidase-deficient mice. Virchows Arch 458:477-486, 2011.
 
Valbuena C, Leitão D, Carneiro F, Oliveira JP. Immunohistochemical diagnosis of Fabry nephropathy and localization of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections. Virchows Archiv 460:211-221, 2012. doi: 10.1007/s00428-011-1182-y.
 
Valente IM, Lima R, Carvalho C, Ferreira H, Marcelino F, Mota C, Ramos A, Duarte C, Carneiro F, Pereira F, Rocha H. Diarreia Intratável: doença de inclusão das microvilosidades num recém-nascido. Jornal Português de Gastrenterologia 18: 298-302, 2011.
 
van Bon AC, Kristinsson JO, van Krieken JH, Wanten GJ. Concurrent Splenic Peliosis and Vascular Ehlers-Danlos Syndrome: A Case Report. Ann Vasc Surg. 2008 Sep 18. [Epub ahead of print] PMID: 18804950 [PubMed - as supplied by publisher]
 
van der Post RS, Kets CM, Ligtenberg MJ, van Krieken JH, Hoogerbrugge N. Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis. Virchows Arch. 2009 Jan;454(1):25-9. Epub 2008 Nov 25. PMID: 19031083 [PubMed - in process]
 
van Herpen CM, van der Voort R, van der Laak JA, Klasen IS, de Graaf AO, van Kempen LC, de Vries IJ, Boer TD, Dolstra H, Torensma R, van Krieken JH, Adema GJ, De Mulder PH. Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation. Int J Cancer. 2008 Nov 15;123(10):2354-61. PMID: 18729197 [PubMed - indexed for MEDLINE]
 
van Krieken JH, Jung A, Kirchner T, Carneiro F, Seruca R, Bosman FT, Quirke P, Fléjou JF, Plato Hansen T, de Hertogh G, Jares P, Langner C, Hoefler G, Ligtenberg M, Tiniakos D, Tejpar S, Bevilacqua G, Ensari A. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch. 2008 Nov;453(5):417-31. Epub 2008 Sep 18. Review. PMID: 18802721 [PubMed - indexed for MEDLINE]
 
van Krieken JH, Jung A, Kirchner T, Carneiro F, Seruca R, Bosman FT, Quirke P, Fléjou JF, Hansen TP, de Hertogh G, Jares P, Langner C, Hoefler G, Ligtenberg M, Tiniakos D, Tejpar S, Bevilacqua G, Ensari A. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for a European quality assurance program. Virchows Archiv, 454:233-235, 2009. doi: 10.1007/s00428-008-0712-8.
 
van Krieken H, Tol J. Setting future standards for KRAS testing in colorectal cancer. Pharmacogenomics. 2009, 10(1), 1-3.  
 
van Krieken J.H. The 2008 WHO-classification: small and big changes! Journal of Hematopathology, 2009, 2(2), 63-63.
 
van Krieken JH, Jansen C, Hebeda KM, Groenen PJ. Biomarkers as disease definition: mantle cell lymphoma as an example. Proteomics Clin Appl. 2010 Dec;4(12):922-5.
 
van Krieken JH, Ligtenberg MJ, Groenen PJ. Molecular pathology in contemporary diagnostic pathology laboratory. Am J Surg Pathol. 2010 May;34(5):e14.
 
van Krieken JH, Hoefler G. The times have changed: molecular pathology is here to stay : A commentary on: Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma, by Lee et al. In this issue. Virchows Arch. 2012; 460(2):129-130.
 
van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008 Jul;135(1):82-90. Epub 2008 Mar 25. PMID: 18482589 [PubMed - indexed for MEDLINE]
 
van Speybroeck D, van Krieken J, van Daal W, Ruiter D. Memento of the post-mortem. J Pathol. 2008 Jun;215(2):103-7. PMID: 18446755 [PubMed - indexed for MEDLINE]
 
Vannucci L, Chiuppesi F, di Martino F, Caligo MA, Bevilacqua G, Pistello M. Feline immunodeficiency virus vector as a tool for preventative strategies against human breast cancer. Vet Immunol Immunopathol 134: 132-137, 2010
 
Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C Seruca R: BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 8:255, 2008. doi:10.1007/s00428-008-0653-2.
 
Velho S, Oliveira C, Paredes J, Sousa S, Leite M, Matos P, Milanezi F, Ribeiro AS, Mendes N, Licastro D, Karhu A, Oliveira MJ, Ligtenberg M, Hamelin R, Carneiro F, Lindblom A, Peltomaki P, Castedo S, Schwartz Jr S, Jordan P, Aaltonen LA, Hofstra R, Suriano G, Stupka E, Fialho AS, Seruca R. Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours. Human Molecular Genetics 19:697-706, 2010. doi: 10.1093/hmg/ddp536.
 
Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, Swerts K, Bravo S, Scaruffi P, Tonini GP, De Bernardi B, Noguera R, Piqueras M, Cañete A, Castel V, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Michon J, Combaret V, Fischer M, Oberthuer A, Ambros PF, Beiske K, Bénard J, Marques B, Rubie H, Kohler J, Pötschger U, Ladenstein R, Hogarty MD, McGrady P, London WB, Laureys G, Speleman F, Vandesompele J. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol. 2009 Jul;10(7):663-71. Epub 2009 Jun 8.
 
Vesely PW, Staber PB, Höfler G, Kenner L: Translational regulation mechanisms of AP-1 proteins. Mutat Res. 2009; [Fulltext] [PubMed] [Fulltext MUG-login]
 
Viacava P., Bocci G., Tonacchera M., Fanelli G., De Servi M., Agretti P., Berti E., Goletti O., Aretini P., Resta M., Bevilacqua G., Naccarato A.: “Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules”. Thyroid. 2007 Mar;17(3):191-7. PMID: 17381350 [PubMed - indexed for MEDLINE]
 
Vilarinho S, Guimarães NM, Ferreira RM, Gomes B, Wen X, Vieira MJ, Carneiro F, Godinho T, Figueiredo C. Helicobacter pylori colonization of the adenotonsillar tissue: Fact or fiction? International Journal of Pediatric Otorhinolaryngology 74:807-811, 2010. doi: 10.1016/j.ijporl.2010.04.007.
 
Villamón E, Piqueras M, Mackintosh C, Alonso J, De Alava E, Navarro S, Noguera R. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma. Virchows Arch. 453(1): 47-55, 2008
 
Villamón E, Piqueras M, Navarro S, Noguera R. The use of MLPA for cytogenetic diagnosis in neuroblastoma tumours. Volumen ISBN 978-88-7587-447-6. CD ISBN 978-88-7587-448-3. Editores: J Bombí, J Ordi, T Ribalta, J Ramirez. Ed. MEDIMOND Srl International Proce edings, Bologna, Italy, 2008
 
Villamón E, Piqueras M, Berbegall AP, Tadeo I, Castel V, Navarro S, Noguera R. Comparative study of MLPA-FISH to determine DNA copy number alterations in neuroblastic tumors. Histol Histopathol. 2011 Mar;26(3):343-50.
 
Vladusic T, Hrascan R, Vrhovac I, Kruslin B, Gamulin M, Grgic M, Pecina-Slaus N, Franekic Colic J. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors. Pathol Res Pract. 2010 Mar 15;206(3):163-7.
 
Voland P, Besig S, Rad R, Braun T, Baur DM, Perren A, Langer R, Höfler H, Prinz C. Correlation of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinase Expression in Ileal Carcinoids, Lymph Nodes and Liver Metastasis with Prognosis and Survival. Neuroendocrinology. 2009;89(1):66-78.
 
Volante M, Rapa I, Gandhi M, Bussolati G, Giachino D, Papotti M, Nikiforov YE. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab. 2009 Dec;94(12):4735-41. Epub 2009 Oct 16. PubMed PMID: 19837916.
 
von Minckwitz G, Müller BM, Loibl S, Budczies J, Hanusch C, Darb-Esfahani S, Hilfrich J, Weiss E, Huober J, Blohmer JU, du Bois A, Zahm DM, Khandan F, Hoffmann G, Gerber B, Eidtmann H, Fend F, Dietel M, Mehta K, Denkert C. Cytoplasmatic poly(adenosine diphosphate –ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol. 2011 Jun 1;29(16):2150-7. Epub 2011 Apr 25.
 
Vranic S, Bilalovic N, Lee LM, Kruslin B, Lilleberg SL, Gatalica Z.“PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney“. Hum Pathol 2007;38:1425-31.
 
Vucic M, Cupic H, Tomic K, Kruslin B.“An unusual pattern of pseudoepitheliomatous hyperplasia associated with cutaneous primary melanoma: report of two cases with analysis of p53 and bcl-2 immunoreactivity“. Acta Dermatovenerol Croat. 2007;15:72-5.
 
Vucic M, Tomas D, Zovak M, Mijic A, Krušlin B. “Retroperitoneal peripancreatic bronhogenic cyst mimicking panreatic cystic tumor“. Acta Clin Croat 2007;46:171-174.
 
Vucicevic Ž, Jajic Bencic I, Krušlin B, Degoricija V. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult. J Microbiol Immunol Infect 2008;41:351-4.
 
Waanders E, Van Krieken JH, Lameris AL, Drenth JP. Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease. Mod Pathol. 2008 Nov;21(11):1293-302. Epub 2008 Jun 27. PMID: 18587325 [PubMed - indexed for MEDLINE]
 
Waanders E, Croes HJ, Maass CN, te Morsche RH, van Geffen HJ, van Krieken JH, Fransen JA, Drenth JP. Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p. Histochem Cell Biol. 2008 Mar;129(3):301-10. Epub 2008 Jan 26. PMID: 18224332 [PubMed - indexed for MEDLINE]
 
Walch A, Seidl S, Hermannstädter C, Rauser S, Deplazes J, Langer R, von Weyhern CH, Sarbia M, Busch R, Feith M, Gillen S, Höfler H, Luber B. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer. Mod Pathol. 2008 May;21(5):544-52.
 
Walch A, Rauser S, Deininger SO, Höfler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol. 2008 Sep;130(3):421-34.
 
Walther W, Siegel R, Kobelt D, Knösel T, Dietel M, Bembenek A, Aumann J, Schleef M, Baier R, Stein U, Schlag PM. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer. Clin Cancer Res. 2008 Nov 15;14(22):7545-53.
 
Warth A, Penzel R, Brandt R, Sers C, Fischer JR, Thomas M, Herth FJ, Dietel M, Schirmacher P, Bläker H. Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies. Virchows Arch. 2012 Apr;460(4):407-14. Epub 2012 Mar 15.
 
Wassermann S, Scheel SK, Hiendlmeyer E, Palmqvist R, Horst D, Hlubek F, Haynl A, Kriegl L, Reu S, Merkel S, Brabletz T, Kirchner T, Jung A. p16(INK4a) Is a beta-Catenin Target Gene and Indicates Low Survival in Human Colorectal Tumors. Gastroenterology. 2009;136(1):196-205.
 
Weichert W, Schewe C, Denkert C, Morawietz L, Dietel M, Petersen I. Molecular HPV Typing as a Diagnostic Tool to Discriminate Primary From Metastatic Squamous Cell Carcinoma of the Lung. Am J Surg Pathol. 2009 Jan 13. [Epub ahead of print]
 
Weichert W, Denkert C, Noske A, Darb-Esfahani S, Dietel M, Kalloger SE, Huntsman DG, Köbel M. Expression of calss I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas. Neoplasia. 2008 Sep;10(9):1021-7.
 
Weichert W, Röske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res. 2008 Mar 15;14(6):1669-77.
 
Weichert W, Schewe C, Lehmann A, Sers C, Denkert C, Budczies J, Stenzinger A, Joos H, Landt O, Heiser V, Röcken C, Dietel M. KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology. J Mol Diagn. 2010 Jan;12(1):35-42. Epub 2009 Dec 10.PMID: 20007841
 
Weiler C, Reu S, Zengel P, Kirchner T, Ihrler S. Obligate basal cell component in salivary oncocytoma facilitates distinction from acinic cell carcinoma. Pathol Res Pract. 2009;205(12):838-42. Epub 2009 Jul 30. PubMed PMID: 19646823.
 
Wiech T, Nikolopoulos E, Weis R, Langer R, Bartholomé K, Timmer J, Walch AK, Höfler H, Werner M. Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. Lab Invest. 2008 Jul 28. [Epub ahead of print]
 
Willers IM, Isidoro A, Ortega AD, Fernández PL, Cuezva JM. Selective inhibition of-F1-ATPase mRNA translation in human tumors. Biochem J 2010 426:319-26.
 
Williamson CT, Muzik H, Turhan AG, Zamò A, O'Connor MJ, Bebb DG, Lees-Miller SP. ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors. Mol Cancer Ther. 2010 Feb;9(2):347-57. Epub 2010 Feb 2.PMID: 20124459
 
Wolff C, Malinowsky K, Berg D, Schragner K, Schuster T, Walch A, Bronger H, Höfler H, Becker KF. Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis. J Pathol 2011; 223: 54–63. IF 6.4
 
Wolff C, Schott C, Porschewski P, Reischauer B, Becker K-F (2011) Successful Protein Extraction from Over-Fixed and Long-Term Stored Formalin-Fixed Tissues. PLoS One 6(1): e16353. doi:10.1371/journal.pone.0016353. IF 4.4
 
Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P, Shulkes A, Grimpen F, Clouston A, Moore D, Cullen D, Ormonde D, Mounkley D, Wen X, Lindor N, Carneiro F, Huntsman DG, Chenevix-Trench G, Suthers GK. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut 61:774-779, 2012. doi:10.1136/gutjnl-2011-300348.
 
Yáñez Y, Grau E, Oltra S, Cañete A, Martínez F, Orellana C, Noguera R, Palanca S, Castel V. Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma. J Cancer Res Clin Oncol. 2011 Aug;137(8):1263-72. Epub 2011 Jun 25.
 
Young KH, Leroy K, Moller MB, Colleoni GW, Sanchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, Campo E, Delabie J, Gascoyne RD, Rosenwald A, Rimsza L, Huang J, Braziel RM, Jaffe ES, Wilson WH, Staudt LM, Vose JM, Chan WC, Weisenburger DD, Greiner TC. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood. 2008;112(8):3088-98
 
Zamagni C, Wirtz RM, De Iaco P, Rosati M, Veltrup E, Rosati F, Capizzi E, Cacciari N, Alboni C, Bernardi A, Massari F, Quercia S, D'Errico Grigioni A, Dietel M, Sehouli J, Denkert C, Martoni AA. Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies. Endocr Relat Cancer. 2009 Dec;16(4):1241-9. Epub 2009 Sep 11.PMID: 19749010
 
Zamboni G, Capelli P, Scarpa A, Bogina G, Pesci A, Brunello E, Kloppel G. Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med, 133:439-453, 2009.
 
Zamò A, Bertolaso A, Franceschetti I, Weirich G, Capelli P, Pecori S, Chilosi M, Hoefler H, Menestrina F, Scarpa A.: “Microfluidic deletion/insertion analysis for rapid screening of KIT and PDGFRA mutations in CD117-positive gastrointestinal stromal tumors: diagnostic applications and report of a new KIT mutation”. J Mol Diagn. 2007 Apr;9(2):151-7. PMID: 17384206
 
Zamò A, Cecconi D. Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery. J Proteomics. 2010 Jan 3;73(3):508-20. Epub 2009 Sep 13.PMID: 19755177
 
Zamò A, Bertolaso A, van Raaij AW, Mancini F, Scardoni M, Montresor M, Menestrina F, van Krieken JH, Chilosi M, Groenen PJ, Scarpa A. Application of microfluidic technology to the BIOMED-2 protocol for detection of B-cell clonality. J Mol Diagn. 2012 Jan;14(1):30-7.
 
Zamuner M, Pozzi Mucelli S, Tormen M, Stanta G, Ugo P “Electrochemical Nanobiosensors and Protein Detection” Eur J Nanomedicine 1:33-36;2008
 
Zanotti R, Frattini F, Ghia P, Visco C, Zamò A, Perbellini O, Stella S, Facco M, Giaretta I, Chilosi M, Pizzolo G, Ambrosetti A. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients. Am J Hematol. 2010 Jul;85(7):494-8. PubMed PMID: 20575031.
 
Zebisch A, Haller M, Hiden K, Goebel T, Hoefler G, Troppmair J, Sill H Loss of RAF kinase inhibitor protein is a somatic event in thepathogenesis of therapy-related acute myeloid leukemias with C-RAFgermline mutations. Leukemia. 2009; 23(6):1049-1053[Fulltext][PubMed][Fulltext MUG-login] Übersichtsarbeit
 
Zhang H, Slewa A, Janssen E, Skaland I, Yu Y, Gudlaugsson E, Feng W, Kjellevold K, Søiland H, Baak JP. The Prognostic Value of the Orphan Nuclear Receptor DAX-1 (NROB1) in Node-negative Breast Cancer. Anticancer Res. 2011 Feb;31(2):443-9. PubMed PMID: 21378322.
 
Zidar N, Odar K, Glavac D, Jerše M, Zupanc T, Stajer D. Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med. 2008 Jul 24.
 
Zidar N, Gale N, Kojc N, Volavsek M, Cardesa A, Alos L, Höfler H, Blechschmidt K, Becker KF. Cadherin-catenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2008 Sep;453(3):267-74.
 
Zidar N, Gale N, Zupevc A, Zargi M. Salivary gland tumours as second neoplasms: two cases and literature review. J Laryngol Otol. 2009 Nov 19:1-4.